QUANTUM CORP /DE/00007092833/312025Q3False0.20.05http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#DerivativeLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#DerivativeLiabilitiesCurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureqtm:segmentqtm:region00007092832024-04-012024-12-3100007092832025-02-1100007092832024-12-3100007092832024-03-310000709283us-gaap:ProductMember2024-10-012024-12-310000709283us-gaap:ProductMember2023-10-012023-12-310000709283us-gaap:ProductMember2024-04-012024-12-310000709283us-gaap:ProductMember2023-04-012023-12-310000709283qtm:ServiceAndSubscriptionsMember2024-10-012024-12-310000709283qtm:ServiceAndSubscriptionsMember2023-10-012023-12-310000709283qtm:ServiceAndSubscriptionsMember2024-04-012024-12-310000709283qtm:ServiceAndSubscriptionsMember2023-04-012023-12-310000709283us-gaap:RoyaltyMember2024-10-012024-12-310000709283us-gaap:RoyaltyMember2023-10-012023-12-310000709283us-gaap:RoyaltyMember2024-04-012024-12-310000709283us-gaap:RoyaltyMember2023-04-012023-12-3100007092832024-10-012024-12-3100007092832023-10-012023-12-3100007092832023-04-012023-12-3100007092832023-03-3100007092832023-12-310000709283us-gaap:CommonStockMember2023-09-300000709283us-gaap:AdditionalPaidInCapitalMember2023-09-300000709283us-gaap:RetainedEarningsMember2023-09-300000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-3000007092832023-09-300000709283us-gaap:RetainedEarningsMember2023-10-012023-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-012023-12-310000709283us-gaap:CommonStockMember2023-10-012023-12-310000709283us-gaap:AdditionalPaidInCapitalMember2023-10-012023-12-310000709283us-gaap:CommonStockMember2023-12-310000709283us-gaap:AdditionalPaidInCapitalMember2023-12-310000709283us-gaap:RetainedEarningsMember2023-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310000709283us-gaap:CommonStockMember2024-09-300000709283us-gaap:AdditionalPaidInCapitalMember2024-09-300000709283us-gaap:RetainedEarningsMember2024-09-300000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-3000007092832024-09-300000709283us-gaap:RetainedEarningsMember2024-10-012024-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310000709283us-gaap:CommonStockMember2024-10-012024-12-310000709283us-gaap:AdditionalPaidInCapitalMember2024-10-012024-12-310000709283us-gaap:CommonStockMember2024-12-310000709283us-gaap:AdditionalPaidInCapitalMember2024-12-310000709283us-gaap:RetainedEarningsMember2024-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310000709283us-gaap:CommonStockMember2023-03-310000709283us-gaap:AdditionalPaidInCapitalMember2023-03-310000709283us-gaap:RetainedEarningsMember2023-03-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310000709283us-gaap:RetainedEarningsMember2023-04-012023-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-12-310000709283us-gaap:CommonStockMember2023-04-012023-12-310000709283us-gaap:AdditionalPaidInCapitalMember2023-04-012023-12-310000709283us-gaap:CommonStockMember2024-03-310000709283us-gaap:AdditionalPaidInCapitalMember2024-03-310000709283us-gaap:RetainedEarningsMember2024-03-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310000709283us-gaap:RetainedEarningsMember2024-04-012024-12-310000709283us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-12-310000709283us-gaap:CommonStockMember2024-04-012024-12-310000709283us-gaap:AdditionalPaidInCapitalMember2024-04-012024-12-3100007092832024-08-1500007092832024-08-2500007092832024-08-260000709283us-gaap:SubsequentEventMemberqtm:StandbyEquityPurchaseAgreementMembersrt:MaximumMember2025-01-252025-01-250000709283us-gaap:SubsequentEventMemberqtm:StandbyEquityPurchaseAgreementMember2025-01-252025-01-250000709283srt:MinimumMember2024-08-152024-08-150000709283srt:MaximumMember2024-08-152024-08-150000709283srt:AmericasMemberus-gaap:ProductMember2024-10-012024-12-310000709283srt:AmericasMemberus-gaap:ProductMember2023-10-012023-12-310000709283srt:AmericasMemberus-gaap:ProductMember2024-04-012024-12-310000709283srt:AmericasMemberus-gaap:ProductMember2023-04-012023-12-310000709283srt:AmericasMemberqtm:ServiceAndSubscriptionsMember2024-10-012024-12-310000709283srt:AmericasMemberqtm:ServiceAndSubscriptionsMember2023-10-012023-12-310000709283srt:AmericasMemberqtm:ServiceAndSubscriptionsMember2024-04-012024-12-310000709283srt:AmericasMemberqtm:ServiceAndSubscriptionsMember2023-04-012023-12-310000709283srt:AmericasMember2024-10-012024-12-310000709283srt:AmericasMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283srt:AmericasMember2023-10-012023-12-310000709283srt:AmericasMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283srt:AmericasMember2024-04-012024-12-310000709283srt:AmericasMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283srt:AmericasMember2023-04-012023-12-310000709283srt:AmericasMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283srt:EuropeMemberus-gaap:ProductMember2024-10-012024-12-310000709283srt:EuropeMemberus-gaap:ProductMember2023-10-012023-12-310000709283srt:EuropeMemberus-gaap:ProductMember2024-04-012024-12-310000709283srt:EuropeMemberus-gaap:ProductMember2023-04-012023-12-310000709283srt:EuropeMemberqtm:ServiceAndSubscriptionsMember2024-10-012024-12-310000709283srt:EuropeMemberqtm:ServiceAndSubscriptionsMember2023-10-012023-12-310000709283srt:EuropeMemberqtm:ServiceAndSubscriptionsMember2024-04-012024-12-310000709283srt:EuropeMemberqtm:ServiceAndSubscriptionsMember2023-04-012023-12-310000709283srt:EuropeMember2024-10-012024-12-310000709283srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283srt:EuropeMember2023-10-012023-12-310000709283srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283srt:EuropeMember2024-04-012024-12-310000709283srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283srt:EuropeMember2023-04-012023-12-310000709283srt:EuropeMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283srt:AsiaPacificMemberus-gaap:ProductMember2024-10-012024-12-310000709283srt:AsiaPacificMemberus-gaap:ProductMember2023-10-012023-12-310000709283srt:AsiaPacificMemberus-gaap:ProductMember2024-04-012024-12-310000709283srt:AsiaPacificMemberus-gaap:ProductMember2023-04-012023-12-310000709283srt:AsiaPacificMemberqtm:ServiceAndSubscriptionsMember2024-10-012024-12-310000709283srt:AsiaPacificMemberqtm:ServiceAndSubscriptionsMember2023-10-012023-12-310000709283srt:AsiaPacificMemberqtm:ServiceAndSubscriptionsMember2024-04-012024-12-310000709283srt:AsiaPacificMemberqtm:ServiceAndSubscriptionsMember2023-04-012023-12-310000709283srt:AsiaPacificMember2024-10-012024-12-310000709283srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283srt:AsiaPacificMember2023-10-012023-12-310000709283srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283srt:AsiaPacificMember2024-04-012024-12-310000709283srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283srt:AsiaPacificMember2023-04-012023-12-310000709283srt:AsiaPacificMemberus-gaap:GeographicConcentrationRiskMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283us-gaap:GeographicConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283us-gaap:GeographicConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283us-gaap:GeographicConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283us-gaap:GeographicConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283qtm:PrimaryStorageSystemsMember2024-10-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:PrimaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283qtm:PrimaryStorageSystemsMember2023-10-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:PrimaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283qtm:PrimaryStorageSystemsMember2024-04-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:PrimaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283qtm:PrimaryStorageSystemsMember2023-04-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:PrimaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283qtm:SecondaryStorageSystemsMember2024-10-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:SecondaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283qtm:SecondaryStorageSystemsMember2023-10-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:SecondaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283qtm:SecondaryStorageSystemsMember2024-04-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:SecondaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283qtm:SecondaryStorageSystemsMember2023-04-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:SecondaryStorageSystemsMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283qtm:DeviceandMediaMember2024-10-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:DeviceandMediaMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283qtm:DeviceandMediaMember2023-10-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:DeviceandMediaMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283qtm:DeviceandMediaMember2024-04-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:DeviceandMediaMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283qtm:DeviceandMediaMember2023-04-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberqtm:DeviceandMediaMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283us-gaap:ServiceMember2024-10-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:ServiceMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283us-gaap:ServiceMember2023-10-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:ServiceMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283us-gaap:ServiceMember2024-04-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:ServiceMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283us-gaap:ServiceMember2023-04-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:ServiceMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2024-10-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2023-10-012023-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2024-04-012024-12-310000709283us-gaap:ProductConcentrationRiskMemberus-gaap:RoyaltyMemberus-gaap:SalesRevenueNetMember2023-04-012023-12-310000709283qtm:SubscriptionsMember2024-10-012024-12-310000709283qtm:SubscriptionsMember2023-10-012023-12-310000709283qtm:SubscriptionsMember2024-04-012024-12-310000709283qtm:SubscriptionsMember2023-04-012023-12-3100007092832023-04-012024-03-3100007092832025-01-012024-12-3100007092832026-01-012024-12-310000709283us-gaap:ServiceMember2024-12-310000709283qtm:SubscriptionsMember2024-12-310000709283us-gaap:DevelopedTechnologyRightsMember2024-12-310000709283us-gaap:DevelopedTechnologyRightsMember2024-03-310000709283us-gaap:CustomerListsMember2024-12-310000709283us-gaap:CustomerListsMember2024-03-310000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-12-310000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-03-310000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2024-12-310000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2024-03-310000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2021-08-050000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2023-06-012023-06-010000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2023-06-010000709283qtm:TermLoanMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-06-012023-06-010000709283qtm:TermLoanWarrantMemberqtm:TermLoanMemberus-gaap:SecuredDebtMember2023-06-010000709283qtm:TermLoanWarrantMemberqtm:TermLoanMemberqtm:TermLoanMember2023-06-010000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2023-06-010000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-02-142024-02-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2024-02-140000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-04-012024-06-300000709283qtm:AmendedPNCCreditFacilityMember2024-03-310000709283qtm:TermLoanWarrantMemberqtm:TermLoanMemberus-gaap:SecuredDebtMember2024-05-240000709283qtm:TermLoanWarrantMemberqtm:TermLoanMemberqtm:TermLoanMember2024-05-240000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-05-242024-05-240000709283qtm:A2024TermLoanWarrantsMember2024-05-242024-05-240000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:SecuredDebtMember2024-05-240000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:SecuredDebtMember2024-05-310000709283qtm:July2024WarrantsMember2024-07-110000709283qtm:July2024WarrantsMemberqtm:TermLoanMemberus-gaap:SecuredDebtMember2024-07-310000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2024-07-310000709283qtm:AmendedPNCCreditFacilityMember2024-08-130000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-08-310000709283qtm:TermLoanMemberus-gaap:SecuredDebtMember2024-08-312024-08-310000709283qtm:TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-08-312024-08-310000709283qtm:TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMember2024-08-310000709283qtm:TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-08-312024-08-310000709283qtm:TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMember2024-08-310000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMember2024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMemberqtm:AlternateBaseRateMember2024-08-142024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMemberqtm:FederalFundsRateMember2024-08-142024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-08-142024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodOneMemberus-gaap:SecuredDebtMemberus-gaap:PrimeRateMember2024-08-142024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMemberqtm:AlternateBaseRateMember2024-08-142024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMember2024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMemberqtm:PaidInKindThresholdOneMember2024-08-140000709283qtm:A2021TermLoanMemberqtm:CovenantPeriodTwoMemberus-gaap:SecuredDebtMemberqtm:PaidInKindThresholdTwoMember2024-08-140000709283qtm:A2021TermLoanMemberus-gaap:SecuredDebtMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMemberqtm:CovenantPeriodTwoMember2024-08-142024-08-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMembersrt:MinimumMemberqtm:CovenantPeriodOneMember2024-08-142024-08-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberqtm:CovenantPeriodOneMemberus-gaap:LineOfCreditMember2024-08-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberqtm:CovenantPeriodTwoMemberus-gaap:LineOfCreditMemberqtm:OvernightBankingFundRateMember2024-08-142024-08-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberqtm:CovenantPeriodTwoMemberus-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-08-142024-08-140000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberqtm:CovenantPeriodTwoMemberus-gaap:LineOfCreditMember2024-08-140000709283qtm:August2024WarrantsMemberqtm:TermLoanMemberus-gaap:SecuredDebtMember2024-08-310000709283qtm:August2024WarrantsMember2024-08-312024-08-310000709283qtm:August2024WarrantsMemberqtm:TermLoanCreditAgreementMemberus-gaap:SecuredDebtMember2024-08-312024-08-310000709283qtm:AmendedRevolvingCreditAgreementWithPNCMemberus-gaap:LineOfCreditMember2024-08-310000709283qtm:A2021TermLoanMemberus-gaap:SecuredDebtMember2024-12-310000709283qtm:A2023TermLoanMemberus-gaap:SecuredDebtMember2024-12-310000709283qtm:A2024TermLoanMemberus-gaap:SecuredDebtMember2024-12-310000709283qtm:DomesticRateAndSwingLineLoansMemberus-gaap:LineOfCreditMember2024-12-310000709283qtm:TermLoanMemberus-gaap:SecuredDebtMemberus-gaap:RelatedPartyMember2024-09-300000709283us-gaap:FairValueInputsLevel2Memberqtm:TermLoanMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310000709283us-gaap:FairValueInputsLevel2Memberqtm:TermLoanMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310000709283us-gaap:FairValueInputsLevel2Memberqtm:TermLoanMemberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-03-310000709283us-gaap:FairValueInputsLevel2Memberqtm:TermLoanMemberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-03-310000709283us-gaap:FairValueInputsLevel2Memberqtm:RevolvingCreditAgreementwithPNCMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:LineOfCreditMember2024-12-310000709283us-gaap:FairValueInputsLevel2Memberqtm:RevolvingCreditAgreementwithPNCMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:LineOfCreditMember2024-12-310000709283us-gaap:FairValueInputsLevel2Memberqtm:RevolvingCreditAgreementwithPNCMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:LineOfCreditMember2024-03-310000709283us-gaap:FairValueInputsLevel2Memberqtm:RevolvingCreditAgreementwithPNCMemberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:LineOfCreditMember2024-03-310000709283us-gaap:EmployeeSeveranceMember2023-03-310000709283us-gaap:EmployeeSeveranceMember2023-04-012023-12-310000709283us-gaap:EmployeeSeveranceMember2023-12-310000709283us-gaap:EmployeeSeveranceMember2024-03-310000709283us-gaap:EmployeeSeveranceMember2024-04-012024-12-310000709283us-gaap:EmployeeSeveranceMember2024-12-310000709283qtm:A2023LongTermIncentivePlanMember2024-08-152024-08-150000709283qtm:AmendedAndRestatedWarrantsMember2024-08-260000709283qtm:AmendedAndRestatedWarrantsMember2024-04-012024-12-310000709283qtm:AmendedAndRestatedWarrantsMember2024-12-310000709283qtm:AmendedAndRestatedWarrantsMember2024-12-300000709283qtm:December2018WarrantsMember2024-03-310000709283qtm:June2020WarrantsMember2024-03-310000709283qtm:June2023WarrantsMember2024-03-310000709283qtm:December2018WarrantsMembersrt:MinimumMember2024-12-310000709283qtm:December2018WarrantsMembersrt:MaximumMember2024-12-310000709283qtm:June2020WarrantsMembersrt:MinimumMember2024-12-310000709283qtm:June2020WarrantsMembersrt:MaximumMember2024-12-310000709283qtm:June2023WarrantsMember2024-12-310000709283qtm:May2024WarrantsMember2024-12-310000709283qtm:July2024WarrantsMember2024-12-310000709283qtm:August2024WarrantsMember2024-12-310000709283qtm:December2018WarrantsMember2024-12-310000709283qtm:June2020WarrantsMember2024-12-310000709283us-gaap:FairValueInputsLevel2Member2023-03-310000709283us-gaap:FairValueInputsLevel2Member2023-04-012023-12-310000709283us-gaap:FairValueInputsLevel2Member2023-12-310000709283us-gaap:FairValueInputsLevel2Member2024-03-310000709283us-gaap:FairValueInputsLevel2Member2024-04-012024-12-310000709283us-gaap:FairValueInputsLevel2Member2024-12-310000709283qtm:June2020WarrantsMemberqtm:AdvisorMember2020-06-300000709283qtm:June2023WarrantsMemberqtm:AdvisorMember2023-06-300000709283qtm:SeniorSecuredTermLoanMember2020-06-160000709283us-gaap:StockCompensationPlanMember2024-10-012024-12-310000709283us-gaap:StockCompensationPlanMember2023-10-012023-12-310000709283us-gaap:StockCompensationPlanMember2024-04-012024-12-310000709283us-gaap:StockCompensationPlanMember2023-04-012023-12-310000709283us-gaap:WarrantMember2024-10-012024-12-310000709283us-gaap:WarrantMember2023-10-012023-12-310000709283us-gaap:WarrantMember2024-04-012024-12-310000709283us-gaap:WarrantMember2023-04-012023-12-310000709283us-gaap:RestrictedStockUnitsRSUMember2024-04-012024-12-310000709283us-gaap:OtherNoncurrentAssetsMember2024-12-310000709283us-gaap:OtherNoncurrentLiabilitiesMember2024-12-310000709283qtm:ArrowElectronicsMatterMember2023-07-272023-07-270000709283qtm:AmendedAndRestatedWarrantsMemberus-gaap:SubsequentEventMember2025-01-032025-01-030000709283qtm:AmendedAndRestatedWarrantsMemberus-gaap:SubsequentEventMember2025-01-030000709283us-gaap:SubsequentEventMemberqtm:StandbyEquityPurchaseAgreementMember2025-01-25
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 31, 2024
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___ to ___

Commission File Number 001-13449

Q logo.jpg
Quantum Corporation
(Exact name of registrant as specified in its charter)
Delaware94-2665054
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
224 Airport ParkwaySuite 550
San JoseCA95110
(Address of Principal Executive Offices)(Zip Code)

(408)944-4000
Registrant's telephone number, including area code
(Former name, former address and former fiscal year, if changed since last report)


Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common Stock, $0.01 par value per shareQMCONasdaq Global Market




Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
x
Yes
 ¨
 No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
x
Yes
 ¨
 No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
Accelerated filer
Non-accelerated filer  
Smaller reporting company
x
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
x
 No
As of the close of business on February 11, 2025 there were 5,834,199 shares of Quantum Corporation’s common stock issued and outstanding.


QUANTUM CORPORATION
QUARTERLY REPORT ON FORM 10-Q
For the Quarter Ended December 31, 2024

Table of Contents




As used in this Quarterly Report on Form 10-Q, the terms "Quantum," the “Company,” "we," "us," and "our" refer to Quantum Corporation and its subsidiaries taken as a whole, unless otherwise noted or unless the context indicates otherwise.

Note Regarding Forward-Looking Statements

This report contains forward-looking statements. All statements contained in this report other than statements of historical fact, including, but not limited to, statements regarding our future operating results and financial position; our business strategy, focus and plans; our market growth and trends; our products, services and expected benefits thereof; and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “could,” “would,” “project,” “plan,” “potentially,” “preliminary,” “likely,” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties, and assumptions, including: the competitive pressures that we face; risks associated with executing our strategy; the impact of macroeconomic and geopolitical trends and events; the need to manage third-party suppliers and the distribution of our products and the delivery of our services effectively; the protection of our intellectual property assets, including intellectual property licensed from third parties; risks associated with our international operations; the development and transition of new products and services and the enhancement of existing products and services to meet customer needs; our response to emerging technological trends; the execution and performance of contracts by us and our suppliers, customers, clients and partners; the hiring and retention of key employees; risks associated with business combination and investment transactions; the execution, timing and results of any transformation or restructuring plans, including estimates and assumptions related to the cost and the anticipated benefits of the transformation and restructuring plans; the outcome of any claims and disputes; and those risks described under Part II, Item 1A. Risk Factors. Moreover, we operate in a competitive and changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the effect of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties, and assumptions, the future events and trends discussed in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, you should not rely on forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that the future results, performance, or events and circumstances reflected in the forward-looking statements will be achieved or occur. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this report or to conform these statements to actual results or revised expectations.



PART I—FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS

QUANTUM CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts, unaudited)
December 31, 2024March 31, 2024
Assets
Current assets:
Cash and cash equivalents$20,381 $25,692 
Restricted cash222 168 
Accounts receivable, net of allowance for credit losses of $99 and $22, respectively
61,373 67,788 
Manufacturing inventories18,861 17,753 
Service parts inventories1,884 9,783 
Prepaid expenses2,569 2,186 
Other current assets8,538 8,414 
Total current assets113,828 131,784 
Property and equipment, net 11,268 12,028 
Goodwill 12,969 12,969 
Intangible assets, net 509 1,669 
Right-of-use assets8,670 9,425 
Other long-term assets20,812 19,740 
Total assets$168,056 $187,615 
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable$34,704 $26,087 
Accrued compensation11,702 18,214 
Deferred revenue, current portion69,916 78,511 
Term debt
98,609 82,496 
Revolving credit facility37,500 26,604 
Warrant liabilities34,005 4,046 
Other accrued liabilities19,108 13,986 
Total current liabilities305,544 249,944 
Deferred revenue, net of current portion35,350 38,176 
Operating lease liabilities9,067 9,621 
Other long-term liabilities13,150 11,372 
Total liabilities363,111 309,113 
Commitments and contingencies (Note 11)
Stockholders' deficit
Preferred stock, 20,000 shares authorized; no shares issued and outstanding
  
Common stock, $0.01 par value; 225,000 shares authorized; 5,307 and 4,792 shares issued and outstanding
53 48 
Additional paid-in capital740,521 708,027 
Accumulated deficit(933,160)(827,380)
Accumulated other comprehensive loss(2,469)(2,193)
Total stockholders’ deficit(195,055)(121,498)
Total liabilities and stockholders’ deficit$168,056 $187,615 
See accompanying Notes to Condensed Consolidated Financial Statements.
1

QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(in thousands, except per share amounts, unaudited)

Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Revenue:
   Product$38,610 $37,113 $116,389 $138,635 
   Service and subscription31,615 32,771 90,383 94,229 
   Royalty2,326 2,042 7,592 7,235 
      Total revenue72,551 71,926 214,364 240,099 
Cost of revenue:
   Product30,922 30,044 93,251 105,214 
   Service and subscription9,874 12,701 33,954 37,329 
      Total cost of revenue40,796 42,745 127,205 142,543 
Gross profit31,755 29,181 87,159 97,556 
Operating expenses:
Sales and marketing12,448 14,244 39,321 45,800 
General and administrative14,142 11,893 49,186 34,833 
Research and development7,683 8,763 24,255 28,828 
Restructuring charges1,342 497 2,916 3,164 
      Total operating expenses35,615 35,397 115,678 112,625 
Loss from operations(3,860)(6,216)(28,519)(15,069)
Other income (expense), net967 (1,419)(408)(2,049)
Interest expense(6,840)(3,937)(16,761)(10,992)
Change in fair value of warrant liabilities(61,630)2,213 (56,414)7,341 
Loss on debt extinguishment  (3,003) 
      Net loss before income taxes(71,363)(9,359)(105,105)(20,769)
Income tax provision70 510 675 1,573 
Net loss$(71,433)$(9,869)$(105,780)$(22,342)
Net loss per share - basic and diluted
$(14.56)$(2.08)$(21.90)$(4.74)
Weighted average shares - basic and diluted
4,907 4,751 4,831 4,717 
Net loss(71,433)$(9,869)(105,780)$(22,342)
Foreign currency translation adjustments, net(1,077)1,465 (276)994 
Total comprehensive loss$(72,510)$(8,404)$(106,056)$(21,348)
See accompanying Notes to Condensed Consolidated Financial Statements.
2

QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands, unaudited)
Nine Months Ended December 31,
20242023
Operating activities
Net loss$(105,780)$(22,342)
  Adjustments to reconcile net loss to net cash used in operating activities
Depreciation and amortization4,440 7,593 
Amortization of debt issuance costs3,704 1,948 
Loss on debt extinguishment3,003  
Provision for product and service inventories1,165 3,328 
Stock-based compensation2,376 3,741 
Paid in kind interest3,515 1,401 
Change in fair value of warrant liabilities56,408 (7,340)
Other non-cash(281)1,609 
Changes in assets and liabilities:
Accounts receivable, net6,337 12,616 
Manufacturing inventories(2,347)(3,099)
Service parts inventories7,972 (1,520)
Prepaid expenses(382)394 
Accounts payable 9,405 (13,226)
Accrued compensation(6,512)(425)
Deferred revenue(11,421)(4,780)
Other current assets(124)(1,698)
Other non-current assets1,367 (1,532)
Other current liabilities5,369 569 
Other non-current liabilities1,441 2,036 
Net cash used in operating activities(20,345)(20,727)
Investing activities
Purchases of property and equipment(4,324)(5,025)
Net cash used in investing activities(4,324)(5,025)
Financing activities
Borrowings of long-term debt, net of debt issuance costs25,000 14,083 
Repayments of long-term debt(14,092)(4,497)
Borrowings of credit facility311,135 318,223 
Repayments of credit facility(302,628)(303,671)
Net cash provided by financing activities19,415 24,138 
Effect of exchange rate changes on cash, cash equivalents and restricted cash(3)(12)
Net change in cash, cash equivalents and restricted cash (5,257)(1,626)
Cash, cash equivalents, and restricted cash at beginning of period25,860 26,175 
Cash, cash equivalents, and restricted cash at end of period $20,603 $24,549 
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statement of cash flows:
Cash and cash equivalents20,381 $24,377 
Restricted cash, current222 172 
Cash, cash equivalents and restricted cash at the end of period
$20,603 $24,549 
Supplemental disclosure of cash flow information
      Cash paid for interest$8,841 $9,154 
      Cash paid for income taxes, net$1,798 $1,136 
   Non-cash transactions
     Purchases of property and equipment included in accounts payable $88 $164 
     Paid-in-kind interest$3,515 $1,401 
See accompanying Notes to Condensed Consolidated Financial Statements.
3

QUANTUM CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT
(in thousands, unaudited)

Common StockAdditional
Paid-in Capital
Accumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Deficit
Three Months EndedSharesAmount
Balance, September 30, 2023
4,775 $47 $706,138 $(798,567)$(2,052)$(94,434)
Net loss— — — (9,869)— (9,869)
Foreign currency translation adjustments, net— — — — 1,465 1,465 
Shares issued under employee incentive plans, net17 — — — —  
Stock-based compensation— — 906 — — 906 
Balance, December 31, 2023
4,792 $47 $707,044 $(808,436)$(587)$(101,932)
Balance, September 30, 2024
4,792 $48 $709,667 $(861,727)$(1,392)$(153,404)
Net loss— — — (71,433)— (71,433)
Foreign currency translation adjustments, net— — — — (1,077)(1,077)
Shares issued under employee incentive plans, net109 1 (1)— —  
Shares issued related to warrants
406 4 30,119 — — 30,123 
Stock-based compensation— — 736 — — 736 
Balance, December 31, 2024
5,307 $53 $740,521 $(933,160)$(2,469)$(195,055)

See accompanying Notes to Condensed Consolidated Financial Statements.
4

Common StockAdditional
Paid-in Capital
Accumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Deficit
Nine Months EndedSharesAmount
Balance, March 31, 20234,678 $47 $703,259 $(786,094)$(1,581)$(84,369)
Net loss— — — (22,342)— (22,342)
Foreign currency translation adjustments, net— — — — 994 994 
Shares issued under employee incentive plans, net114 — — — —  
Warrants issued in connection with debt refinancing— — 49 — — 49 
Stock-based compensation— — 3,736 — — 3,736 
Balance, December 31, 2023
4,792 $47 $707,044 $(808,436)$(587)$(101,932)
Balance, March 31, 20244,792 $48 $708,027 $(827,380)$(2,193)$(121,498)
Net loss— — — (105,780)— (105,780)
Foreign currency translation adjustments, net— — — — (276)(276)
Shares issued under employee incentive plans, net109 1 (1)— —  
Shares issued related to warrants
406 4 30,119 — — 30,123 
Stock-based compensation— — 2,376 — — 2,376 
Balance, December 31, 2024
5,307 $53 $740,521 $(933,160)$(2,469)$(195,055)

See accompanying Notes to Condensed Consolidated Financial Statements.
5

INDEX TO NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

6


NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)

NOTE 1: DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business

Quantum Corporation, together with its consolidated subsidiaries (“Quantum” or the “Company”), stores and manages digital video and other forms of unstructured data, providing streaming performance for video and rich media applications, along with low-cost, long-term storage systems for data protection and archiving. The Company helps customers around the world capture, create and share digital data and preserve and protect it for decades. The Company’s software-defined, hyperconverged storage solutions span from non-volatile memory express, to solid state drives, hard disk drives, tape and the cloud and are tied together leveraging a single namespace view of the entire data environment. The Company works closely with a broad network of distributors, value-added resellers, direct marketing resellers, original equipment manufacturers and other suppliers to meet customers’ evolving needs.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. All intercompany balances and transactions have been eliminated. Certain information and footnote disclosures normally included in annual financial statements have been condensed or omitted. The Company believes the disclosures made are adequate to prevent the information presented from being misleading. However, the accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included within the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024 (the “Annual Report”).

The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal and recurring items, necessary to present fairly our financial position as of December 31, 2024, the results of operations and comprehensive loss, statements of cash flows, and changes in stockholders’ deficit for the three and nine months ended December 31, 2024 and 2023. Interim results are not necessarily indicative of full year performance because of short-term variations.

Reverse Stock Split

On August 15, 2024, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the issued shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a ratio ranging from 1 share-for-5 shares up to a ratio of 1-for-20 shares, with the exact ratio, if any, to be selected by the board of directors (the “Board”). On August 15, 2024, the Board approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Common Stock. The Reverse Stock Split became effective as of August 26, 2024 at 4:01 p.m., Eastern Time (the “Effective Time”). At the Effective Time, every twenty issued shares of Common Stock were automatically reclassified into one issued share of Common Stock, with any fractional shares resulting from the Reverse Stock Split rounded up to the nearest whole share. The number of outstanding shares of Common Stock was reduced from approximately 95.9 million shares to approximately 4.8 million shares.

All share and per share amounts for Common Stock in these condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Split.

Going Concern

These consolidated financial statements have been prepared in accordance with GAAP assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern has been raised.

7

The Company believes it is probable that it will be in violation of the net leverage covenant at the testing date for the first quarter of fiscal 2026. If the Company is unable to obtain waivers, the Term Loan and PNC Credit Facility will become immediately due, and additional liquidity will be required to satisfy the obligations. Due to the fact that a violation of the debt covenants results in the debt becoming currently payable, the long-term portion of the Term Loan and PNC Credit Facility have been classified as a current liability in the accompanying consolidated balance sheet as of December 31, 2024. See Note 4: Debt for additional information related to the Company’s debt agreements.
The Company entered into a Standby Equity Purchase Agreement (the “SEPA”) on January 25, 2025, pursuant to which the Company has the right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. See Note 12: Subsequent Events for additional information related to the SEPA. Additionally, the Company is evaluating strategies to obtain additional funding, however there is no assurance that the Company will be able to obtain additional liquidity when needed or under acceptable terms.

The consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern. Our credit facilities are collateralized by a pledge of all our assets.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations, inventory adjustments, useful lives of intangible assets and property and equipment, stock-based compensation, fair value of warrants, and provision for income taxes including related reserves. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Restricted Cash

Restricted cash is comprised of bank guarantees and similar required minimum balances that serve as cash collateral in connection with various items including insurance requirements, value added taxes, ongoing tax audits and leases in certain countries.

Recent Accounting Pronouncements

In November 2024, the FASB issued Accounting Standards Update ("ASU") 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220), which requires public entities to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, which includes amendments that further enhance tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for annual periods beginning after December 15, 2024 and may be applied either prospectively or retrospectively. The Company does not anticipate the adoption will have a material impact to the Company's financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. ASU 2023-07 will be effective for our fiscal year beginning April 1, 2024, and interim periods within our fiscal year beginning April 1, 2025, with early adoption permitted and requires application on a fully retrospective basis. We are currently evaluating the impact of this standard on our financial statement disclosures.
8


NOTE 2: REVENUE
Based on how the Company manages its business, the Company has determined that it currently operates in one reportable segment. The Company operates in three geographic regions: (a) Americas; (b) Europe, Middle East and Africa (“EMEA”); and (c) Asia Pacific (“APAC”). Revenue by geography is based on the location of the customer from which the revenue is earned.
In the following table, revenue is disaggregated by major product offerings and geographies (in thousands):
 Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Americas1
   Product revenue18,294 16,159 62,410 78,287 
   Service and subscription16,563 18,282 48,975 53,871 
Total revenue34,857 48 %34,441 47 %111,385 52 %132,158 55 %
EMEA
   Product revenue15,235 14,786 39,892 42,609 
   Service and subscription12,077 12,282 33,471 34,234 
Total revenue27,312 38 %27,068 38 %73,363 34 %76,843 32 %
APAC
   Product revenue5,081 6,168 14,087 17,739 
   Service and subscription2,975 2,207 7,937 6,124 
Total revenue8,056 11 %8,375 12 %22,024 10 %23,863 10 %
Consolidated
   Product revenue38,610 37,113 116,389 138,635 
   Service and subscription31,615 32,771 90,383 94,229 
   Royalty2
2,326 3 %2,042 3 %7,592 4 %7,235 3 %
Total revenue$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Revenue for the Americas geographic region outside of the United States is not significant.
2 Royalty revenue is not allocatable to geographic regions.


Revenue by Solution
Three Months Ended December 31,Nine Months Ended December 31,
2024%2023%2024%2023%
Primary storage systems$12,404 17 %$12,887 18 %$41,034 19 %$41,394 17 %
Secondary storage systems23,276 33 %20,206 28 %60,787 28 %82,118 34 %
Device and media7,575 10 %7,716 11 %24,254 11 %23,801 10 %
Service 26,970 37 %29,075 40 %80,697 38 %85,551 36 %
Royalty2,326 3 %2,042 3 %7,592 4 %7,235 3 %
Total revenue1
$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Subscription revenue of $4.6 million and $2.3 million was allocated to Primary and Secondary storage systems for the three months ended December 31, 2024 and 2023, respectively. Subscription revenue of $11.3 million and $4.8 million was allocated to Primary and Secondary storage systems for the nine months ended December 31, 2024 and 2023, respectively.


9

Contract Balances

The following table presents the Company’s contract liabilities and certain information related to this balance as of March 31, 2024 and December 31, 2024 (in thousands): 

March 31, 2024
Deferred revenue$116,687 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$76,304 
December 31, 2024
Deferred revenue$105,266 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$64,539 

Remaining Performance Obligations

Total remaining performance obligations (“RPO”) representing contracted but not recognized revenue was $122.6 million as of December 31, 2024. RPO consists of both deferred revenue and uninvoiced, non-cancelable contracts that are expected to be invoiced and recognized as revenue in future periods and excludes variable consideration related to sales-based royalties. Of the $122.6 million RPO at the end of the third quarter of fiscal 2025, $105.4 million was for invoiced deferred revenue and $17.2 million was for uninvoiced, non-cancelable contracts. The non-current portion of the RPO will be recognized over the next 13 to 60 months.

RPO consisted of the following (in thousands):
CurrentNon-CurrentTotal
As of December 31, 2024
$84,644 $37,929 $122,573 

Deferred revenue consists of amounts that have been invoiced but have not yet been recognized as revenue including performance obligations pertaining to subscription services. The table below reflects the Company’s deferred revenue as of December 31, 2024 (in thousands):
Deferred revenue by period
Total1 year or less1 – 3 Years3 year or greater
Service revenue84,624 60,782 21,815 $2,027 
Subscription revenue$20,642 $9,134 $8,773 $2,735 
Balance as of December 31, 2024$105,266 $69,916 $30,588 $4,762 

NOTE 3: BALANCE SHEET INFORMATION
Certain significant amounts included in the Company's condensed consolidated balance sheets consist of the following (in thousands):

Manufacturing inventories
December 31, 2024March 31, 2024
   Finished goods$9,741 $7,074 
   Work in progress1,399 770 
   Raw materials7,721 9,909 
Total manufacturing inventories$18,861 $17,753 

Service parts inventories
10

December 31, 2024March 31, 2024
   Finished goods$1,377 $3,660 
   Component parts507 6,123 
Total service parts inventories$1,884 $9,783 

Intangibles, net
December 31, 2024March 31, 2024
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
   Developed technology$9,013 $(9,013)$ $9,013 $(8,550)$463 
   Customer lists4,398 (3,889)509 4,398 (3,192)1,206 
Intangible assets, net$13,411 $(12,902)$509 $13,411 $(11,742)$1,669 

Intangible assets amortization expense was $0.2 million and $1.2 million and $0.8 million and $3.0 million for the three and nine months ended December 31, 2024 and 2023, respectively. As of December 31, 2024, the remaining weighted-average amortization period for definite-lived intangible assets was approximately 0.6 years. The Company recorded amortization of developed technology in cost of product revenue, and customer lists in sales and marketing expenses in the condensed consolidated statements of operations.

As of December 31, 2024, the future expected amortization expense for intangible assets is as follows (in thousands):

Fiscal year ending Estimated future amortization expense
Remainder of 2025$228 
2026281 
Total$509 


Goodwill

As of December 31, 2024 and March 31, 2024, goodwill was $13.0 million. There were no impairments to goodwill as of December 31, 2024 and March 31, 2024.

Other long-term assets
December 31, 2024March 31, 2024
Capitalized SaaS implementation costs for internal use$14,786 $15,349 
Capitalized debt costs3,292 1,923 
Contract asset1,264 1,477 
Deferred taxes711 734 
Other759 257 
   Total other long-term assets$20,812 $19,740 

Other accrued liabilities
December 31, 2024March 31, 2024
Accrued expenses
$8,093 $4,251 
Asset retirement obligation
3,683 2,069 
Accrued warranty
1,195 1,545 
Accrued interest
506 524 
Lease liability1,227 1,256 
Accrued income taxes
390 1,044 
Other
4,014 3,297 
   Total other accrued liabilities$19,108 $13,986 
11


The following table details the change in the accrued warranty balance (in thousands):
December 31, 2024March 31, 2024
Beginning balance$1,545 $2,094 
   Current period accruals1,696 2,563 
   Adjustments to prior estimates46 (141)
   Charges incurred(2,092)(2,971)
Ending balance$1,195 $1,545 

NOTE 4: DEBT
The Company’s debt consisted of the following (in thousands):
 December 31, 2024March 31, 2024
Term Loan$105,880 $87,942 
PNC Credit Facility37,500 26,604 
Less: current portion(136,109)(109,100)
Less: unamortized debt issuance costs (1)
(7,271)(5,446)
Long-term debt, net$ $ 
(1) The unamortized debt issuance costs related to the Term Loan are presented as a reduction of the carrying amount of the corresponding debt balance on the accompanying condensed consolidated balance sheets. Unamortized debt issuance costs related to the PNC Credit Facility are presented within other assets on the accompanying condensed consolidated balance sheets.
On August 5, 2021, the Company entered into a senior secured term loan (as amended, the “2021 Term Loan”), maturing on August 5, 2026. The Company also has a revolving credit facility agreement with PNC Bank (as amended, the “PNC Credit Facility” and together with the Term Loan (as defined below), the “Credit Agreements”) maturing on August 5, 2026 and providing for borrowings up to a maximum principal amount of the lesser of: (a) $40.0 million or (b) the amount of the borrowing base, as defined in the PNC Credit Facility agreement.

On June 1, 2023, the Company entered into amendments to the Credit Agreements (the “June 2023 Amendment”) which, among other things, provided an advance of $15.0 million in additional term loan borrowings (as amended, the “2023 Term Loan” and, together with the 2021 Term Loan, the "Term Loan") and incurred $0.9 million in original issuance discount and origination fees which have been recorded as a reduction to the carrying amount of the 2023 Term Loan and amortized to interest expense over the loan term. The terms of the 2023 Term Loan are substantially similar to the terms of the 2021 Term Loan, including in relation to maturity and security, except that, among other things, (a) the Applicable Margin (i) for any 2023 Term Loan designated an “ABR Loan” is 9.00% per annum and (ii) for any 2023 Term Loan designated as a “SOFR Loan” is 10.00% per annum, (b) accrued interest on the 2023 Term Loan is payable in kind ("PIK"), and is capitalized and added to the principal amount of the 2023 Term Loan at the end of each interest period applicable thereto, (c) the 2023 Term Loan does not amortize prior to the maturity date thereof, and (d) the 2023 Term Loan may not be prepaid prior to the payment in full of the existing term loans. In connection with the 2023 Term Loan, the Company issued warrants to purchase an aggregate of 0.06 million shares (the “June 2023 Warrants”) of the Common Stock, at an exercise price of $20.00 per share. See Note 8: Common Stock for additional discussion related to the June 2023 Warrants.

The June 2023 Amendment to the 2021 Term Loan was accounted for as a modification. The value of the June 2023 Warrants in addition to $0.7 million of fees paid to the lenders have been reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The Company incurred $0.9 million of legal and financial advisory fees which were included in general and administrated expenses in the condensed consolidated statement of operations and comprehensive loss. The June 2023 Amendment to the PNC Credit Facility was accounted for as a modification and $0.7 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On February 14, 2024, the Company entered into amendments to the Credit Agreements (“February 2024 Amendments”) which waived testing of the total net leverage ratio financial covenant for the fiscal quarter ended December 31, 2023. In connection with the amendment, the Company incurred fees related to the Term Loan that
12

was paid-in-kind of $1.2 million and an amendment fee of $0.1 million that was paid in cash. As the February 2024 Amendments were accounted for as a modification, the fees were reflected as a reduction to the carrying amount of the Term Loan and are amortized to interest expense over the remaining loan term. In connection with the related PNC Credit Facility amendment, the Company incurred $0.2 million in fees and expenses.

On March 22, 2024, the Company entered into amendments to the Credit Agreements. The amendments, among other things, (i) permits the sale of certain assets by the Company and (ii) requires that certain proceeds from the sale of such assets be applied to partially prepay the outstanding term loans under the Term Loan credit facility. The Company did not incur any amendment fees related to the March 2024 amendments and the financial terms of the Credit Agreements were not impacted.

During the quarter ended June 30, 2024, the Company prepaid $12.3 million of the Term Loan. In connection with this prepayment, the Company recorded a loss on debt extinguishment of $0.7 million related to the write-off of a portion of unamortized debt issuance costs.

On May 24, 2024, the Company entered into amendments to the Credit Agreements (the “May 2024 Amendments”) which, among other things, (i) waived compliance with the Company’s net leverage covenant as of March 31, 2024; and (ii) reduced the daily minimum liquidity covenant below $15.0 million until June 16, 2023 and waived any default that might arise as a result of the restatement of certain of the Company’s historical financial statements. In connection with the May 2024 Amendments, the Company issued to the Term Loan lenders warrants to purchase an aggregate of 100,000 shares of the Common Stock at a purchase price of $9.20 (the “May 2024 Warrants”). See Note 8: Common Stock for additional discussion related to the May 2024 Warrants. Additionally, in connection with the May 2024 Amendment to the Term Loan, the Company incurred an amendment fee that was paid-in-kind of $0.8 million and issued the 2024 Term Loan Warrants with a fair market value of $0.8 million. In connection with the May 2024 Amendment to the PNC Credit Facility Amendment, the Company incurred $ 0.5 million of fees and expenses paid to the lender.

The May 2024 Amendment to the Term Loan was accounted for as a modification. The value of the May 2024 Warrants, in addition to $0.8 million of amendment fees paid to the lenders, have been reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The May 2024 Amendment to the PNC Credit Facility was accounted for as a modification and the $0.5 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On July 11, 2024, the Company entered into amendments to the Credit Agreements (the “July 2024 Amendments”) which, among other things, delayed the testing of the Company’s June 30, 2024 net leverage ratio financial covenant until July 31, 2024. In connection with the amendments, the Company issued the Term Loan lenders (the “July 2024 Warrants”) to purchase an aggregate of 50,000 shares of the Common Stock at a purchase price of $8.20. See Note 8: Common Stock for additional discussion related to the July 2024 Warrants.

The July 2024 Amendments to the 2021 Term Loan were accounted for as a modification. The fair value of the July 2024 Warrants of $0.4 million is reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The July 2024 Amendment to the PNC Credit Facility was accounted for as a modification and the $0.1 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On August 13, 2024, the Company entered into amendments to the Credit Agreements (the “August 2024 Amendments”) which, among other things, (i) waived compliance with the June 30, 2024 net leverage ratio financial covenant; (ii) waived any non-compliance with the minimum liquidity financial covenant through the date of the amendments; (iii) removed the fixed charges coverage ratio financial covenant until the fiscal quarter ending September 30, 2025; (iv) waived the testing requirement for the net leverage financial covenant for the fiscal quarter ending September 30, 2024; (v) replaced the net leverage financial covenant with a minimum EBITDA financial covenant for the fiscal quarters ending December 31, 2024 and March 31, 2025; (vi) reset the net leverage financial covenant requirements for the fiscal quarters ending June 30, 2025 and September 30, 2025; (vii) reduced the minimum liquidity covenant to $10 million through September 30, 2025; (viii) adjusted the applicable interest rates on the Term Loan and PNC Credit Facility; (ix) removed required 2021 Term Loan principal amortization until the fiscal quarter ending September 30, 2025; and (x) repriced certain Lender Warrants.

13

In connection with the August 2024 Amendments, the Company received a new senior secured delayed draw term loan facility with a borrowing capacity of up to $26.3 million ($25.0 million after original issuance discount) and a commitment period expiring on October 31, 2024 (each draw, an “August 2024 Term Loan”). The Company borrowed $10.5 million at closing (“Initial August 2024 Term Loan”). Borrowings under the August 2024 Term Loan have an August 5, 2026 maturity date which aligns with the 2021 Term Loan. The principal is payable quarterly beginning September 30, 2025, at a rate per annum equal to 5% of the original principal balance. The August 2024 Term Loan’s interest rate margin is (a) until March 31, 2025 (i) for any August 2024 Term Loan designated as a ‘SOFR Loan’ is 12.00% per annum and (ii) for any August 2024 Term Loan designated an ‘ABR Loan’ is 11.00% per annum, in each case, with 6.00% of such interest rate margin paid-in-kind, and (b) from April 1, 2025, (i) for any August 2024 Term Loan designated as a ‘SOFR Loan’ is 14.00% per annum and (ii) for any August 2024 Term Loan designated an ‘ABR Loan’ is 13.00% per annum, in each case, with 8.00% of such interest rate margin paid-in-kind. The August 2024 Term Loan also includes a multiple on invested capital payable to the August 2024 Term Loan lenders. Subsequently, the Company borrowed the remaining $15.8 million of the August 2024 Term Loan’s borrowing capacity before September 30, 2024.

Subsequent to the August 2024 Amendments, the 2021 Term Loan amortizes at 5.00% per annum commencing on September 30, 2025. Subsequent to the August 2024 Amendments and (A) until March 31, 2025, loans under the 2021 Term Loan designated as (x) ABR Loans bear interest at a rate per annum equal to the “ABR Rate” (calculated as the greatest of (i) 1.75%; (ii) the Federal funds rate plus 0.50%; (iii) a secured overnight financing rate based rate (the “SOFR Rate”) based upon an interest period of one month plus 1.0%; and (iv) the “Prime Rate” last quoted by the Wall Street Journal), plus an applicable margin of 8.75%, and (y) SOFR Rate Loans bear interest at a rate per annum equal to the SOFR Rate plus an applicable margin of 9.75%, in each case, with 3.75% of such interest rate margin paid-in-kind, with two specified step-downs in such applicable margin upon the receipt by the Company of cash proceeds from certain specified capital raises, and (B) from and after April 1, 2025, loans under the 2021 Term Loan designated as (x) ABR Loans bear interest at a rate per annum equal to the ABR Rate, plus an applicable margin of 8.75%, and (y) SOFR Rate Loans bear interest at a rate per annum equal to the SOFR Rate plus an applicable margin of 9.75%, in each case, with 3.75% of such applicable margin paid-in-kind, with a step-up of 1.00% per annum (which shall be paid-in-kind) if the Company’s total net leverage ratio is greater than 4.00x, and a step-down of 1.00% per annum if the Company’s total net leverage ratio is less than 3.50x (which shall reduce the paid-in-kind component of the applicable margin). The SOFR Rate is subject to a floor of 2.00%. The Company can designate a loan as an ABR Rate Loan or SOFR Rate Loan in its discretion.

Subsequent to the August 2024 Amendments, PNC Credit Facility loans designated as (x) PNC SOFR Loans bear interest at a rate per annum equal to a SOFR based rate (subject to a 0.0% floor), plus an applicable margin of 4.75%and (y) PNC Domestic Rate Loans and Swing Loans bear interest at a rate per annum equal to the greatest of (i) the base commercial lending rate of PNC Bank; (ii) the Overnight Bank Funding Rate plus 0.5%; and (iii) the daily SOFR rate plus 1.0%, plus an applicable margin of 3.75%. The Company can designate a loan as a PNC SOFR Loan or PNC Domestic Rate Loan in its discretion.

In connection with the August 2024 Amendments, the Company issued warrants to purchase an aggregate of 380,510 shares of the Common Stock, at an exercise price of $6.20 per share (“August 2024 Warrants”) and had a fair value of $2.0 million. See Note 8: Common Stock for additional discussion related to the August 2024 Warrants.

The August 2024 Amendments to the 2021 Term Loan held by one lender was accounted for as a modification. The $1.2 million fair value of the August 2024 Warrants issued to this lender and the $0.5 million of PIK fees paid to this lender are reflected as a reduction to the carrying amount of their Term Loan and their initial delayed draw term loan and amortized to interest expense over the remaining loan terms. The August 2024 Amendments to the 2021 Term Loan held by another lender was accounted for as a debt extinguishment. The Company recorded a loss on debt extinguishment of $3.0 million related to the write-off of a portion of unamortized debt issuance costs and fees and expenses incurred with the August 2024 Amendments.

The August 2024 Amendments to the PNC Credit Facility were accounted for as a modification, and the $0.7 million in related fees and expenses were recorded to other assets and amortized to interest expense over the remaining term of the agreement.

As of December 31, 2024, the interest rate on the 2021 Term Loan, 2023 Term Loan, and 2024 Term Loans were 14.59%, 14.34%, and 16.59%, respectively. As of December 31, 2024, the interest rate on the PNC Credit Facility for Domestic Rate Loans and Swing Loans was 11.25% and for PNC SOFR Loans was 9.66%.

14

The Term Loan amendments and certain warrants issued to term lenders during fiscal 2023 and fiscal 2024 were entered into with certain entities managed by Pacific Investment Management Company, LLC ("PIMCO"), which is considered a related party due to the fact that Christopher D. Neumeyer is a member of the Company's Board of Directors and also an executive vice president and portfolio manager at PIMCO. The principal and PIK interest related to the June 2023 Term Loan which totaled $19.6 million as of December 31, 2024, are payable at maturity.

Also, as of December 31, 2024, the PNC Credit Facility had an available borrowing base of 39.1 million, of which $1.6 million was available to borrow at that date.

NOTE 5: FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company’s assets, measured and recorded at fair value on a recurring basis, may consist of money market funds which are included in cash and cash equivalents in the Condensed Consolidated Balance Sheets and are valued using quoted market prices (level 1 fair value measurements) at the respective balance sheet dates.

No impairment charges were recognized for non-financial assets in the nine months ended December 31, 2024 and 2023. The Company has no non-financial liabilities measured and recorded at fair value on a non-recurring basis.

Long-term Debt

The Company’s financial liabilities were comprised primarily of long-term debt as of December 31, 2024. The Company uses significant other observable market data or assumptions (Level 2 inputs as defined in the accounting guidance) that it believes market participants would use in pricing debt.

The carrying value and fair value of the Company’s financial liabilities were primarily comprised of the following (in thousands):

December 31, 2024March 31, 2024
Carrying ValueFair ValueCarrying ValueFair Value
Term Loan$105,880 $96,780 $87,942 $75,143 
PNC Credit Facility37,500 34,470 26,604 24,743 

NOTE 6: LEASES
Supplemental balance sheet information related to leases is as follows (in thousands):
Operating LeasesDecember 31, 2024March 31, 2024
Operating lease right-of-use asset$8,670 $9,425 
Operating lease liability within other accrued liabilities
1,227 1,256 
Operating lease liability, net9,067 9,621 
   Total operating lease liabilities$10,294 $10,877 

Components of lease cost were as follows (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
Lease Cost2024202320242023
Operating lease cost  $716 $710 $2,207 $2,316 
Variable lease cost  69 51 221 233 
Total lease cost  $785 $761 $2,428 $2,549 

15

Maturity of Lease LiabilitiesOperating Leases
Remainder of fiscal year 2025$670 
2026
2,276 
2027
1,770 
2028
1,550 
2029
1,228 
   Thereafter12,095 
Total lease payments$19,589 
Less: imputed interest(9,295)
Present value of lease liabilities$10,294 



Lease Term and Discount RateDecember 31, 2024March 31, 2024
Weighted average remaining operating lease term (years)10.2510.85
Weighted average discount rate for operating leases12.6 %12.7 %

Operating cash outflows related to operating leases totaled $2.1 million and $2.3 million for the nine months ended December 31, 2024 and 2023, respectively.

NOTE 7: RESTRUCTURING CHARGES
During the quarters ending December 31, 2024 and 2023, the Company had certain approved restructuring plans to improve operational efficiencies and rationalize its cost structure.
The following tables show the activity and the estimated timing of future payouts for accrued restructuring (in thousands) included in other current liabilities:
 Severance and Benefits
Balance as of March 31, 2023
$ 
   Restructuring charges 3,164 
   Cash payments (3,164)
Balance as of December 31, 2023
 $ 
Balance as of March 31, 2024
 $ 
   Restructuring charges 2,916 
   Cash payments (2,849)
   Other non-cash(67)
Balance as of December 31, 2024
 $ 

NOTE 8: COMMON STOCK
Long-Term Incentive Plan
On September 12, 2023 the stockholders of the Company approved the Quantum Corporation 2023 Long-Term incentive plan (“2023 LTIP”). The 2023 LTIP serves as the successor to the Company’s 2012 Long-Term Incentive Plan and provides for grants of performance share units, restricted stock units and stock options. On August 15, 2024, the stockholders of the Company approved an additional 250,000 shares of Common Stock under the 2023 LTIP for future issuance.
Reverse Stock Split
16

On August 26, 2024, the Company effected the Reverse Stock Split of the Company’s our issued and outstanding Common Stock. The Common Stock began to trade on a post-split basis on August 27, 2024. The par value of the Common Stock was unchanged as a result of the Reverse Stock Split, remaining at $0.01 per share, which resulted in the reclassification of capital from par value to capital in excess of par value. All share and per share data for comparative periods included within the Company’s Condensed Consolidated Financial Statements and related footnotes have been adjusted to account for the effect of the Reverse Stock Split.
Warrants
In connection with debt refinancing and amendment activities, the Company issued warrants to purchase shares of the Common Stock in December 2018 which are exercisable until December 27, 2028 (the "December 2018 Warrants”), in June 2020 which are exercisable until June 16, 2030 (the "June 2020 Warrants") and issued the June 2023 Warrants and May 2024 Warrants are until June 1, 2033 and May 24, 2034, respectively (collectively, the “Lender Warrants”). In July 2024, the Company issued warrants which are exercisable until July 11, 2034 and additional warrants were issued in August 2024 which are exercisable until August 13, 2034 (the “August 2024 Warrants”).

As part of the August 2024 Warrants, the Company agreed to lower the exercise price of certain outstanding warrants to purchase an aggregate of 430,711 shares of Common Stock held by the Term Loan lenders or their affiliates to $6.20 per share (the “Amended and Restated Warrants”). Other than lowering the exercise price and inserting certain restrictions on adjustments in the event of dilutive issuances at a price lower than the amended exercise price, the terms of the Amended and Restated Warrants are substantially similar to those contained in the original warrants.

On December 30, 2024, 467,248 warrants were exercised in a cashless exercise whereby 61,270 shares with a value of $6.20 per share were used to settle the exercise price and the remaining 405,978 shares were issued to the warrant holders.

The following summarizes the Company's outstanding Lender Warrants (in thousands, except exercise price):

December 2018 WarrantsJune 2020 WarrantsJune 2023 WarrantsMay 2024 WarrantsJuly 2024 WarrantsAugust 2024 WarrantsTotal
March 31, 2024:
   Exercise price$26.60$55.40$20.00n/an/an/a
   Number shares under warrant(s)357 184 63 n/an/an/a604 
   Fair value$2,320 $1,135 $591 n/an/an/a$4,046 
December 31, 2024:
   Exercise price
$6.20 - $26.04
$6.20 - $54.19
$6.20$6.20$6.20$6.20
   Number shares under warrant(s)220 114 63 38 19 224678 
   Fair value$10,518 $5,369 $3,336 $1,979 $989 $11,814 $34,005 

The table below sets forth a summary of changes in the fair value of the Company’s Level 2 warrant liabilities as of December 31, 2023 and 2024:

Balance as of March 31, 2023$7,989 
Issuance of warrants1,194 
Change in fair value of warrant liabilities(7,340)
Balance as of December 31, 2023$1,843 

17

Balance as of March 31, 2024$4,046 
Issuance of warrants
3,157 
Exercise of warrants
(30,118)
Change in fair value of warrant liabilities56,408 
Repricing adjustment512 
Balance as of December 31, 2024$34,005 

Upon exercise, the aggregate exercise price of the Lender Warrants may be paid, at each warrant holder’s election, in cash or on a net issuance basis, based upon the fair market value of the Common Stock at the time of exercise. The exercise price and the number of shares underlying the Lender Warrants are subject to adjustment in the event of specified events, including dilutive issuances of equity instruments at a price lower than the exercise price of the respective warrants (the "Down Round Feature"), repricing of existing equity-linked instruments at a price lower than the exercise price of the respective warrants (the "Warrant Repricing Feature"), a subdivision or combination of the Common Stock, a reclassification of the Common Stock or specified dividend payments. The Company's warrants also have a provision that determines the potential stock price used when applying the Black-Scholes valuation model to determine the settlement price of the warrants in Successor Major Transactions ("SMT"), as defined in the respective warrant agreements, which include a change in control or liquidation (the "Warrant Settlement Price Provision"). The Warrant Settlement Price Provision requires the use of the greater of the closing price of the Common Stock on the trading day immediately preceding the date on which an SMT is consummated, the closing market price of the Common Stock following the first public announcement of an SMT or the closing market of the Common Stock immediately preceding the announcement of an SMT. Due to these terms, equity classification was precluded, and these warrants are carried as liabilities at fair value.
The Company also issued 2,500 warrants to purchase the Common Stock in June 2020 and June 2023 to advisors of the Company at an exercise price of $60.00 and $20.00, respectively (collectively the "Other Warrants"). The Company has concluded that the Other Warrants do not contain provisions that would require liability classification under Topic 480 or Topic 718 and have been equity classified.
Registration Rights Agreements

The Lender Warrants grant the holders certain registration rights for the shares of Common Stock issuable upon the exercise of the applicable warrants, including (a) the ability of a holder to request that the Company file a Form S-1 registration statement with respect to at least 40% of the registrable securities held by such holder as of the issuance date of the applicable warrants; (b) the ability of a holder to request that the Company file a Form S-3 registration statement with respect to outstanding registrable securities if at any time the Company is eligible to use a Form S-3 registration statement; and (c) certain piggyback registration rights related to potential future equity offerings of the Company, subject to certain limitations.

NOTE 9: NET LOSS PER SHARE
The Company has performance share units, restricted stock units and options to purchase shares under its Employee Stock Purchase Plan, as amended and restated on July 25, 2023 (“ESPP”), granted under various stock incentive plans that, upon exercise and vesting, would increase shares outstanding. The Company has also issued warrants to purchase shares of the Common Stock.
The dilutive impact related to Common Stock from restricted stock units and warrants is determined by applying the treasury stock method to the assumed vesting of outstanding restricted stock units and the exercise of outstanding warrants. The dilutive impact related to Common Stock from contingently issuable performance share units is determined by applying a two-step approach using both the contingently issuable share guidance and the treasury stock method.
The following weighted-average outstanding shares of Common Stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
18

Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Stock Awards181  76 17 
Warrants678 608 845 608 

The Company had outstanding market based restricted stock units as of December 31, 2024 that were eligible to vest into shares of the Common Stock subject to the achievement of certain stock price targets in addition to a time-based vesting period. These contingently issuable shares are excluded from the computation of diluted earnings per share if, based on current period results, the shares would not be issuable if the end of the reporting period were the end of the contingency period. There were 170,750 shares of contingently issuable market-based restricted stock units that were excluded from the table above as the market conditions were not satisfied as of December 31, 2024.

NOTE 10: INCOME TAXES
The effective tax rate for the three and nine months ended December 31, 2024 was (0.1)% and (0.6)%, respectively, as compared to (5.5)% and (7.6)%, for the three and nine months ended December 31, 2023, respectively. The effective tax rates differed from the federal statutory tax rate of 21% during each of these periods due primarily to unbenefited losses experienced in jurisdictions with valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions.

As of December 31, 2024, including interest and penalties, the Company had $90.9 million of unrecognized tax benefits, $78.5 million of which, if recognized, would favorably affect the effective tax rate without consideration of the valuation allowance. As of December 31, 2024, the Company had accrued interest and penalties related to these unrecognized tax benefits of $1.4 million. The Company recognizes interest and penalties related to income tax matters in the income tax provision in the condensed consolidated statements of operations. As of December 31, 2024, $83.2 million of unrecognized tax benefits were recorded as a contra deferred tax asset in other long-term assets in the condensed consolidated balance sheet and $7.8 million (including interest and penalties) were recorded in other long-term liabilities in the condensed consolidated balance sheets. During the next 12 months, it is reasonably possible that approximately $12.8 million of tax benefits, inclusive of interest and penalties, that are currently unrecognized could be recognized as a result of the expiration of applicable statutes of limitations. Upon recognition of the tax benefit related to the expiring statutes of limitation, $11.8 million will be offset by the establishment of a related valuation allowance. The net tax benefit recognized in the statements of operation is estimated to be $1.0 million.

NOTE 11: COMMITMENTS AND CONTINGENCIES
Commitments to Purchase Inventory
The Company uses contract manufacturers for its manufacturing operations. Under these arrangements, the contract manufacturer procures inventory to manufacture products based upon the Company’s forecast of customer demand. The Company has similar arrangements with certain other suppliers. The Company is responsible for the financial impact on the supplier or contract manufacturer of any reduction or product mix shift in the forecast relative to materials that the third party had already purchased under a prior forecast. Such a variance in forecasted demand could require a cash payment for inventory in excess of current customer demand or for costs of excess or obsolete inventory. As of December 31, 2024, the Company had issued non-cancelable commitments for $29.5 million to purchase inventory from its contract manufacturers and suppliers.

Legal Proceedings
Arrow Electronics Matter
On July 27, 2023, an electronics component distributor filed a lawsuit in a federal court in the Northern District of California against Quantum, alleging breach of contract and breach of the covenant of good faith and fair dealing, seeking, among other things just over $4.0 million in damages. Quantum has filed a responsive pleading disputing Arrow Electronics’ claims and plans to aggressively defend itself against them. Written and oral discovery is complete and both parties have filed motions for summary judgment. As of date, Arrow Electronics’ motion for summary judgment has been denied, and Quantum’s motion for summary judgment has been granted in part and denied in part. Quantum also filed a motion to exclude Arrow Electronics’ expert witness report, which was granted. Trial is currently set to commence in February 2025. At this time, Quantum believes the probability that this lawsuit will have a material adverse effect on our business, operating results, or financial condition is remote.
19


Other Commitments
Additionally, from time to time, the Company is party to various legal proceedings and claims arising from the normal course of business activities. Based on current available information, the Company does not expect that the ultimate outcome of any currently pending matters, individually or in the aggregate, will have a material adverse effect on the Company’s results of operations, cash flows or financial position.

NOTE 12: SUBSEQUENT EVENTS
Warrants
On January 3, 2025, 677,905 warrants were exercised in a cashless exercise whereby 228,195 shares with a weighted average value of $35.42 per share were used to settle the exercise price and the remaining 449,710 shares were issued to the warrant holders.
Standby Equity Purchase Agreement
On January 25, 2025, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”), with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“YA”) managed by Yorkville Advisors Global, LP. Pursuant to and subject to the terms of the SEPA, YA has committed to purchase up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA.

Any sale of Common Stock pursuant to the SEPA is subject to certain limitations, including that we may not issue to YA more than 19.99% of the Common Stock outstanding immediately prior to the execution of the SEPA. In connection with the execution of the SEPA, the Company has issued to YA 42,158 shares of Common Stock as consideration for YA’s commitment to purchase shares of Common Stock under the SEPA.

Term Loan Amendments
On January 27, 2025, the Company entered into an amendment (the “January 2025 Term Loan Amendment”) to the Term Loan. The January 2025 Term Loan Amendment, among other things, (i) amends the minimum EBITDA covenant so that such covenant is not tested on December 31, 2024 or March 31, 2025, (ii) amends certain mandatory prepayment events, and (iii) waives certain events of default, in each case, as set forth in the January 2025 Term Loan Amendment.
On January 27, 2025, the Company entered into an amendment (the “January 2025 Revolver Amendment”) to the PNC Credit Facility. The January 2025 Revolver Amendment, among other things, (i) amends the minimum EBITDA covenant so that such covenant is not tested on December 31, 2024 or March 31, 2025, (ii) amends certain mandatory prepayment events, and (iii) waives certain events of default, in each case, as set forth in the January 2025 Revolver Amendment.

20


ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis compares the change in the consolidated financial statements for quarters ending December 31, 2024 and December 31, 2023 and should be read together with our consolidated financial statements, the accompanying notes, and other information included in this Quarterly Report. In particular, the risk factors contained in Part II, Item 1A may reflect trends, demands, commitments, events, or uncertainties that could materially impact our results of operations and liquidity and capital resources. For comparisons of quarters ended December 31, 2023 and December 31, 2022, see our Management's Discussion and Analysis of Financial Condition and Results of Operations in Item 2 of our Quarterly Report on Form 10-Q for the quarter ended December 31, 2023, filed with the SEC on September 6, 2024, and incorporated herein by reference. Our fiscal year ends on March 31 of each calendar year. "Fiscal 2024" refers to the fiscal year ended March 31, 2024.

The following discussion contains forward-looking statements, such as statements regarding anticipated impacts on our business, our future operating results and financial position, our business strategy and plans, our market growth and trends, and our objectives for future operations. Please see "Note Regarding Forward-Looking Statements" for more information about relying on these forward-looking statements.

OVERVIEW
We are a technology company whose mission is to deliver innovative solutions to organizations across the world. We design, manufacture and sell technology and services that help customers capture, create and share digital content, and protect it for decades. We emphasize innovative technology in the design and manufacture of our products to help our customers unlock the value in their video and unstructured data in new ways to solve their most pressing business challenges.

We generate revenue by designing, manufacturing, and selling technology and services. Our most significant expenses are related to compensating employees; designing, manufacturing, marketing, and selling our products and services; data center costs in support of our cloud-based services; and interest associated with our long-term debt and income taxes.

Macroeconomic Conditions

We continue to actively monitor, evaluate and respond to the current uncertain macro environment, including the impact of higher interest rates, inflation, tariffs, lingering supply chain challenges, and a stronger U.S. dollar. During the quarter we continued to experience longer sales cycle for opportunities with our enterprise as well as commercial customers.

The macro environment remains unpredictable and our past results may not be indicative of future performance.


21

RESULTS OF OPERATIONS
Three Months Ended December 31,Nine Months Ended December 31,
(in thousands)2024202320242023
Total revenue$72,551 $71,926 $214,364 $240,099 
Total cost of revenue (1)
40,796 42,745 127,205 142,543 
Gross profit31,755 29,181 87,159 97,556 
Operating expenses
Sales and marketing (1)
12,448 14,244 39,321 45,800 
General and administrative (1)
14,142 11,893 49,186 34,833 
Research and development (1)
7,683 8,763 24,255 28,828 
Restructuring charges (1)
1,342 497 2,916 3,164 
Total operating expenses35,615 35,397 115,678 112,625 
Loss from operations(3,860)(6,216)(28,519)(15,069)
Other income (expense), net967 (1,419)(408)(2,049)
Interest expense(6,840)(3,937)(16,761)(10,992)
Change in fair value of warrant liabilities(61,630)2,213 (56,414)7,341 
Loss on debt extinguishment— — (3,003)— 
      Net loss before income taxes(71,363)(9,359)(105,105)(20,769)
Income tax provision70 510 675 1,573 
Net loss$(71,433)$(9,869)$(105,780)$(22,342)
(1) Includes stock-based compensation as follows:
Three Months Ended December 31,Nine Months Ended December 31,
(in thousands)2024202320242023
Cost of revenue$95 $195 $361 $576 
Research and development105 325 454 989 
Sales and marketing46 (123)219 516 
General and administrative490 509 1,342 1,657 
   Total$736 $906 $2,376 $3,738 


Comparison of the Three Months Ended December 31, 2024 and 2023

Revenue
Three Months Ended December 31,
(dollars in thousands)2024% of
revenue
2023% of
revenue
$ Change% Change
Product revenue$38,610 53 %$37,113 51 %$1,497 %
Service and subscription31,615 44 %32,771 46 %(1,156)(4)%
Royalty2,326 %2,042 %284 14 %
Total revenue$72,551 100 %$71,926 100 %$625 %
Product Revenue
In the three months ended December 31, 2024, product revenue increased $1.5 million, or 4%, as compared to the same period in fiscal 2024. The primary driver of the increase was in Primary storage systems with higher sales of our StorNext based solutions.
22

Service and Subscription Revenue
Service and subscription revenue decreased $1.2 million, or 4%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024. This decrease was due to certain long-lived products reaching their end-of-service-life.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw a small increase of $0.3 million, or 14%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024 due to product mix.

Gross Profit and Margin
Three Months Ended December 31,
(dollars in thousands)2024Gross
margin %
2023Gross
margin %
$ ChangeBasis point change
Product $7,688 19.9 %$7,069 19.0 %$619 90 
Service and subscription21,741 68.8 %20,070 61.2 %1,671 760 
Royalty 2,326 100.0 %2,042 100.0 %284 — 
Gross profit$31,755 43.8 %$29,181 40.6 %$2,574 320 
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin increased by $0.6 million, or by 90 basis points, for the three months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily due to a more favorable mix of revenues, weighted towards our higher margin product lines, as well as improvements in our operational efficiency and logistics costs.
Service and Subscription Gross Margin
Service and subscription gross margins increased 760 basis points for the three months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily driven by improvements in our operations efficiency.
Royalty Gross Margin
Royalties do not have significant related cost of sales.

Operating Expenses
Three Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Sales and marketing$12,448 17 %$14,244 20 %$(1,796)(13)%
General and administrative14,142 19 %11,893 17 %2,249 19 %
Research and development7,683 11 %8,763 12 %(1,080)(12)%
Restructuring charges1,342 %497 %845 170 %
   Total operating expenses$35,615 49 %$35,397 49 %$218 %
In the three months ended December 31, 2024, sales and marketing expenses decreased $1.8 million, or 13%, as compared with the same period in fiscal 2024. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.
In the three months ended December 31, 2024, general and administrative expenses increased $2.2 million, or 19%, as compared with the same period in fiscal 2024 This increase was primarily driven by higher expense in compliance focused outside services related to ongoing projects.
23

In the three months ended December 31, 2024, research and development expenses decreased $1.1 million, or 12%, as compared with the same period in fiscal 2024 This decrease was the result of the continued consolidation of acquisition costs, and efficiencies realized through improved organization design.
In the three months ended December 31, 2024, restructuring expenses increased $0.8 million, or 170% as compared with the same period in fiscal 2024 The increase was the result of cost reduction initiatives in the current year.

Other Income (Expense)
Three Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Other income (expense)$967 %$(1,419)(2)%$2,386 168 %
The change in other income (expense), net during the three months ended December 31, 2024 compared with the same period in fiscal 2024 was related primarily to fluctuations in foreign currency exchange rates during the three months ended December 31, 2024.

Interest Expense
Three Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Interest expense$(6,840)(9)%$(3,937)(5)%$(2,903)74 %
In the three months ended December 31, 2024, interest expense increased $2.9 million, or 74%, as compared with the same period in fiscal 2024 due to a higher effective interest rate on our Term Loan.

Warrant liabilities
Three Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Change in fair value of warrant liabilities$(61,630)(85)%$4,402 %$(66,032)(1,500)%

In December 31, 2024, the change in fair value of warrant liabilities increased $66.0 million, or (1,500)%, as compared with the same period in fiscal 2024, due to a lower average stock price in the second fiscal quarter of 2024.

Income Taxes
Three Months Ended December 31,
(dollars in thousands)2024% of pretax income2023% of pretax income$ Change% Change
Income tax provision$70 — %$510 (5)%$(440)(86)%
The income tax provision for the three months ended December 31, 2024 and 2023 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.

24

Comparison of the Nine Months Ended December 31, 2024 and 2023

Revenue
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Product revenue$116,389 54 %$138,635 58 %$(22,246)(16)%
Service and subscription90,383 42 %94,229 39 %(3,846)(4)%
Royalty7,592 %7,235 %357 %
Total revenue$214,364 100 %$240,099 100 %$(25,735)(11)%
Product Revenue
In the nine months ended December 31, 2024, product revenue decreased $22.2 million, or 16%, as compared to the same period in fiscal 2024. The primary driver of the decrease was a $20 million decrease in demand from our large hyperscale customers, as well as more general decreases in the overall tape market with declines in media and devices revenue. Outside of the Tape and Hyperscale business, our remaining Secondary and Primary storage systems are also offered as a subscription. We expect the product revenue portion of our Primary and Secondary storage systems to decrease as we continue to transition to subscription-based offerings.
Service and Subscription Revenue
We offer a broad range of services including product maintenance, implementation, and training as well as software subscriptions. Service revenue is primarily comprised of customer field support contracts which provide standard support services for our hardware. Standard service contracts may be extended or include enhanced service, such as faster service response times.
Service and subscription revenue decreased $3.8 million, or 4%, in the nine months ended December 31, 2024 compared to the same period in fiscal 2024. This decrease was primarily driven by certain long-lived products reaching their end-of-service-life, partially offset by increases in subscription-based revenue.
Royalty Revenue
We receive royalties from third parties that license our linear-tape open media patents through our membership in the linear-tape open consortium. Royalty revenue saw a small increase of $0.4 million, or 5%, in the three months ended December 31, 2024 compared to the same period in fiscal 2024 due to product mix.

Gross Profit and Margin
Nine Months Ended December 31,
(dollars in thousands)2024Gross
margin %
2023Gross
margin %
$ ChangeBasis point change
Product $23,137 19.9 %$33,421 24.1 %$(10,284)(420)
Service and subscription56,428 62.4 %56,900 60.4 %(472)200 
Royalty 7,592 100.0 %7,235 100.0 %357 — 
Gross profit$87,157 40.7 %$97,556 40.6 %$(10,399)10 
Gross profit and margin percentages are key metrics that management monitors to assess the performance on the business.
Product Gross Margin
Product gross margin decreased 420 basis points, for the nine months ended December 31, 2024, as compared with the same period in fiscal 2024. This decrease was primarily due to a less favorable mix of revenues, weighted towards our lower margin product lines, which were partially offset from improvements in our operational efficiency and logistics costs.
Service and Subscription Gross Margin
25

Service and subscription gross margin increased 200 basis points for the nine months ended December 31, 2024, as compared with the same period in fiscal 2024. This increase was primarily driven by lowered operation costs as we continue to drive efficiencies.
Royalty Gross Margin
Royalties do not have significant related cost of sales.

Operating Expenses
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Sales and marketing$39,321 18 %$45,800 19 %$(6,479)(14)%
General and administrative49,186 23 %34,833 15 %14,353 41 %
Research and development24,255 11 %28,828 12 %(4,573)(16)%
Restructuring charges2,916 %3,164 %(248)(8)%
   Total operating expenses$115,678 54 %$112,625 47 %$3,053 %

In the nine months ended December 31, 2024, sales and marketing expense decreased $6.5 million, or 14%, compared with the same period in fiscal 2024. This decrease was primarily driven by improved operational efficiency and increased leverage of our channel.
In the nine months ended December 31, 2024, general and administrative expense increased $14.4 million, or 41%, compared with the same period in fiscal 2024. This increase was primarily driven by non-recurring costs related to our previously announced restatement of our historical financial statements, and other related projects.
In the nine months ended December 31, 2024, research and development expenses decreased $4.6 million, or 16%, as compared with the same period in fiscal 2024. This decrease was the result of the continued consolidation of acquisition costs, and efficiencies realized through improved organization design.
In the nine months ended December 31, 2024, restructuring expenses decreased $0.2 million, or 8%, as compared with the same period in fiscal 2024. The decrease was the result of cost reduction initiatives in the prior year.

Other Income (Expense)
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Other income (expense)$(408)%$(2,049)(1)%$1,641 80 %
The change in other income (expense), net during the nine months ended December 31, 2024 compared with the same period in fiscal 2024 was related primarily to fluctuations in foreign currency exchange rates during the three months ended December 31, 2024.

Interest Expense
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Interest expense$(16,761)(8)%$(10,992)(5)%$(5,769)52 %
In the nine months ended December 31, 2024, interest expense increased $5.8 million, or 52%, as compared with the same period in fiscal 2024 due to a higher effective interest rate on our Term Loan.

26

Warrant liabilities
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Change in fair value of warrant liabilities$(56,414)(26)%$7,341 %$(63,755)(868)%

In December 31, 2024, the change in fair value of warrant liabilities increased $63.8 million, or 868%, as compared with the same period in fiscal 2024 due to a lower average stock price in the second fiscal quarter of 2024.

Loss on Debt Extinguishment
Nine Months Ended December 31,
(dollars in thousands)2024% of revenue2023% of revenue$ Change% Change
Loss on debt extinguishment$(3,003)%$— — %$(3,003)100 %
In the nine months ended December 31, 2024, loss on debt extinguishment was related to a prepayment of our Term Loan.

Income Taxes
Nine Months Ended December 31,
(dollars in thousands)2024% of pretax income2023% of pretax income$ Change% Change
Income tax provision$675 (1)%$1,573 (8)%$(898)(57)%
The income tax provision for the nine months ended December 31, 2024 and 2023 is primarily influenced by foreign and state income taxes. Due to our history of net losses in the United States, the protracted period for utilizing tax attributes in certain foreign jurisdictions, and the difficulty in predicting future results, we believe that we cannot rely on projections of future taxable income to realize most of our deferred tax assets. Accordingly, we have established a full valuation allowance against our U.S. and certain foreign net deferred tax assets. Significant management judgment is required in assessing our ability to realize any future benefit from our net deferred tax assets. We intend to maintain this valuation allowance until sufficient positive evidence exists to support its reversal. Our income tax expense recorded in the future will be reduced to the extent that sufficient positive evidence materializes to support a reversal of, or decrease in, our valuation allowance.

27

LIQUIDITY AND CAPITAL RESOURCES
We consider liquidity in terms of the sufficiency of internal and external cash resources to fund our operating, investing and financing activities. Our principal sources of liquidity include cash from operating activities, cash and cash equivalents on our balance sheet and amounts available under our revolving credit facility agreement with PNC Bank, National Association, as amended from time to time (the “PNC Credit Facility”). We require significant cash resources to meet obligations to pay principal and interest on our outstanding debt, provide for our research and development activities, fund our working capital needs, and make capital expenditures. Our future liquidity requirements will depend on multiple factors, including our research and development plans and capital asset needs.
We had cash and cash equivalents of $20.4 million as of December 31, 2024, which consisted primarily of bank deposits and money market accounts. As of December 31, 2024, our total outstanding Term Loan debt was $105.9 million and PNC Credit Facility borrowings were $37.5 million. As of December 31, 2024, we had $1.6 million available to borrow under the PNC Credit Facility.
We are subject to various debt covenants under our debt agreements. Our failure to comply with our debt covenants could materially and adversely affect our financial condition and ability to service our obligations. As discussed in Note 1: Description of Business and Significant Accounting Policies—Going Concern, we expect to be in violation of our net leverage covenant as of the June 30, 2025 testing date and the violation will cause the outstanding Term Loan and PNC Credit Facility outstanding balances to become due as an event of default. As a result, we have classified the Term Loan and PNC Credit Facility as current liabilities in the accompanying consolidated balance sheet. We entered into a Standby Equity Purchase Agreement (the “SEPA”) on January 25, 2025, pursuant to which we have a right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. See Note 12: Subsequent Events for additional information related to the SEPA. Additionally, the Company is evaluating strategies to obtain the additional funding, including potential covenant waivers. We may be unable to obtain additional funding. As such, there can be no assurance that we will be able to obtain additional liquidity when needed or under acceptable terms, if at all. For additional information about our debt, see the sections entitled “Risk Factors—Risks Related to Our Indebtedness” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” in the Annual Report.

Cash Flows

The following table summarizes our consolidated cash flows for the periods indicated.
 
 Nine Months Ended December 31,
(in thousands)20242023
Cash provided by (used in):
   Operating activities$(20,345)$(20,727)
   Investing activities(4,324)(5,025)
   Financing activities19,415 24,138 
   Effect of exchange rate changes(3)(12)
Net decrease in cash, cash equivalents and restricted cash
$(5,257)$(1,626)

Cash Used In Operating Activities

Net cash used in operating activities was $20.3 million for the nine months ended December 31, 2024. This use of cash was primarily attributed to lower earnings.

Net cash used in operating activities was $20.7 million for the nine months ended December 31, 2023. This use of cash was primarily attributed to cash used in operations excluding changes in assets and liabilities of $8.0 million in addition to cash used from working capital changes.

Cash Used in Investing Activities

28

Net cash used in investing activities was $4.3 million in the nine months ended December 31, 2024, which was attributable to capital expenditures.

Net cash used in investing activities was $5.0 million in the nine months ended December 31, 2023, which was attributable to capital expenditures.

Cash Provided by Financing Activities

Net cash provided by financing activities was $19.4 million for the nine months ended December 31, 2024, which was related primarily to borrowings on our Term Loan.

Net cash provided by financing activities was $24.1 million for the nine months ended December 31, 2023, which was related primarily to borrowings on the PNC Credit Facility of $14.6 million and borrowing on our Term Loan of $9.6 million net of issuance costs.

Commitments and Contingencies

Our contingent liabilities consist primarily of certain financial guarantees, both express and implied, related to product liability and potential infringement of intellectual property. We have little history of costs associated with such indemnification requirements and contingent liabilities associated with product liability may be mitigated by our insurance coverage. In the normal course of business to facilitate transactions of our services and products, we indemnify certain parties with respect to certain matters, such as intellectual property infringement or other claims. We also have indemnification agreements with our current and former officers and directors. It is not possible to determine the maximum potential amount under these indemnification agreements due to the limited history of our indemnification claims, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these agreements have not had a material impact on our operating results, financial position or cash flows.

We are also subject to ordinary course litigation.

Off Balance Sheet Arrangements

Except for the indemnification commitments described under “Commitments and Contingencies” above, we do not currently have any other off-balance sheet arrangements and do not have any holdings in variable interest entities.

Contractual Obligations

We have contractual obligations and commercial commitments, some of which, such as purchase obligations, are not recognized as liabilities in our financial statements. There have not been any material changes to the contractual obligations disclosed in the Annual Report.
Critical Accounting Estimates and Policies
The preparation of our consolidated financial statements in accordance with generally accepted accounting principles requires management to make judgments, estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes included elsewhere in this Quarterly Report. On an ongoing basis, we evaluate estimates, which are based on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. We consider certain accounting policies to be critical to understanding our financial statements because the application of these policies requires significant judgment on the part of management, which could have a material impact on our financial statements if actual performance should differ from historical experience or if our assumptions were to change. Our accounting policies that include estimates that require management’s subjective or complex judgments about the effects of matters that are inherently uncertain are summarized in the Annual Report under the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Estimates and Policies.” For additional information on our significant accounting policies, see Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.

Recently Issued and Adopted Accounting Pronouncements

29

See Note 1 to our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
There have been no material changes to our quantitative and qualitative disclosures about market risk from those described under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in the Form 10-K, which such section is incorporated herein by reference.

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive and principal financial officers, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)), as of the end of the period covered by this Quarterly Report. Based on such evaluation, our principal executive and principal financial officers have concluded that as of such date, our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses described below.

Notwithstanding the identified material weaknesses, management, including our chief executive officer and chief financial officer have determined, that the condensed consolidated financial statements included in this Form 10-Q fairly represent in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, for the periods presented in accordance with U.S. generally accepted accounting principles.

Material Weaknesses in Internal Control Over Financial Reporting

The following material weaknesses in our internal control over financial reporting, as initially disclosed in Part II, Item 9A, “Controls and Procedures” of our Annual Report on Form 10-K for the year ended March 31, 2024 had not been remediated as of December 31, 2024. Specifically:
The Company’s accounting practices and procedures for applying standalone selling price under Accounting Standards Codification Topic 606 Revenue from Contracts with Customers (“Topic 606”) were not adequate to conclude on the application of standalone selling price consistent with the generally accepted application of the guidance in Topic 606.
The Company did not maintain effective controls over the accuracy of the inputs in the sales order entry process to ensure accuracy of the price, quantity, and related customer data.
Remediation Plan
The Company is implementing enhancements to its internal controls to remediate these material weaknesses in its internal control over financial reporting, including:
Review and update significant relevant accounting policies, procedures and controls.
Provide additional training to individuals involved in the assessments for these topics.
Engage with external third parties to assist with assessments for these topics, where necessary.

The Company is committed to maintaining a strong internal control environment and believes the remediation efforts, will represent significant improvements in its controls over the control environment. These steps will take time to be fully implemented and confirmed to be effective and sustainable. Additional controls may also be required over time. While the Company believes that these efforts will improve its internal control over financial reporting, the Company will not be able to conclude whether the steps the Company is taking will remediate the material weakness in internal control over financial reporting until a sufficient period has passed to allow management to test the design and operational effectiveness of the new and enhanced controls. Until the remediation steps set forth above are fully implemented and tested, the material weaknesses will continue to exist.

Changes in Internal Control

Except for the ongoing remediation measures to address the remaining material weaknesses, in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act, there were no changes in our internal control over
30

financial reporting that occurred during the quarter ended December 31, 2024 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls

Our management does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected. The design of any system of controls is also based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
See Note 11: Commitments and Contingencies to the unaudited condensed consolidated financial statements for a discussion of our legal matters.

ITEM 1A. RISK FACTORS
Except as set forth below, there have been no material changes to the previously disclosed risk factors discussed in “Part I, Item 1A, Risk Factors” in the Annual Report. You should consider carefully these factors, together with all of the other information in this Quarterly Report, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report, before making an investment decision.

It is not possible to predict the actual number of shares we will sell under the SEPA, or the actual gross proceeds resulting from those sales.

On January 25, 2025, we entered into the SEPA with YA, pursuant to which YA committed to purchase up to $200.0 million in shares of our Common Stock, subject to certain limitations and conditions.

We generally have the right to control the timing and amount of any sales of our shares of Common Stock to YA under the SEPA. Because the purchase price per share to be paid by YA for the shares of Common Stock that we may elect to sell to YA under the SEPA will fluctuate based on the market prices of our Common Stock during the applicable purchase valuation period for each purchase made pursuant to the SEPA, it is not possible for us to predict the total number of shares of Common Stock that we will sell to YA under the SEPA, the purchase price per share that YA will pay for shares purchased from us in the future under the SEPA, or the aggregate gross proceeds that we will receive from those purchases by YA under the SEPA. Sales of shares of our Common Stock pursuant to the SEPA will be dilutive to stockholders.

Moreover, although the SEPA provides that we may sell up to an aggregate of $200.0 million of our Common Stock to YA, only 2,302,733 shares of our Common Stock under the SEPA are being registered for resale by YA, which registration statement on Form S-1 filed with the SEC on January 27, 2025, as amended (as amended, the “Registration Statement”), has not yet been declared effective. If it becomes necessary for us to issue and sell to YA under the SEPA more than the shares that are being registered for resale under the Registration Statement in order to receive aggregate gross proceeds equal to the total commitment of aggregate of $200.0 million under the SEPA, we must file with the SEC one or more additional registration statements to register under the Securities Act of 1933 the resale by YA of any such additional shares of our Common Stock we wish to sell from time to time under the SEPA, which the SEC must declare effective and we may need to obtain stockholder approval to issue shares of Common Stock in excess of the exchange cap under the SEPA in accordance with applicable listing rules of The Nasdaq Stock Market.

31

ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Arrangement

During the period covered by this Quarterly Report, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
32

ITEM 6. EXHIBITS

The exhibits required to be filed or furnished as part of this Quarterly Report are listed below. Notwithstanding any language to the contrary, exhibits 32.1 and 32.2 shall not be deemed to be filed as part of this Quarterly Report for purposes of Section 18 of the Exchange Act or deemed to be incorporated by reference into any filing under the Exchange Act or the Securities Act of 1933, except to the extent that the Company specifically incorporates it by reference.
Incorporated by Reference
Exhibit
Number
Exhibit DescriptionFormFiling DateExhibitFiled or Furnished Herewith
3.1
S-1
1/27/253.1

3.2
10-K
6/28/243.2
10.1*
X
10.2*
X
10.3*
X
31.1X
31.2X
32.1X
32.2X
101.SCHXBRL Taxonomy Extension Schema DocumentX
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentX
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentX
101.LABXBRL Taxonomy Extension Label Linkbase DocumentX
101.PREXBRL Taxonomy Extension Presentation Linkbase DocumentX
104Cover page interactive data file, submitted using inline XBRL (contained in Exhibit 101)X
* Schedules and attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish supplemental copies of any of the omitted schedules and attachments upon request by the Securities and Exchange Commission.
# Indicates management contract or compensatory plan or arrangement.

33


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Quantum Corporation
(Registrant)
 
February 12, 2025/s/ James J. Lerner
(Date)James J. Lerner
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
February 12, 2025/s/ Kenneth P. Gianella
(Date)Kenneth P. Gianella
Chief Financial Officer
(Principal Financial Officer)
34
Exhibit 10.1
ELEVENTH AMENDMENT TO TERM LOAN CREDIT AND SECURITY AGREEMENT
THIS ELEVENTH AMENDMENT TO TERM LOAN CREDIT AND SECURITY AGREEMENT (this  “Amendment”), dated as of October 28, 2024 (the  “Eleventh Amendment Effective Date”), is entered into by and among QUANTUM CORPORATION, a Delaware corporation (“Quantum”, and together with each other Person joined to the Credit Agreement as a borrower from time to time, collectively, the “Borrowers”, and each, a “Borrower”), QUANTUM LTO HOLDINGS, LLC, a Delaware limited liability company (“Quantum LTO”), SQUARE BOX SYSTEMS LIMITED, a company incorporated in England and Wales (registered number 03819556) (“Square Box”, and together with Quantum LTO and each other Person joined to the Credit Agreement as a guarantor from time to time, collectively, the “Guarantors”, and each, a “Guarantor”, and together with the Borrowers, collectively, the “Loan Parties”, and each, a “Loan Party”), the financial institutions which are now or which hereafter become a party to the Credit Agreement as lenders (collectively, the “Lenders”, and each, a “Lender”) constituting the Required Lenders, and BLUE TORCH FINANCE LLC (“Blue Torch”), in its capacity as disbursing agent and collateral agent for the Lenders (in such capacity, together with its successors and assigns, “Agent”).
RECITALS
A.Agent, the Lenders and certain of the Loan Parties are parties to that certain Term Loan Credit and Security Agreement, dated as of August 5, 2021, as amended by that certain First Amendment to Term Loan Credit and Security Agreement, dated as of September 30, 2021, that certain Second Amendment to Term Loan Credit and Security Agreement, dated as of March 15, 2022, that certain Third Amendment to Term Loan Credit and Security Agreement, dated as of April 25, 2022, that certain Fourth Amendment to Term Loan Credit and Security Agreement, dated as of June 1, 2023, that certain Fifth Amendment and Waiver to Term Loan Credit and Security Agreement, dated as of February 14, 2024 and subject to the Waiver to Term Loan Credit and Security Agreement, dated as of November 13, 2023, that certain Sixth Amendment to Term Loan Credit and Security Agreement, dated as of March 22, 2024, that certain Seventh Amendment and Waiver to Term Loan Credit and Security Agreement, dated as of May 15, 2024, that certain Eighth Amendment and Waiver to Term Loan Credit and Security Agreement, dated as of May 24, 2024, that certain Ninth Amendment to Term Loan Credit and Security Agreement, dated as of July 11, 2024, and that certain Tenth Amendment to Term Loan Credit and Security Agreement, dated as of August 13, 2024 (as amended hereby and as the same may have been further amended, supplemented or otherwise modified from time to time prior to the date hereof, the  “Credit Agreement”), pursuant to which the Lenders have made and may hereafter make certain loans and have provided and may hereafter provide certain financial accommodations to the Borrowers.
B.The Borrowers have requested that Agent and the Required Lenders agree to amend certain provisions of the Credit Agreement as set forth herein, and Agent and the Required Lenders have agreed to make such amendments, subject to the terms and conditions set forth herein.







AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
1.Interpretation. Capitalized terms used herein and not defined shall have the meanings given to such terms in the Credit Agreement.
2.Amendments to Credit Agreement. Pursuant to the request of the Loan Parties and subject to the satisfaction of the conditions set forth in Section 3 hereof and in reliance on the representations and warranties set forth in Section 4 hereof and otherwise herein, the Credit Agreement is hereby amended effective as of the Eleventh Amendment Effective Date as follows:
(a)The following definitions are hereby added to Section 1.2 of the Credit Agreement in their proper alphabetical order:
(b)“ “Eleventh Amendment” shall mean the Eleventh Amendment to Term Loan Credit and Security Agreement, dated as of the Eleventh Amendment Effective Date, by and among Agent, the Lenders party thereto, and the Loan Parties.”
(c)“ “Eleventh Amendment Effective Date” shall mean October 28, 2024.”
(d)The definition of “Permitted Dispositions” in Section 1.2 of the Credit Agreement is hereby amended by (i) deleting the word “and” from the end of clause (q) in such definition, and (ii) deleting clause (r) of such definition in its entirety and replacing it with the following:
“(r)    Dispositions of Service Inventory on or after the Sixth Amendment Effective Date but prior to the Eleventh Amendment Effective Date, so long as (i) the aggregate purchase price received by Quantum and its Subsidiaries in respect of all such Dispositions pursuant to this clause (r) does not exceed $15,000,000, (ii) in any such Disposition, the purchase price is paid to such Loan Party or Subsidiary in cash, and (iii) the Net Cash Proceeds of any such Specified Inventory Disposition are applied to prepay the Loans as (and to the extent) required by Section 2.3(a), in the amounts set forth therein; and”

“(s)    Dispositions of Service Inventory pursuant to one or more transactions to a purchaser separately identified to Agent on or after the Eleventh Amendment Effective Date, so long as (i) the aggregate purchase price received by Quantum and its Subsidiaries in respect of all such Dispositions pursuant to this clause (s) does not exceed $7,600,000, (ii) in any such Disposition, the purchase price is (x) no less than the cost value of such Service Inventory as



2


reflected in the financial statements of Quantum and its Subsidiaries in accordance with GAAP and (y) paid to such Loan Party or Subsidiary 100% in cash and (iii) the Net Cash Proceeds of any such Disposition are applied to prepay the Loans as (and to the extent) required by Section 2.3(a), in the amounts set forth therein;”
(e)Section 2.3 of the Credit Agreement is hereby amended by deleting clause (a) thereof in its entirety and replacing it with the following:
“(a)    Subject to the Intercreditor Agreement, from and after the Tenth Amendment Effective Date, concurrently upon receipt by any Loan Party of any Net Cash Proceeds as a result of any Disposition pursuant to clauses (h), (n), (p), (q), (r) and (s) of the definition of “Permitted Dispositions” of any Collateral which constitutes Term Priority Collateral, Borrowers shall prepay the Loans in an amount equal to 100% of such Net Cash Proceeds of such Disposition; provided that up to $7,000,000 of Net Cash Proceeds from any Disposition permitted under clause (s) of the definition of “Permitted Dispositions” shall not be subject to this clause (a) and may be retained by the Loan Parties to be used for general working capital purposes and any Net Cash Proceeds required to be paid under this clause (a) with respect to such Disposition permitted under such clause (s) may be paid no later than two Business Days following receipt thereof. Net Cash Proceeds received prior to the Tenth Amendment Effective Date shall be subject to the terms of this Agreement as in effect prior to the Tenth Amendment Effective Date.”
3.Conditions Precedent. The effectiveness of this Amendment is expressly conditioned upon the satisfaction of each of the following conditions precedent:
(a)Agent shall have received this Amendment, duly authorized, executed and delivered by each Loan Party and the Required Lenders.
(b)As of the Eleventh Amendment Effective Date and immediately after giving effect to this Amendment and the Revolving Loan Amendment (as defined below), no Default or Event of Default shall have occurred and be continuing.
(c)As of the Eleventh Amendment Effective Date and immediately after giving effect to this Amendment and the Revolving Loan Amendment, the representations and warranties set forth in Section 4 hereof shall be true and correct in all material respects (without duplication of any materiality qualifier).
(d)Agent shall have received, in form and substance reasonably satisfactory to Agent, an amendment under the Revolving Loan Agreement (the  “Revolving Loan Amendment”), duly authorized, executed and delivered by the Borrowers, the Guarantors, the Revolving Loan Agent and the Revolving Loan Lenders.



3


Agent shall notify the Borrowers in writing of the effectiveness of this Amendment, which notice shall be conclusive and binding on all parties to the Credit Agreement. For the avoidance of doubt, it is understood and agreed that such written notification shall not be a condition to the effectiveness of this Amendment or the occurrence of the Eleventh Amendment Effective Date.
4.Representations and Warranties. In addition to the continuing representations and warranties heretofore or hereafter made by the Loan Parties to Agent and Lenders pursuant to the Credit Agreement and the Other Documents, each Loan Party hereby represents and warrants to Agent and each Lender as follows:
(a)each Loan Party has full power, authority and legal right to enter into this Amendment and to perform all its respective Obligations hereunder;
(b)this Amendment has been duly executed and delivered by each Loan Party;
(c)this Amendment constitutes the legal, valid and binding obligation of each Loan Party enforceable in accordance with its terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency, moratorium or similar Laws affecting creditors’ rights generally;
(d)the execution, delivery and performance of this Amendment (i) are within each Loan Party’s corporate or limited liability company powers, as applicable, (ii) have been duly authorized by all necessary corporate or limited liability company action, as applicable, (iii) are not in contravention of law or the terms of such Loan Party’s Organizational Documents or to the conduct of such Loan Party’s business or any Material Contract or undertaking to which such Loan Party is a party or by which such Loan Party is bound, including without limitation the Revolving Loan Documents, (iv) will not conflict with or violate any material provisions of any law or regulation, or any judgment, order or decree of any Governmental Body, (v) will not require the Consent of any Governmental Body, any party to a Material Contract or any other Person, except (x) any Consents of any party to a Material Contract or any other Person (other than a Governmental Body) with respect to which the failure to obtain could not reasonably be expected, individually or in the aggregate to have a Material Adverse Effect, (y) any immaterial Consents of any Governmental Body, or (z) those Consents set forth on Schedule 5.1 to the Credit Agreement, all of which will have been duly obtained, made or complied with prior to the Eleventh Amendment Effective Date and which are in full force and effect on the Eleventh Amendment Effective Date, and (vi) will not conflict with, nor result in any breach in any of the provisions of or constitute a default under or result in the creation of any Lien except Permitted Encumbrances upon any asset of such Loan Party under the provisions of any material agreement, instrument, or other document to which such Loan Party is a party or by which it or its property is a party or by which it may be bound, including without limitation any of the Revolving Loan Documents;
(e)each Loan Party is duly formed or incorporated, as applicable, and in good standing under the laws of the state of its incorporation or formation, as applicable, and



4


is good standing in such state and is qualified to do business in any state where the failure to be so qualified could reasonably be expected to result in a Material Adverse Effect;
(f)each of the representations and warranties made by any Loan Party in the Credit Agreement and the Other Documents, after giving effect to this Amendment and the Revolving Loan Amendment, are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as if made on the Eleventh Amendment Effective Date and after giving effect to this Amendment and the Revolving Loan Amendment and the transactions contemplated hereby and thereby, except to the extent that any such representation or warranty is made as of an earlier and/or specified date, in which case such representation or warranty shall have been true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as of such earlier or specified date; and
(g)on the Eleventh Amendment Effective Date and immediately after giving effect to this Amendment and the Revolving Loan Amendment, no Default or Event of Default exists or has occurred and is continuing.
5.Costs and Expenses. Each Loan Party, jointly and severally, agrees to pay on demand all costs and expenses of Agent and the Lenders incurred in connection with the preparation, negotiation, execution and delivery of this Amendment and the other agreements, instruments and documents to be delivered hereunder (including, without limitation, the reasonable fees, disbursements and other charges of counsel to each of Agent and the Lenders with respect thereto) in accordance with the Credit Agreement.
6.Reaffirmation.
(a)Each Loan Party hereby ratifies and reaffirms (i) all of its payment and performance obligations, contingent or otherwise, under the Credit Agreement and each of the Other Documents to which it is a party, and (ii) its grant to Agent of a security interest in the Collateral under the Credit Agreement and each of the Other Documents to which it is a party.
(b)Square Box hereby confirms for the benefit of the Secured Parties that all obligations owed by it pursuant to Article XVII of the Credit Agreement shall remain in full force and effect notwithstanding the amendments referred to in this Amendment.
7.Acknowledgments. To induce Agent and Lenders to enter into this Amendment, each Loan Party acknowledges that:
(a)as of the Eleventh Amendment Effective Date, (i) Agent and Lenders have performed without default all obligations required of Agent and Lenders under the Credit Agreement and each of the Other Documents; and (ii) there are no disputes with or claims against Agent or Lenders, or any knowledge of any facts giving rise to any disputes or claims, related to the Credit Agreement or any of the Other Documents, including, without limitation, any disputes or claims or knowledge of facts giving rise thereto, that involve a breach or



5


violation on the part of Agent or any Lender of the terms and conditions of the Credit Agreement or any of the Other Documents; and
(b)no Loan Party has any valid defense to the enforcement of its respective obligations set forth in the Credit Agreement, the Other Documents or this Amendment, as applicable, by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to the Eleventh Amendment Effective Date.
8.Governing Law. This Amendment and all matters relating hereto or arising herefrom (whether arising under contract law, tort law or otherwise) shall, in accordance with Section 5-1401 of the General Obligations Law of the State of New York, be governed by and construed in accordance with the Laws of the State of New York.
9.Reference to Credit Agreement. Each of the Credit Agreement and the Other Documents, and any and all other agreements, documents or instruments now or hereafter executed and/or delivered pursuant to the terms hereof or pursuant to the terms of the Credit Agreement as modified hereby, are hereby amended so that any reference therein to the Credit Agreement, whether direct or indirect, shall mean a reference to the Credit Agreement as modified hereby. This Amendment shall constitute an Other Document under the Credit Agreement.
10.Effect of this Amendment. Except as expressly amended pursuant hereto, no other changes or modifications to the Credit Agreement or any of the Other Documents are intended or implied, and in all other respects, the Credit Agreement and each of the Other Documents is hereby specifically ratified, restated and confirmed by all parties hereto as of the Eleventh Amendment Effective Date. To the extent that any provision of the Credit Agreement or any of the Other Documents are inconsistent with the provisions of this Amendment, the provisions of this Amendment shall control.
11.Binding Effect. This Amendment shall be binding upon and inure to the benefit of each party hereto and their respective successors and permitted assigns.
12.Further Assurances. The Loan Parties shall execute and deliver such further documents and do such further acts and things as may be reasonably requested by Agent to effectuate the provisions and purposes of this Amendment.
13.Counterparts; Electronic Signature. This Amendment may be executed in any number of separate counterparts, all of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or electronic transmission (including email transmission of a.pdf image) shall be deemed to be an original signature hereto and shall be as effective as delivery of a manually executed counterpart hereof. The words  “execution,”  “execute”,  “signed,”  “signature,” and words of like import in or related to this Amendment or any document to be signed in connection with this Amendment shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms, or the keeping of records in electronic form, each of which shall be of the same legal



6


effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.
14.Entire Understanding. This Amendment and the documents executed concurrently herewith contain the entire understanding between each Loan Party, Agent and each Lender and supersede all prior agreements and understandings, if any, relating to the subject matter hereof.
15.Severability. If any part of this Amendment is contrary to, prohibited by, or deemed invalid under Applicable Laws, such provision shall be inapplicable and deemed omitted to the extent so contrary, prohibited or invalid, but the remainder hereof shall not be invalidated thereby and shall be given effect so far as possible.
16.Captions. The captions at various places in this Amendment are intended for convenience only and do not constitute and shall not be interpreted as part of this Amendment.
17.Jury Waiver. EACH PARTY TO THIS AMENDMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR THE TRANSACTIONS RELATED HERETO OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE AND EACH PARTY HEREBY CONSENTS THAT ANY SUCH CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AMENDMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

[Remainder of Page Intentionally Left Blank]




7


IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first above written.
BORROWERS:
QUANTUM CORPORATION
By:
/s/ Lewis Moorehead
Name:Lewis Moorehead
Title:Vice President of Finance and Treasurer
GUARANTORS:
SQUARE BOX SYSTEMS LIMITED
By:
/s/ Lewis Moorehead
Name:Lewis Moorehead
Title:Director
QUANTUM LTO HOLDINGS, LLC
By:
/s/ Lewis Moorehead
Name:Lewis Moorehead
Title:Vice President of Finance and Treasurer




[Eleventh Amendment to Term Loan Credit and Security Agreement]


AGENT AND LENDERS:
BLUE TORCH FINANCE LLC, solely in its
capacity as Agent and not in its individual capacity
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory
BTC HOLDINGS FUND II, LLC, as a Lender
By:
Blue Torch Credit Opportunities Fund II LP,
its sole member
By:
Blue Torch Credit Opportunities GP LLC, its
general partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory
BTC HOLDINGS SBAF FUND LLC, as a Lender
By:
Blue Torch Credit Opportunities SBAF Fund
LP, its sole member
By:Blue Torch Credit Opportunities SBAF GP LLC, its general partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory
BTC HOLDINGS KRS FUND LLC, as a Lender
By:
Blue Torch Credit Opportunities KRS Fund LP,
its sole member
By:
Blue Torch Credit Opportunities KRS GP LLC,
its general partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory




[Eleventh Amendment to Term Loan Credit and Security Agreement]







[Eleventh Amendment to Term Loan Credit and Security Agreement]


BTC OFFSHORE HOLDINGS FUND II-B LLC
By:Blue Torch Offshore Credit Opportunities Master Fund II LP, its Sole Member
By:
Blue Torch Offshore Credit Opportunities GP
II LLC, its General Partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory
BTC OFFSHORE HOLDINGS FUND II-C LLC
By:Blue Torch Offshore Credit Opportunities Master Fund II LP, its Sole Member
By:Blue Torch Offshore Credit Opportunities GP II LLC, its General Partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory
BTC HOLDINGS SC FUND LLC
By:Blue Torch Credit Opportunities SC Master Fund LP, its sole member
By:Blue Torch Credit Opportunities SC GP LLC, its general partner
By:KPG BTC Management LLC, its sole member
By:
/s/ Kevin Genda
Name:Kevin Genda
Title:Authorized Signatory




[Eleventh Amendment to Term Loan Credit and Security Agreement]


OC III LVS XXXIII LP, as a Lender
By:By: OC III GP II LLC, its general partner
By:
/s/ Adam L. Gubner
Name:Adam L. Gubner
Title:Authorized Person
CO FINANCE LVS XVII LLC, as a Lender
By:
/s/ Gabe Goldstein
Name:Gabe Goldstein
Title:Authorized Person





[Eleventh Amendment to Term Loan Credit and Security Agreement]
Exhibit 10.2
Execution Version
SEVENTEENTH AMENDMENT TO
AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT
THIS SEVENTEENTH AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT (this  “Amendment”), dated as of October 28, 2024, is entered into by and among QUANTUM CORPORATION, a Delaware corporation (“Quantum”), QUANTUM LTO HOLDINGS, LLC, a Delaware limited liability company (“Quantum LTO”, and together with Quantum and each other Person joined to the Credit Agreement as a borrower from time to time, collectively, the “Borrowers”, and each, a “Borrower”), SQUARE BOX SYSTEMS LIMITED, a company incorporated in England and Wales (registered number 03819556) (“Square Box”, and together with each other Person joined to the Credit Agreement as a guarantor from time to time, collectively, the “Guarantors”, and each, a “Guarantor”, and together with the Borrowers, collectively, the “Loan Parties”, and each, a “Loan Party”), the financial institutions which are now or which hereafter become a party to the Credit Agreement as lenders (collectively, the “Lenders”, and each, a “Lender”), and PNC BANK, NATIONAL ASSOCIATION, in its capacity as agent for the Lenders (in such capacity, together with its successors and assigns, “Agent”).
RECITALS
A.Agent, the Lenders and certain of the Loan Parties are parties to the Amended and Restated Revolving Credit and Security Agreement, dated as of December 27, 2018, as amended by the First Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 3, 2020, the Second Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 11, 2020, the Third Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of June 16, 2020, the Fourth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of December 10, 2020, the Fifth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of February 5, 2021, the Sixth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of August 5, 2021, the Seventh Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of September 30, 2021, the Eighth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of March 15, 2022, the Ninth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 25, 2022, the Tenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of June 1, 2023, the Eleventh Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of February 14, 2024, the Twelfth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of March 22, 2024, the Thirteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of May 15, 2024, the Fourteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of May 24, 2024, the Fifteenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of July 10, 2024, and the Sixteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of August 13, 2024 (as amended hereby and as the same may be further amended, modified, supplemented, renewed, restated or replaced from time to time, the “Credit Agreement”), pursuant to which the Lenders have made and may hereafter make certain loans and have provided and may hereafter provide certain financial accommodations to the Borrowers.
B.The Borrowers have requested that Agent and the Lenders agree to amend certain provisions of the Credit Agreement as set forth herein, and Agent and the Lenders have agreed to make such amendments, subject to the terms and conditions set forth herein.






AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
1.Interpretation. Capitalized terms used herein and not defined shall have the meanings given to such terms in the Credit Agreement.
2.Amendments to Credit Agreement. Subject to the satisfaction of the conditions set forth in Section 3 hereof and in reliance on the representations and warranties set forth in Section 4 hereof and otherwise herein, the Credit Agreement and the Eleventh Amendment are hereby amended effective as of the Seventeenth Amendment Effective Date as follows:
(a)New Definitions. The following definitions are hereby added to Section 1.2 of the Credit Agreement in their proper alphabetical order:
(b)    “Term Loan Eleventh Amendment” shall have the meaning given to such term in the Seventeenth Amendment.
(c)Seventeenth Amendment” shall mean the Seventeenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of the Seventeenth Amendment Effective Date, by and among Agent, Lenders and the Loan Parties.
(d)    “Seventeenth Amendment Effective Date” shall mean October 28, 2024.
(e)Amendments to Definitions. The definition of “Permitted Dispositions” in Section 1.2 of the Credit Agreement is hereby amended by deleting clause (r) of such definition in its entirety and replacing it with the following:
“(r)    Dispositions of Service Inventory on or after the Twelfth Amendment Effective Date but prior to the Seventeenth Amendment Effective Date, so long as (i) the aggregate purchase price received by Quantum and its Subsidiaries in respect of all such Dispositions pursuant to this clause (r) does not exceed $15,000,000, (ii) in any such Disposition, the purchase price is paid to Quantum or its Subsidiaries in cash, and (iii) the Net Cash Proceeds of any such Disposition are applied in accordance with Section 2.3(a) of the Term Loan Credit Agreement (as in effect on the Twelfth Amendment Effective Date, after giving effect to the Term Loan Sixth Amendment); and

(s)    Dispositions of Service Inventory pursuant to one or more transactions to a purchaser separately identified to Agent on or after the Seventeenth Amendment Effective Date, so long as (i) the aggregate purchase price received by Quantum and its Subsidiaries in respect of all such Dispositions pursuant to this clause (s) does not exceed $7,600,000, (ii) in any such Disposition, the purchase price (x) is paid to Quantum or its Subsidiaries in cash and (y) is no less than the cost value of such Service Inventory as reflected in the financial statements of Quantum and its Subsidiaries in accordance with GAAP, and (iii) the Net Cash Proceeds of any Disposition pursuant to this clause (s) are applied (x) first, to the outstanding Revolving Advances as of the Seventeenth Amendment Effective Date in the amount of up to $7,000,000 (which amount may be



2


immediately re-borrowed in accordance with the terms of this Agreement), and (y) then, in accordance with Section 2.3(a) of the Term Loan Credit Agreement (as in effect on the Seventeenth Amendment Effective Date, after giving effect to the Term Loan Eleventh Amendment);”.

(f)Section 2.20 of the Credit Agreement. Section 2.20 of the Credit Agreement is hereby amended by deleting clause (a) thereof in its entirety and replacing it with the following:
“(a)    Subject to the Intercreditor Agreement, from and after the Sixteenth Amendment Effective Date, concurrently upon receipt by any Loan Party of any Net Cash Proceeds as a result of any Disposition pursuant to clauses (h), (n), (p), (q), or (s) of the definition of “Permitted Dispositions” of any Collateral which constitutes ABL Priority Collateral, Borrowers shall prepay the Advances in an amount equal to 100% of such Net Cash Proceeds of such Disposition; provided that up to $7,000,000 of any Net Cash Proceeds from any Disposition permitted under clause (s) of the definition of “Permitted Dispositions” shall not be subject to this clause (a) and may be retained by the Loan Parties to be used for general working capital purposes. Net Cash Proceeds received prior to the Sixteenth Amendment Effective Date shall be subject to the terms of this Agreement as in effect prior to the Sixteenth Amendment Effective Date. The foregoing shall not be deemed to be implied consent to any Disposition otherwise prohibited by the terms and conditions hereof.”

3.Conditions Precedent. The effectiveness of this Amendment is expressly conditioned upon the satisfaction of each of the following conditions precedent:
(a)Agent shall have received this Amendment, duly authorized, executed and delivered by each Loan Party and the Lenders;
(b)Agent shall have received, in form and substance reasonably satisfactory to Agent, an amendment to the Term Loan Agreement (the  “Term Loan Eleventh Amendment”), duly authorized, executed and delivered by the Borrowers, the Guarantors, the Term Loan Agent and the Term Loan Lenders.
(c)as of the Seventeenth Amendment Effective Date and immediately after giving effect to this Amendment and the Term Loan Eleventh Amendment, no Default or Event of Default shall have occurred and be continuing; and
(d)as of the Seventeenth Amendment Effective Date and immediately after giving effect to this Amendment and the Term Loan Eleventh Amendment, the representations and warranties set forth in Section 4 hereof shall be true and correct in all material respects (without duplication of any materiality qualifier).
Agent shall notify the Borrowers in writing of the effectiveness of this Amendment, which notice shall be conclusive and binding on all parties to the Credit Agreement. For the avoidance of doubt, it is understood and agreed that such written notification shall not be a condition to the effectiveness of this Amendment or the occurrence of the Seventeenth Amendment Effective Date.
4.Representations and Warranties. In addition to the continuing representations and warranties heretofore or hereafter made by the Loan Parties to Agent and Lenders pursuant to the Credit



3


Agreement and the Other Documents, each Loan Party hereby represents and warrants to Agent and each Lender as follows:
(a)each Loan Party has full power, authority and legal right to enter into this Amendment and to perform all its respective Obligations hereunder;
(b)this Amendment has been duly executed and delivered by each Loan Party;
(c)this Amendment constitutes the legal, valid and binding obligation of each Loan Party enforceable in accordance with its terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency, moratorium or similar Laws affecting creditors’ rights generally;
(d)the execution, delivery and performance of this Amendment (i) are within each Loan Party’s corporate or limited liability company powers, as applicable, (ii) have been duly authorized by all necessary corporate or limited liability company action, as applicable, (iii) are not in contravention of law or the terms of such Loan Party’s Organizational Documents or to the conduct of such Loan Party’s business or any Material Contract or undertaking to which such Loan Party is a party or by which such Loan Party is bound, including without limitation the Term Loan Documents, (iv) will not conflict with or violate any material provisions of any law or regulation, or any judgment, order or decree of any Governmental Body, (v) will not require the Consent of any Governmental Body, any party to a Material Contract or any other Person, except (x) any Consents of any party to a Material Contract or any other Person (other than a Governmental Body) with respect to which the failure to obtain could not reasonably be expected, individually or in the aggregate to have a Material Adverse Effect, (y) any immaterial Consents of any Governmental Body, or (z) those Consents set forth on Schedule 5.1 to the Credit Agreement, all of which will have been duly obtained, made or complied with prior to the Seventeenth Amendment Effective Date and which are in full force and effect on the Seventeenth Amendment Effective Date, and (vi) will not conflict with, nor result in any breach in any of the provisions of or constitute a default under or result in the creation of any Lien except Permitted Encumbrances upon any asset of such Loan Party under the provisions of any material agreement, instrument, or other document to which such Loan Party is a party or by which it or its property is a party or by which it may be bound, including without limitation any of the Term Loan Documents;
(e)each Loan Party is duly formed or incorporated, as applicable, and in good standing under the laws of the state of its incorporation or formation, as applicable, and is good standing in such state and is qualified to do business in any state where the failure to be so qualified could reasonably be expected to result in a Material Adverse Effect;
(f)each of the representations and warranties made by any Loan Party in the Credit Agreement and the Other Documents, after giving effect to this Amendment and the Term Eleventh Loan Amendment, are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as if made on the Seventeenth Amendment Effective Date and after giving effect to this Amendment and the Term Loan Eleventh Amendment and the transactions contemplated hereby and thereby, except to the extent that any such representation or warranty is made as of an earlier and/or specified date, in which case such representation or warranty shall have been true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as of such earlier or specified date; and



4


(g)on the Seventeenth Amendment Effective Date and immediately after giving effect to this Amendment and the Term Loan Eleventh Amendment, no Default or Event of Default exists or has occurred and is continuing.
5.Costs and Expenses. Each Loan Party, jointly and severally, agrees to pay on demand all costs and expenses of Agent and the Lenders incurred in connection with the preparation, negotiation, execution and delivery of this Amendment and the other agreements, instruments and documents to be delivered hereunder (including, without limitation, the reasonable fees, disbursements and other charges of counsel to each of Agent and the Lenders with respect thereto) in accordance with the Credit Agreement.
6.Reaffirmation.
(a)Each Loan Party hereby ratifies and reaffirms (i) all of its payment and performance obligations, contingent or otherwise, under the Credit Agreement and each of the Other Documents to which it is a party, and (ii) its grant to Agent of a security interest in the Collateral under the Credit Agreement and each of the Other Documents to which it is a party.
(b)Square Box hereby confirms for the benefit of the Secured Parties that all obligations owed by it pursuant to Article XVII of the Credit Agreement shall remain in full force and effect notwithstanding the amendments referred to in this Amendment.
7.Acknowledgments. To induce Agent and Lenders to enter into this Amendment, each Loan Party acknowledges that:
(a)as of the Seventeenth Amendment Effective Date, (i) Agent and Lenders have performed without default all obligations required of Agent and Lenders under the Credit Agreement and each of the Other Documents; and (ii) there are no disputes with or claims against Agent or Lenders, or any knowledge of any facts giving rise to any disputes or claims, related to the Credit Agreement or any of the Other Documents, including, without limitation, any disputes or claims or knowledge of facts giving rise thereto, that involve a breach or violation on the part of Agent or any Lender of the terms and conditions of the Credit Agreement or any of the Other Documents; and
(b)no Loan Party has any valid defense to the enforcement of its respective obligations set forth in the Credit Agreement, the Other Documents or this Amendment, as applicable, by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to Seventeenth Amendment Effective Date.
8.Governing Law. This Amendment and all matters relating hereto or arising herefrom (whether arising under contract law, tort law or otherwise) shall, in accordance with Section 5-1401 of the General Obligations Law of the State of New York, be governed by and construed in accordance with the Laws of the State of New York.
9.Reference to Credit Agreement. Each of the Credit Agreement and the Other Documents, and any and all other agreements, documents or instruments nor or hereafter executed and/or delivered pursuant to the terms hereof or pursuant to the terms of the Credit Agreement as modified hereby, are hereby amended so that any reference therein to the Credit Agreement, whether direct or indirect, shall mean a reference to the Credit Agreement as modified hereby. This Amendment shall constitute an Other Document under the Credit Agreement.



5


10.Effect of this Amendment. Except as expressly amended pursuant hereto, no other changes or modifications to the Credit Agreement or any of the Other Documents are intended or implied, and in all other respects, the Credit Agreement and each of the Other Documents is hereby specifically ratified, restated and confirmed by all parties hereto as of the Seventeenth Amendment Effective Date. To the extent that any provision of the Credit Agreement or any of the Other Documents are inconsistent with the provisions of this Amendment, the provisions of this Amendment shall control.
11.Binding Effect. This Amendment shall be binding upon and inure to the benefit of each party hereto and their respective successors and permitted assigns.
12.Further Assurances. The Loan Parties shall execute and deliver such further documents and do such further acts and things as may be reasonably requested by Agent to effectuate the provisions and purposes of this Amendment.
13.Counterparts; Electronic Signature. This Amendment may be executed in any number of separate counterparts, all of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or electronic transmission (including email transmission of a.pdf image) shall be deemed to be an original signature hereto and shall be as effective as delivery of a manually executed counterpart hereof. The words  “execution,”  “execute”,  “signed,”  “signature,” and words of like import in or related to this Amendment or any document to be signed in connection with this Amendment shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.
14.Entire Understanding. This Amendment and the documents executed concurrently herewith contain the entire understanding between each Loan Party, Agent and each Lender and supersede all prior agreements and understandings, if any, relating to the subject matter hereof.
15.Severability. If any part of this Amendment is contrary to, prohibited by, or deemed invalid under Applicable Laws, such provision shall be inapplicable and deemed omitted to the extent so contrary, prohibited or invalid, but the remainder hereof shall not be invalidated thereby and shall be given effect so far as possible.
16.Captions. The captions at various places in this Amendment are intended for convenience only and do not constitute and shall not be interpreted as part of this Amendment.
17.Jury Waiver. EACH PARTY TO THIS AMENDMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR THE TRANSACTIONS RELATED HERETO OR THERETO IN EACH CASE



6


WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE AND EACH PARTY HEREBY CONSENTS THAT ANY SUCH CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AMENDMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

[Remainder of Page Intentionally Left Blank]




7


IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first above written.

BORROWERS:
QUANTUM CORPORATION

By:    /s/ Lewis Moorehead
Name: Lewis Moorehead
Title: Vice President of Finance and Treasurer

QUANTUM LTO HOLDINGS, LLC

By:    /s/ Lewis Moorehead
Name:    Lewis Moorehead
Title:    Vice President of Finance and Treasurer
GUARANTORS:
SQUARE BOX SYSTEMS LIMITED

By:    /s/ Lewis Moorehead
Name:    Lewis Moorehead
Title:    Director

AGENT AND LENDERS:
PNC BANK, NATIONAL ASSOCIATION,
as Agent and Lender

By:    /s/ Jeffrey Kessler
Name:    Jeffrey Kessler
Title:     Senior Vice President
 










[Seventeenth Amendment to Amended and Restated Revolving Credit and Security Agreement]
074658.16079/134868452v.2
074658.16079/150837206v.3
074658.16079/150837206v.7
Exhibit 10.3
[Execution]
EIGHTEENTH AMENDMENT TO
AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT
THIS EIGHTEENTH AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AND SECURITY AGREEMENT (this  “Amendment”), dated as of November 25, 2024 (the “Eighteenth Amendment Effective Date”), is entered into by and among QUANTUM CORPORATION, a Delaware corporation (“Quantum”), QUANTUM LTO HOLDINGS, LLC, a Delaware limited liability company (“Quantum LTO”, and together with Quantum and each other Person joined to the Credit Agreement as a borrower from time to time, collectively, the “Borrowers”, and each, a “Borrower”), SQUARE BOX SYSTEMS LIMITED, a company incorporated in England and Wales (registered number 03819556) (“Square Box”, and together with each other Person joined to the Credit Agreement as a guarantor from time to time, collectively, the “Guarantors”, and each, a “Guarantor”, and together with the Borrowers, collectively, the “Loan Parties”, and each, a “Loan Party”), the financial institutions which are now or which hereafter become a party to the Credit Agreement as lenders (collectively, the “Lenders”, and each, a “Lender”), and PNC BANK, NATIONAL ASSOCIATION, in its capacity as agent for the Lenders (in such capacity, together with its successors and assigns, “Agent”).
RECITALS
A.Agent, the Lenders and certain of the Loan Parties are parties to the Amended and Restated Revolving Credit and Security Agreement, dated as of December 27, 2018, as amended by the First Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 3, 2020, the Second Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 11, 2020, the Third Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of June 16, 2020, the Fourth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of December 10, 2020, the Fifth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of February 5, 2021, the Sixth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of August 5, 2021, the Seventh Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of September 30, 2021, the Eighth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of March 15, 2022, the Ninth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of April 25, 2022, the Tenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of June 1, 2023, the Eleventh Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of February 14, 2024, the Twelfth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of March 22, 2024, the Thirteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of May 15, 2024, the Fourteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of May 24, 2024, the Fifteenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of July 10, 2024, the Sixteenth Amendment and Waiver to Amended and Restated Revolving Credit and Security Agreement, dated as of August 13, 2024, and the Seventeenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of October 28, 2024 (as amended hereby and as the same may be further amended, modified, supplemented, renewed, restated or replaced from time to time, the “Credit Agreement”), pursuant to which the Lenders have made and may hereafter make certain loans and have provided and may hereafter provide certain financial accommodations to the Borrowers.
B.The Borrowers have requested that Agent and the Lenders agree to amend certain provisions of the Credit Agreement as set forth herein, and Agent and the Lenders have agreed to make such amendments, subject to the terms and conditions set forth herein.






AGREEMENT
NOW, THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:
1.Interpretation. Capitalized terms used herein and not defined shall have the meanings given to such terms in the Credit Agreement.
2.Amendments to Credit Agreement. Subject to the satisfaction of the conditions set forth in Section 3 hereof and in reliance on the representations and warranties set forth in Section 4 hereof and otherwise herein, the Credit Agreement is hereby amended effective as of the Eighteenth Amendment Effective Date as follows:
(a)New Definitions. The following definitions are hereby added to Section 1.2 of the Credit Agreement in their proper alphabetical order:
(b)Eighteenth Amendment” shall mean the Eighteenth Amendment to Amended and Restated Revolving Credit and Security Agreement, dated as of the Eighteenth Amendment Effective Date, by and among Agent, Lenders and the Loan Parties.
(c)    “Eighteenth Amendment Effective Date” shall have the meaning given to such term in the Eighteenth Amendment.
(d)Undrawn Availability. Section 6.5 of the Credit Agreement is hereby amended by deleting clause (d) thereof in its entirety and replacing it with the following:
(e)(d) Minimum Undrawn Availability. Not permit Undrawn Availability on any day during the period from and including the Eighteenth Amendment Effective Date through and including December 26, 2024 to be less than $5,000,000.

(f)Minimum Liquidity. Section 6.5 of the Credit Agreement is hereby amended by deleting clause (e) thereof in its entirety and replacing it with the following:
(g)(e) Minimum Liquidity. Not permit Liquidity on any day to be less than the following: (i) for the period from and including December 27, 2024 through and including September 30, 2025, $10,000,000, and (ii) from and after October 1, 2025, $15,000,000; provided that, solely for purposes of determining compliance with this Section 6.5(e), the cash and Cash Equivalents described in clause (a) of the definition of “Qualified Cash” shall not be included in the calculation of Liquidity.



2


3.Conditions Precedent. The effectiveness of this Amendment is expressly conditioned upon the satisfaction of each of the following conditions precedent:
(a)Agent shall have received this Amendment, duly authorized, executed and delivered by each Loan Party and the Lenders;
(b)as of the Eighteenth Amendment Effective Date and immediately after giving effect to this Amendment, no Default or Event of Default shall have occurred and be continuing;
(c)as of the Eighteenth Amendment Effective Date and immediately after giving effect to this Amendment, the representations and warranties set forth in Section 4 hereof shall be true and correct in all material respects (without duplication of any materiality qualifier); and
(d)the Loan Parties shall have paid (or shall pay substantially concurrently with the Eighteenth Amendment Effective Date): (i) the Eighteenth Amendment Fee (as hereinafter defined) and (ii) all costs, expenses and fees owed to Agent and the Lenders in connection with the preparation, execution and delivery of this Amendment to the extent invoiced prior to the Eighteenth Amendment Effective Date.
Agent shall notify the Borrowers in writing of the effectiveness of this Amendment, which notice shall be conclusive and binding on all parties to the Credit Agreement. For the avoidance of doubt, it is understood and agreed that such written notification shall not be a condition to the effectiveness of this Amendment or the occurrence of the Eighteenth Amendment Effective Date.
4.Representations and Warranties. In addition to the continuing representations and warranties heretofore or hereafter made by the Loan Parties to Agent and Lenders pursuant to the Credit Agreement and the Other Documents, each Loan Party hereby represents and warrants to Agent and each Lender as follows:
(a)each Loan Party has full power, authority and legal right to enter into this Amendment and to perform all its respective Obligations hereunder;
(b)this Amendment has been duly executed and delivered by each Loan Party;
(c)this Amendment constitutes the legal, valid and binding obligation of each Loan Party enforceable in accordance with its terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency, moratorium or similar Laws affecting creditors’ rights generally;
(d)the execution, delivery and performance of this Amendment (i) are within each Loan Party’s corporate or limited liability company powers, as applicable, (ii) have been duly authorized by all necessary corporate or limited liability company action, as applicable, (iii) are not in contravention of law or the terms of such Loan Party’s Organizational Documents or to the conduct of such Loan Party’s business or any Material Contract or undertaking to which such Loan Party is a party or by which such Loan Party is bound, including without limitation the Term Loan Documents, (iv) will not conflict with or violate any material provisions of any law or regulation, or any judgment, order or decree of any Governmental Body, (v) will not require the Consent of any Governmental Body, any party to a Material Contract or any other Person, except (x) any Consents of any party to a Material Contract or any other Person (other than a Governmental Body) with respect to which the failure to obtain could not reasonably be expected, individually or in the aggregate to have a Material Adverse Effect, (y) any immaterial Consents of any Governmental Body, or (z) those Consents set forth on Schedule 5.1 to the Credit Agreement, all of which will have been duly obtained, made or complied with prior to the Eighteenth



3


Amendment Effective Date and which are in full force and effect on the Eighteenth Amendment Effective Date, and (vi) will not conflict with, nor result in any breach in any of the provisions of or constitute a default under or result in the creation of any Lien except Permitted Encumbrances upon any asset of such Loan Party under the provisions of any material agreement, instrument, or other document to which such Loan Party is a party or by which it or its property is a party or by which it may be bound, including without limitation any of the Term Loan Documents;
(e)each Loan Party is duly formed or incorporated, as applicable, and in good standing under the laws of the state of its incorporation or formation, as applicable, and is good standing in such state and is qualified to do business in any state where the failure to be so qualified could reasonably be expected to result in a Material Adverse Effect;
(f)each of the representations and warranties made by any Loan Party in the Credit Agreement and the Other Documents, after giving effect to this Amendment, are true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as if made on the Eighteenth Amendment Effective Date and after giving effect to this Amendment and the transactions contemplated hereby, except to the extent that any such representation or warranty is made as of an earlier and/or specified date, in which case such representation or warranty shall have been true and correct in all material respects (except that such materiality qualifier shall not be applicable to any representations and warranties that are qualified or modified by materiality in the text thereof) as of such earlier or specified date; and
(g)on the Eighteenth Amendment Effective Date and immediately after giving effect to this Amendment, no Default or Event of Default exists or has occurred and is continuing.
5.Costs and Expenses. Each Loan Party, jointly and severally, agrees to pay on demand all costs and expenses of Agent and the Lenders incurred in connection with the preparation, negotiation, execution and delivery of this Amendment and the other agreements, instruments and documents to be delivered hereunder (including, without limitation, the reasonable fees, disbursements and other charges of counsel to each of Agent and the Lenders with respect thereto) in accordance with the Credit Agreement.
6.Amendment Fee. In consideration of the agreements set forth herein, Borrowers hereby agree to pay to Agent, for the benefit of the Lenders, an amendment fee in the amount of $100,000 (the “Eighteenth Amendment Fee”), which fee shall be fully earned, due and payable on and as of (and subject to the occurrence of) the effectiveness of this Amendment on the Eighteenth Amendment Effective Date. Borrowers hereby agree that Agent may, in its sole discretion, charge Borrowers’ Account with the amount of the Eighteenth Amendment Fee in satisfaction thereof.
7.Reaffirmation.
(a)Each Loan Party hereby ratifies and reaffirms (i) all of its payment and performance obligations, contingent or otherwise, under the Credit Agreement and each of the Other Documents to which it is a party, and (ii) its grant to Agent of a security interest in the Collateral under the Credit Agreement and each of the Other Documents to which it is a party.
(b)Square Box hereby confirms for the benefit of the Secured Parties that all obligations owed by it pursuant to Article XVII of the Credit Agreement shall remain in full force and effect notwithstanding the amendments referred to in this Amendment.



4


8.Acknowledgments. To induce Agent and Lenders to enter into this Amendment, each Loan Party acknowledges that:
(a)as of the Eighteenth Amendment Effective Date, (i) Agent and Lenders have performed without default all obligations required of Agent and Lenders under the Credit Agreement and each of the Other Documents; and (ii) there are no disputes with or claims against Agent or Lenders, or any knowledge of any facts giving rise to any disputes or claims, related to the Credit Agreement or any of the Other Documents, including, without limitation, any disputes or claims or knowledge of facts giving rise thereto, that involve a breach or violation on the part of Agent or any Lender of the terms and conditions of the Credit Agreement or any of the Other Documents; and
(b)no Loan Party has any valid defense to the enforcement of its respective obligations set forth in the Credit Agreement, the Other Documents or this Amendment, as applicable, by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to Eighteenth Amendment Effective Date.
9.Governing Law. This Amendment and all matters relating hereto or arising herefrom (whether arising under contract law, tort law or otherwise) shall, in accordance with Section 5-1401 of the General Obligations Law of the State of New York, be governed by and construed in accordance with the Laws of the State of New York.
10.Reference to Credit Agreement. Each of the Credit Agreement and the Other Documents, and any and all other agreements, documents or instruments nor or hereafter executed and/or delivered pursuant to the terms hereof or pursuant to the terms of the Credit Agreement as modified hereby, are hereby amended so that any reference therein to the Credit Agreement, whether direct or indirect, shall mean a reference to the Credit Agreement as modified hereby. This Amendment shall constitute an Other Document under the Credit Agreement.
11.Effect of this Amendment. Except as expressly amended pursuant hereto, no other changes or modifications to the Credit Agreement or any of the Other Documents are intended or implied, and in all other respects, the Credit Agreement and each of the Other Documents is hereby specifically ratified, restated and confirmed by all parties hereto as of the Eighteenth Amendment Effective Date. To the extent that any provision of the Credit Agreement or any of the Other Documents are inconsistent with the provisions of this Amendment, the provisions of this Amendment shall control.
12.Binding Effect. This Amendment shall be binding upon and inure to the benefit of each party hereto and their respective successors and permitted assigns.
13.Further Assurances. The Loan Parties shall execute and deliver such further documents and do such further acts and things as may be reasonably requested by Agent to effectuate the provisions and purposes of this Amendment.
14.Counterparts; Electronic Signature. This Amendment may be executed in any number of separate counterparts, all of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or electronic transmission (including email transmission of a.pdf image) shall be deemed to be an original signature hereto and shall be as effective as delivery of a manually executed counterpart hereof. The words  “execution,”  “execute”,  “signed,”  “signature,” and words of like import in or related to this Amendment or any document to be signed in connection with this Amendment shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on



5


electronic platforms, or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act.
15.Entire Understanding. This Amendment and the documents executed concurrently herewith contain the entire understanding between each Loan Party, Agent and each Lender and supersede all prior agreements and understandings, if any, relating to the subject matter hereof.
16.Severability. If any part of this Amendment is contrary to, prohibited by, or deemed invalid under Applicable Laws, such provision shall be inapplicable and deemed omitted to the extent so contrary, prohibited or invalid, but the remainder hereof shall not be invalidated thereby and shall be given effect so far as possible.
17.Captions. The captions at various places in this Amendment are intended for convenience only and do not constitute and shall not be interpreted as part of this Amendment.
18.Jury Waiver. EACH PARTY TO THIS AMENDMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THIS AMENDMENT, ANY OTHER DOCUMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR THE TRANSACTIONS RELATED HERETO OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE AND EACH PARTY HEREBY CONSENTS THAT ANY SUCH CLAIM, COUNTERCLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AMENDMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.

[Remainder of Page Intentionally Left Blank]




6


IN WITNESS WHEREOF, the parties have entered into this Amendment as of the date first above written.

BORROWERS:
QUANTUM CORPORATION

By:    /s/ Lewis Moorehead
Name: Lewis Moorehead
Title: Vice President of Finance and Treasurer

QUANTUM LTO HOLDINGS, LLC

By:    /s/ Lewis Moorehead
Name:    Lewis Moorehead
Title:    Vice President of Finance and Treasurer
GUARANTORS:
SQUARE BOX SYSTEMS LIMITED

By:    /s/ Lewis Moorehead
Name:    Lewis Moorehead
Title:    Director

AGENT AND LENDERS:
PNC BANK, NATIONAL ASSOCIATION,
as Agent and Lender

By:    /s/ Jeffrey Kessler
Name:    Jeffrey Kessler
Title:     Senior Vice President
 










[Eighteenth Amendment to Amended and Restated Revolving Credit and Security Agreement]
074658.16079/134868452v.2
074658.16079/150837206v.3
074658.16079/151299385v.3
074658.16079/151299385v.5
Exhibit 31.1
CERTIFICATION PURSUANT TO SECTION 302(a)
OF THE SARBANES-OXLEY ACT OF 2002
I, James J. Lerner, certify that:
1)I have reviewed this Quarterly Report on Form 10-Q of Quantum Corporation;
2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
DateFebruary 12, 2025
 
/s/ James J. Lerner
James J. Lerner
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)

Exhibit 31.2
CERTIFICATION PURSUANT TO SECTION 302(a)
OF THE SARBANES-OXLEY ACT OF 2002
I, Kenneth P. Gianella, certify that:
1)I have reviewed this Quarterly Report on Form 10-Q of Quantum Corporation;
2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4)The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation; and
d)disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5)The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
DateFebruary 12, 2025
 
/s/ Kenneth P. Gianella
Kenneth P. Gianella
Chief Financial Officer
(Principal Financial Officer)

Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350

I, James J. Lerner, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Quantum Corporation, on Form 10-Q for the quarterly period ended December 31, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Quantum Corporation.

DateFebruary 12, 2025
 
/s/ James J. Lerner
James J. Lerner
President, Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)

Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350

I, Kenneth P. Gianella, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Quantum Corporation, on Form 10-Q for the quarterly period ended December 31, 2024, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects he financial condition and results of operations of Quantum Corporation.
DateFebruary 12, 2025
 
/s/ Kenneth P. Gianella
Kenneth P. Gianella
Chief Financial Officer
(Principal Financial Officer)

v3.25.0.1
Cover Page - shares
9 Months Ended
Dec. 31, 2024
Feb. 11, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2024  
Document Transition Report false  
Entity File Number 001-13449  
Entity Registrant Name QUANTUM CORP /DE/  
Entity Incorporation, State DE  
Entity Tax Identification Number 94-2665054  
Entity Address, Street Address 224 Airport Parkway  
Entity Address, Suite Suite 550  
Entity Address, City San Jose  
Entity Address, State CA  
Entity Address, Postal Zip Code 95110  
City Area Code (408)  
Local Phone Number 944-4000  
Title of each class Common Stock, $0.01 par value per share  
Trading Symbol QMCO  
Name of each exchange on which registered NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   5,834,199
Entity Central Index Key 0000709283  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q3  
Amendment Flag false  
v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Current assets:    
Cash and cash equivalents $ 20,381 $ 25,692
Restricted cash 222 168
Accounts receivable, net of allowance for credit losses of $99 and $22, respectively 61,373 67,788
Manufacturing inventories 18,861 17,753
Service parts inventories 1,884 9,783
Prepaid expenses 2,569 2,186
Other current assets 8,538 8,414
Total current assets 113,828 131,784
Property and equipment, net 11,268 12,028
Goodwill 12,969 12,969
Intangible assets, net 509 1,669
Right-of-use assets 8,670 9,425
Other long-term assets 20,812 19,740
Total assets 168,056 187,615
Current liabilities:    
Accounts payable 34,704 26,087
Accrued compensation 11,702 18,214
Deferred revenue, current portion 69,916 78,511
Term debt 98,609 82,496
Revolving credit facility 37,500 26,604
Warrant liabilities 34,005 4,046
Other accrued liabilities 19,108 13,986
Total current liabilities 305,544 249,944
Deferred revenue, net of current portion 35,350 38,176
Operating lease liabilities 9,067 9,621
Other long-term liabilities 13,150 11,372
Total liabilities 363,111 309,113
Commitments and contingencies (Note 11)
Stockholders' deficit    
Preferred stock, 20,000 shares authorized; no shares issued and outstanding 0 0
Common stock, $0.01 par value; 225,000 shares authorized; 5,307 and 4,792 shares issued and outstanding 53 48
Additional paid-in capital 740,521 708,027
Accumulated deficit (933,160) (827,380)
Accumulated other comprehensive loss (2,469) (2,193)
Total stockholders’ deficit (195,055) (121,498)
Total liabilities and stockholders’ deficit $ 168,056 $ 187,615
v3.25.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Statement of Financial Position [Abstract]    
Allowance for doubtful accounts $ 99 $ 22
Preferred stock shares authorized (in shares) 20,000,000 20,000,000
Preferred stock shares issued (in shares) 0 0
Preferred stock shares outstanding (in shares) 0 0
Common stock par value (in dollars per share) $ 0.01 $ 0.01
Common stock shares authorized (in shares) 225,000,000 225,000,000
Common stock shares issued (in shares) 5,307,000 4,792,000
Common stock shares outstanding (in shares) 5,307,000 4,792,000
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Revenue:        
Total revenue $ 72,551 $ 71,926 $ 214,364 $ 240,099
Cost of revenue:        
Total cost of revenue 40,796 42,745 127,205 142,543
Gross profit 31,755 29,181 87,159 97,556
Operating expenses:        
Sales and marketing 12,448 14,244 39,321 45,800
General and administrative 14,142 11,893 49,186 34,833
Research and development 7,683 8,763 24,255 28,828
Restructuring charges 1,342 497 2,916 3,164
Total operating expenses 35,615 35,397 115,678 112,625
Loss from operations (3,860) (6,216) (28,519) (15,069)
Other income (expense), net 967 (1,419) (408) (2,049)
Interest expense (6,840) (3,937) (16,761) (10,992)
Change in fair value of warrant liabilities (61,630) 2,213 (56,414) 7,341
Loss on debt extinguishment 0 0 (3,003) 0
Net loss before income taxes (71,363) (9,359) (105,105) (20,769)
Income tax provision 70 510 675 1,573
Net loss $ (71,433) $ (9,869) $ (105,780) $ (22,342)
Net loss per share attributable to common stockholders - basic (in dollars per share) $ (14.56) $ (2.08) $ (21.90) $ (4.74)
Net loss per share attributable to common stockholders - diluted (in dollars per share) $ (14.56) $ (2.08) $ (21.90) $ (4.74)
Weighted average shares - basic (in shares) 4,907 4,751 4,831 4,717
Weighted average shares - diluted (in shares) 4,907 4,751 4,831 4,717
Foreign currency translation adjustments, net $ (1,077) $ 1,465 $ (276) $ 994
Total comprehensive loss (72,510) (8,404) (106,056) (21,348)
Product revenue        
Revenue:        
Total revenue 38,610 37,113 116,389 138,635
Cost of revenue:        
Total cost of revenue 30,922 30,044 93,251 105,214
Service and subscription        
Revenue:        
Total revenue 31,615 32,771 90,383 94,229
Cost of revenue:        
Total cost of revenue 9,874 12,701 33,954 37,329
Royalty        
Revenue:        
Total revenue $ 2,326 $ 2,042 $ 7,592 $ 7,235
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating activities    
Net loss $ (105,780) $ (22,342)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 4,440 7,593
Amortization of debt issuance costs 3,704 1,948
Loss on debt extinguishment 3,003 0
Provision for product and service inventories 1,165 3,328
Stock-based compensation 2,376 3,741
Paid in kind interest 3,515 1,401
Change in fair value of warrant liabilities 56,408 (7,340)
Other non-cash (281) 1,609
Changes in assets and liabilities:    
Accounts receivable, net 6,337 12,616
Manufacturing inventories (2,347) (3,099)
Service parts inventories 7,972 (1,520)
Prepaid expenses (382) 394
Accounts payable 9,405 (13,226)
Accrued compensation (6,512) (425)
Deferred revenue (11,421) (4,780)
Other current assets (124) (1,698)
Other non-current assets 1,367 (1,532)
Other current liabilities 5,369 569
Other non-current liabilities 1,441 2,036
Net cash used in operating activities (20,345) (20,727)
Investing activities    
Purchases of property and equipment (4,324) (5,025)
Net cash used in investing activities (4,324) (5,025)
Financing activities    
Borrowings of long-term debt, net of debt issuance costs 25,000 14,083
Repayments of long-term debt (14,092) (4,497)
Borrowings of credit facility 311,135 318,223
Repayments of credit facility (302,628) (303,671)
Net cash provided by financing activities 19,415 24,138
Effect of exchange rate changes on cash, cash equivalents and restricted cash (3) (12)
Net change in cash, cash equivalents and restricted cash (5,257) (1,626)
Cash, cash equivalents, and restricted cash at beginning of period 25,860 26,175
Cash, cash equivalents, and restricted cash at end of period 20,603 24,549
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the statement of cash flows:    
Cash and cash equivalents 20,381 24,377
Restricted cash, current 222 172
Cash, cash equivalents and restricted cash at the end of period 20,603 24,549
Supplemental disclosure of cash flow information    
Cash paid for interest 8,841 9,154
Cash paid for income taxes, net 1,798 1,136
Non-cash transactions    
Purchases of property and equipment included in accounts payable 88 164
Paid-in-kind interest $ 3,515 $ 1,401
v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2023 $ (84,369) $ 47 $ 703,259 $ (786,094) $ (1,581)
Beginning balance (in shares) at Mar. 31, 2023   4,678      
Increase (Decrease) in Stockholders' Equity          
Net loss (22,342)     (22,342)  
Foreign currency translation adjustments, net 994       994
Shares issued under employee incentive plans, net 0        
Shares issued under employee incentive plans, net (in shares)   114      
Warrants issued in connection with debt refinancing 49   49    
Stock-based compensation 3,736   3,736    
Ending balance at Dec. 31, 2023 (101,932) $ 47 707,044 (808,436) (587)
Ending balance (in shares) at Dec. 31, 2023   4,792      
Beginning balance at Sep. 30, 2023 (94,434) $ 47 706,138 (798,567) (2,052)
Beginning balance (in shares) at Sep. 30, 2023   4,775      
Increase (Decrease) in Stockholders' Equity          
Net loss (9,869)     (9,869)  
Foreign currency translation adjustments, net 1,465       1,465
Shares issued under employee incentive plans, net 0        
Shares issued under employee incentive plans, net (in shares)   17      
Stock-based compensation 906   906    
Ending balance at Dec. 31, 2023 (101,932) $ 47 707,044 (808,436) (587)
Ending balance (in shares) at Dec. 31, 2023   4,792      
Beginning balance at Mar. 31, 2024 $ (121,498) $ 48 708,027 (827,380) (2,193)
Beginning balance (in shares) at Mar. 31, 2024 4,792 4,792      
Increase (Decrease) in Stockholders' Equity          
Net loss $ (105,780)     (105,780)  
Foreign currency translation adjustments, net (276)       (276)
Shares issued related to warrants 30,123 $ 4 30,119    
Shares issued related to warrants (in shares)   406      
Shares issued under employee incentive plans, net 0 $ 1 (1)    
Shares issued under employee incentive plans, net (in shares)   109      
Stock-based compensation 2,376   2,376    
Ending balance at Dec. 31, 2024 $ (195,055) $ 53 740,521 (933,160) (2,469)
Ending balance (in shares) at Dec. 31, 2024 5,307 5,307      
Beginning balance at Sep. 30, 2024 $ (153,404) $ 48 709,667 (861,727) (1,392)
Beginning balance (in shares) at Sep. 30, 2024   4,792      
Increase (Decrease) in Stockholders' Equity          
Net loss (71,433)     (71,433)  
Foreign currency translation adjustments, net (1,077)       (1,077)
Shares issued related to warrants 30,123 $ 4 30,119    
Shares issued related to warrants (in shares)   406      
Shares issued under employee incentive plans, net 0 $ 1 (1)    
Shares issued under employee incentive plans, net (in shares)   109      
Stock-based compensation 736   736    
Ending balance at Dec. 31, 2024 $ (195,055) $ 53 $ 740,521 $ (933,160) $ (2,469)
Ending balance (in shares) at Dec. 31, 2024 5,307 5,307      
v3.25.0.1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
9 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Description of Business

Quantum Corporation, together with its consolidated subsidiaries (“Quantum” or the “Company”), stores and manages digital video and other forms of unstructured data, providing streaming performance for video and rich media applications, along with low-cost, long-term storage systems for data protection and archiving. The Company helps customers around the world capture, create and share digital data and preserve and protect it for decades. The Company’s software-defined, hyperconverged storage solutions span from non-volatile memory express, to solid state drives, hard disk drives, tape and the cloud and are tied together leveraging a single namespace view of the entire data environment. The Company works closely with a broad network of distributors, value-added resellers, direct marketing resellers, original equipment manufacturers and other suppliers to meet customers’ evolving needs.

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. All intercompany balances and transactions have been eliminated. Certain information and footnote disclosures normally included in annual financial statements have been condensed or omitted. The Company believes the disclosures made are adequate to prevent the information presented from being misleading. However, the accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included within the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024 (the “Annual Report”).

The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal and recurring items, necessary to present fairly our financial position as of December 31, 2024, the results of operations and comprehensive loss, statements of cash flows, and changes in stockholders’ deficit for the three and nine months ended December 31, 2024 and 2023. Interim results are not necessarily indicative of full year performance because of short-term variations.

Reverse Stock Split

On August 15, 2024, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the issued shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a ratio ranging from 1 share-for-5 shares up to a ratio of 1-for-20 shares, with the exact ratio, if any, to be selected by the board of directors (the “Board”). On August 15, 2024, the Board approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Common Stock. The Reverse Stock Split became effective as of August 26, 2024 at 4:01 p.m., Eastern Time (the “Effective Time”). At the Effective Time, every twenty issued shares of Common Stock were automatically reclassified into one issued share of Common Stock, with any fractional shares resulting from the Reverse Stock Split rounded up to the nearest whole share. The number of outstanding shares of Common Stock was reduced from approximately 95.9 million shares to approximately 4.8 million shares.

All share and per share amounts for Common Stock in these condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Split.

Going Concern

These consolidated financial statements have been prepared in accordance with GAAP assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern has been raised.
The Company believes it is probable that it will be in violation of the net leverage covenant at the testing date for the first quarter of fiscal 2026. If the Company is unable to obtain waivers, the Term Loan and PNC Credit Facility will become immediately due, and additional liquidity will be required to satisfy the obligations. Due to the fact that a violation of the debt covenants results in the debt becoming currently payable, the long-term portion of the Term Loan and PNC Credit Facility have been classified as a current liability in the accompanying consolidated balance sheet as of December 31, 2024. See Note 4: Debt for additional information related to the Company’s debt agreements.
The Company entered into a Standby Equity Purchase Agreement (the “SEPA”) on January 25, 2025, pursuant to which the Company has the right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. See Note 12: Subsequent Events for additional information related to the SEPA. Additionally, the Company is evaluating strategies to obtain additional funding, however there is no assurance that the Company will be able to obtain additional liquidity when needed or under acceptable terms.

The consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern. Our credit facilities are collateralized by a pledge of all our assets.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations, inventory adjustments, useful lives of intangible assets and property and equipment, stock-based compensation, fair value of warrants, and provision for income taxes including related reserves. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.

Restricted Cash

Restricted cash is comprised of bank guarantees and similar required minimum balances that serve as cash collateral in connection with various items including insurance requirements, value added taxes, ongoing tax audits and leases in certain countries.

Recent Accounting Pronouncements

In November 2024, the FASB issued Accounting Standards Update ("ASU") 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220), which requires public entities to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, which includes amendments that further enhance tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for annual periods beginning after December 15, 2024 and may be applied either prospectively or retrospectively. The Company does not anticipate the adoption will have a material impact to the Company's financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. ASU 2023-07 will be effective for our fiscal year beginning April 1, 2024, and interim periods within our fiscal year beginning April 1, 2025, with early adoption permitted and requires application on a fully retrospective basis. We are currently evaluating the impact of this standard on our financial statement disclosures.
v3.25.0.1
REVENUE
9 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Based on how the Company manages its business, the Company has determined that it currently operates in one reportable segment. The Company operates in three geographic regions: (a) Americas; (b) Europe, Middle East and Africa (“EMEA”); and (c) Asia Pacific (“APAC”). Revenue by geography is based on the location of the customer from which the revenue is earned.
In the following table, revenue is disaggregated by major product offerings and geographies (in thousands):
 Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Americas1
   Product revenue18,294 16,159 62,410 78,287 
   Service and subscription16,563 18,282 48,975 53,871 
Total revenue34,857 48 %34,441 47 %111,385 52 %132,158 55 %
EMEA
   Product revenue15,235 14,786 39,892 42,609 
   Service and subscription12,077 12,282 33,471 34,234 
Total revenue27,312 38 %27,068 38 %73,363 34 %76,843 32 %
APAC
   Product revenue5,081 6,168 14,087 17,739 
   Service and subscription2,975 2,207 7,937 6,124 
Total revenue8,056 11 %8,375 12 %22,024 10 %23,863 10 %
Consolidated
   Product revenue38,610 37,113 116,389 138,635 
   Service and subscription31,615 32,771 90,383 94,229 
   Royalty2
2,326 %2,042 %7,592 %7,235 %
Total revenue$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Revenue for the Americas geographic region outside of the United States is not significant.
2 Royalty revenue is not allocatable to geographic regions.


Revenue by Solution
Three Months Ended December 31,Nine Months Ended December 31,
2024%2023%2024%2023%
Primary storage systems$12,404 17 %$12,887 18 %$41,034 19 %$41,394 17 %
Secondary storage systems23,276 33 %20,206 28 %60,787 28 %82,118 34 %
Device and media7,575 10 %7,716 11 %24,254 11 %23,801 10 %
Service 26,970 37 %29,075 40 %80,697 38 %85,551 36 %
Royalty2,326 %2,042 %7,592 %7,235 %
Total revenue1
$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Subscription revenue of $4.6 million and $2.3 million was allocated to Primary and Secondary storage systems for the three months ended December 31, 2024 and 2023, respectively. Subscription revenue of $11.3 million and $4.8 million was allocated to Primary and Secondary storage systems for the nine months ended December 31, 2024 and 2023, respectively.
Contract Balances

The following table presents the Company’s contract liabilities and certain information related to this balance as of March 31, 2024 and December 31, 2024 (in thousands): 

March 31, 2024
Deferred revenue$116,687 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$76,304 
December 31, 2024
Deferred revenue$105,266 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$64,539 

Remaining Performance Obligations

Total remaining performance obligations (“RPO”) representing contracted but not recognized revenue was $122.6 million as of December 31, 2024. RPO consists of both deferred revenue and uninvoiced, non-cancelable contracts that are expected to be invoiced and recognized as revenue in future periods and excludes variable consideration related to sales-based royalties. Of the $122.6 million RPO at the end of the third quarter of fiscal 2025, $105.4 million was for invoiced deferred revenue and $17.2 million was for uninvoiced, non-cancelable contracts. The non-current portion of the RPO will be recognized over the next 13 to 60 months.

RPO consisted of the following (in thousands):
CurrentNon-CurrentTotal
As of December 31, 2024
$84,644 $37,929 $122,573 

Deferred revenue consists of amounts that have been invoiced but have not yet been recognized as revenue including performance obligations pertaining to subscription services. The table below reflects the Company’s deferred revenue as of December 31, 2024 (in thousands):
Deferred revenue by period
Total1 year or less1 – 3 Years3 year or greater
Service revenue84,624 60,782 21,815 $2,027 
Subscription revenue$20,642 $9,134 $8,773 $2,735 
Balance as of December 31, 2024$105,266 $69,916 $30,588 $4,762 
v3.25.0.1
BALANCE SHEET INFORMATION
9 Months Ended
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
BALANCE SHEET INFORMATION BALANCE SHEET INFORMATION
Certain significant amounts included in the Company's condensed consolidated balance sheets consist of the following (in thousands):

Manufacturing inventories
December 31, 2024March 31, 2024
   Finished goods$9,741 $7,074 
   Work in progress1,399 770 
   Raw materials7,721 9,909 
Total manufacturing inventories$18,861 $17,753 

Service parts inventories
December 31, 2024March 31, 2024
   Finished goods$1,377 $3,660 
   Component parts507 6,123 
Total service parts inventories$1,884 $9,783 

Intangibles, net
December 31, 2024March 31, 2024
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
   Developed technology$9,013 $(9,013)$— $9,013 $(8,550)$463 
   Customer lists4,398 (3,889)509 4,398 (3,192)1,206 
Intangible assets, net$13,411 $(12,902)$509 $13,411 $(11,742)$1,669 

Intangible assets amortization expense was $0.2 million and $1.2 million and $0.8 million and $3.0 million for the three and nine months ended December 31, 2024 and 2023, respectively. As of December 31, 2024, the remaining weighted-average amortization period for definite-lived intangible assets was approximately 0.6 years. The Company recorded amortization of developed technology in cost of product revenue, and customer lists in sales and marketing expenses in the condensed consolidated statements of operations.

As of December 31, 2024, the future expected amortization expense for intangible assets is as follows (in thousands):

Fiscal year ending Estimated future amortization expense
Remainder of 2025$228 
2026281 
Total$509 


Goodwill

As of December 31, 2024 and March 31, 2024, goodwill was $13.0 million. There were no impairments to goodwill as of December 31, 2024 and March 31, 2024.

Other long-term assets
December 31, 2024March 31, 2024
Capitalized SaaS implementation costs for internal use$14,786 $15,349 
Capitalized debt costs3,292 1,923 
Contract asset1,264 1,477 
Deferred taxes711 734 
Other759 257 
   Total other long-term assets$20,812 $19,740 

Other accrued liabilities
December 31, 2024March 31, 2024
Accrued expenses
$8,093 $4,251 
Asset retirement obligation
3,683 2,069 
Accrued warranty
1,195 1,545 
Accrued interest
506 524 
Lease liability1,227 1,256 
Accrued income taxes
390 1,044 
Other
4,014 3,297 
   Total other accrued liabilities$19,108 $13,986 
The following table details the change in the accrued warranty balance (in thousands):
December 31, 2024March 31, 2024
Beginning balance$1,545 $2,094 
   Current period accruals1,696 2,563 
   Adjustments to prior estimates46 (141)
   Charges incurred(2,092)(2,971)
Ending balance$1,195 $1,545 
v3.25.0.1
DEBT
9 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
DEBT DEBT
The Company’s debt consisted of the following (in thousands):
 December 31, 2024March 31, 2024
Term Loan$105,880 $87,942 
PNC Credit Facility37,500 26,604 
Less: current portion(136,109)(109,100)
Less: unamortized debt issuance costs (1)
(7,271)(5,446)
Long-term debt, net$— $— 
(1) The unamortized debt issuance costs related to the Term Loan are presented as a reduction of the carrying amount of the corresponding debt balance on the accompanying condensed consolidated balance sheets. Unamortized debt issuance costs related to the PNC Credit Facility are presented within other assets on the accompanying condensed consolidated balance sheets.
On August 5, 2021, the Company entered into a senior secured term loan (as amended, the “2021 Term Loan”), maturing on August 5, 2026. The Company also has a revolving credit facility agreement with PNC Bank (as amended, the “PNC Credit Facility” and together with the Term Loan (as defined below), the “Credit Agreements”) maturing on August 5, 2026 and providing for borrowings up to a maximum principal amount of the lesser of: (a) $40.0 million or (b) the amount of the borrowing base, as defined in the PNC Credit Facility agreement.

On June 1, 2023, the Company entered into amendments to the Credit Agreements (the “June 2023 Amendment”) which, among other things, provided an advance of $15.0 million in additional term loan borrowings (as amended, the “2023 Term Loan” and, together with the 2021 Term Loan, the "Term Loan") and incurred $0.9 million in original issuance discount and origination fees which have been recorded as a reduction to the carrying amount of the 2023 Term Loan and amortized to interest expense over the loan term. The terms of the 2023 Term Loan are substantially similar to the terms of the 2021 Term Loan, including in relation to maturity and security, except that, among other things, (a) the Applicable Margin (i) for any 2023 Term Loan designated an “ABR Loan” is 9.00% per annum and (ii) for any 2023 Term Loan designated as a “SOFR Loan” is 10.00% per annum, (b) accrued interest on the 2023 Term Loan is payable in kind ("PIK"), and is capitalized and added to the principal amount of the 2023 Term Loan at the end of each interest period applicable thereto, (c) the 2023 Term Loan does not amortize prior to the maturity date thereof, and (d) the 2023 Term Loan may not be prepaid prior to the payment in full of the existing term loans. In connection with the 2023 Term Loan, the Company issued warrants to purchase an aggregate of 0.06 million shares (the “June 2023 Warrants”) of the Common Stock, at an exercise price of $20.00 per share. See Note 8: Common Stock for additional discussion related to the June 2023 Warrants.

The June 2023 Amendment to the 2021 Term Loan was accounted for as a modification. The value of the June 2023 Warrants in addition to $0.7 million of fees paid to the lenders have been reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The Company incurred $0.9 million of legal and financial advisory fees which were included in general and administrated expenses in the condensed consolidated statement of operations and comprehensive loss. The June 2023 Amendment to the PNC Credit Facility was accounted for as a modification and $0.7 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On February 14, 2024, the Company entered into amendments to the Credit Agreements (“February 2024 Amendments”) which waived testing of the total net leverage ratio financial covenant for the fiscal quarter ended December 31, 2023. In connection with the amendment, the Company incurred fees related to the Term Loan that
was paid-in-kind of $1.2 million and an amendment fee of $0.1 million that was paid in cash. As the February 2024 Amendments were accounted for as a modification, the fees were reflected as a reduction to the carrying amount of the Term Loan and are amortized to interest expense over the remaining loan term. In connection with the related PNC Credit Facility amendment, the Company incurred $0.2 million in fees and expenses.

On March 22, 2024, the Company entered into amendments to the Credit Agreements. The amendments, among other things, (i) permits the sale of certain assets by the Company and (ii) requires that certain proceeds from the sale of such assets be applied to partially prepay the outstanding term loans under the Term Loan credit facility. The Company did not incur any amendment fees related to the March 2024 amendments and the financial terms of the Credit Agreements were not impacted.

During the quarter ended June 30, 2024, the Company prepaid $12.3 million of the Term Loan. In connection with this prepayment, the Company recorded a loss on debt extinguishment of $0.7 million related to the write-off of a portion of unamortized debt issuance costs.

On May 24, 2024, the Company entered into amendments to the Credit Agreements (the “May 2024 Amendments”) which, among other things, (i) waived compliance with the Company’s net leverage covenant as of March 31, 2024; and (ii) reduced the daily minimum liquidity covenant below $15.0 million until June 16, 2023 and waived any default that might arise as a result of the restatement of certain of the Company’s historical financial statements. In connection with the May 2024 Amendments, the Company issued to the Term Loan lenders warrants to purchase an aggregate of 100,000 shares of the Common Stock at a purchase price of $9.20 (the “May 2024 Warrants”). See Note 8: Common Stock for additional discussion related to the May 2024 Warrants. Additionally, in connection with the May 2024 Amendment to the Term Loan, the Company incurred an amendment fee that was paid-in-kind of $0.8 million and issued the 2024 Term Loan Warrants with a fair market value of $0.8 million. In connection with the May 2024 Amendment to the PNC Credit Facility Amendment, the Company incurred $ 0.5 million of fees and expenses paid to the lender.

The May 2024 Amendment to the Term Loan was accounted for as a modification. The value of the May 2024 Warrants, in addition to $0.8 million of amendment fees paid to the lenders, have been reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The May 2024 Amendment to the PNC Credit Facility was accounted for as a modification and the $0.5 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On July 11, 2024, the Company entered into amendments to the Credit Agreements (the “July 2024 Amendments”) which, among other things, delayed the testing of the Company’s June 30, 2024 net leverage ratio financial covenant until July 31, 2024. In connection with the amendments, the Company issued the Term Loan lenders (the “July 2024 Warrants”) to purchase an aggregate of 50,000 shares of the Common Stock at a purchase price of $8.20. See Note 8: Common Stock for additional discussion related to the July 2024 Warrants.

The July 2024 Amendments to the 2021 Term Loan were accounted for as a modification. The fair value of the July 2024 Warrants of $0.4 million is reflected as a reduction to the carrying amount of the Term Loan and amortized to interest expense over the remaining loan term. The July 2024 Amendment to the PNC Credit Facility was accounted for as a modification and the $0.1 million in related fees and expenses were recorded to other assets and are amortized to interest expense over the remaining term of the agreement.

On August 13, 2024, the Company entered into amendments to the Credit Agreements (the “August 2024 Amendments”) which, among other things, (i) waived compliance with the June 30, 2024 net leverage ratio financial covenant; (ii) waived any non-compliance with the minimum liquidity financial covenant through the date of the amendments; (iii) removed the fixed charges coverage ratio financial covenant until the fiscal quarter ending September 30, 2025; (iv) waived the testing requirement for the net leverage financial covenant for the fiscal quarter ending September 30, 2024; (v) replaced the net leverage financial covenant with a minimum EBITDA financial covenant for the fiscal quarters ending December 31, 2024 and March 31, 2025; (vi) reset the net leverage financial covenant requirements for the fiscal quarters ending June 30, 2025 and September 30, 2025; (vii) reduced the minimum liquidity covenant to $10 million through September 30, 2025; (viii) adjusted the applicable interest rates on the Term Loan and PNC Credit Facility; (ix) removed required 2021 Term Loan principal amortization until the fiscal quarter ending September 30, 2025; and (x) repriced certain Lender Warrants.
In connection with the August 2024 Amendments, the Company received a new senior secured delayed draw term loan facility with a borrowing capacity of up to $26.3 million ($25.0 million after original issuance discount) and a commitment period expiring on October 31, 2024 (each draw, an “August 2024 Term Loan”). The Company borrowed $10.5 million at closing (“Initial August 2024 Term Loan”). Borrowings under the August 2024 Term Loan have an August 5, 2026 maturity date which aligns with the 2021 Term Loan. The principal is payable quarterly beginning September 30, 2025, at a rate per annum equal to 5% of the original principal balance. The August 2024 Term Loan’s interest rate margin is (a) until March 31, 2025 (i) for any August 2024 Term Loan designated as a ‘SOFR Loan’ is 12.00% per annum and (ii) for any August 2024 Term Loan designated an ‘ABR Loan’ is 11.00% per annum, in each case, with 6.00% of such interest rate margin paid-in-kind, and (b) from April 1, 2025, (i) for any August 2024 Term Loan designated as a ‘SOFR Loan’ is 14.00% per annum and (ii) for any August 2024 Term Loan designated an ‘ABR Loan’ is 13.00% per annum, in each case, with 8.00% of such interest rate margin paid-in-kind. The August 2024 Term Loan also includes a multiple on invested capital payable to the August 2024 Term Loan lenders. Subsequently, the Company borrowed the remaining $15.8 million of the August 2024 Term Loan’s borrowing capacity before September 30, 2024.

Subsequent to the August 2024 Amendments, the 2021 Term Loan amortizes at 5.00% per annum commencing on September 30, 2025. Subsequent to the August 2024 Amendments and (A) until March 31, 2025, loans under the 2021 Term Loan designated as (x) ABR Loans bear interest at a rate per annum equal to the “ABR Rate” (calculated as the greatest of (i) 1.75%; (ii) the Federal funds rate plus 0.50%; (iii) a secured overnight financing rate based rate (the “SOFR Rate”) based upon an interest period of one month plus 1.0%; and (iv) the “Prime Rate” last quoted by the Wall Street Journal), plus an applicable margin of 8.75%, and (y) SOFR Rate Loans bear interest at a rate per annum equal to the SOFR Rate plus an applicable margin of 9.75%, in each case, with 3.75% of such interest rate margin paid-in-kind, with two specified step-downs in such applicable margin upon the receipt by the Company of cash proceeds from certain specified capital raises, and (B) from and after April 1, 2025, loans under the 2021 Term Loan designated as (x) ABR Loans bear interest at a rate per annum equal to the ABR Rate, plus an applicable margin of 8.75%, and (y) SOFR Rate Loans bear interest at a rate per annum equal to the SOFR Rate plus an applicable margin of 9.75%, in each case, with 3.75% of such applicable margin paid-in-kind, with a step-up of 1.00% per annum (which shall be paid-in-kind) if the Company’s total net leverage ratio is greater than 4.00x, and a step-down of 1.00% per annum if the Company’s total net leverage ratio is less than 3.50x (which shall reduce the paid-in-kind component of the applicable margin). The SOFR Rate is subject to a floor of 2.00%. The Company can designate a loan as an ABR Rate Loan or SOFR Rate Loan in its discretion.

Subsequent to the August 2024 Amendments, PNC Credit Facility loans designated as (x) PNC SOFR Loans bear interest at a rate per annum equal to a SOFR based rate (subject to a 0.0% floor), plus an applicable margin of 4.75%and (y) PNC Domestic Rate Loans and Swing Loans bear interest at a rate per annum equal to the greatest of (i) the base commercial lending rate of PNC Bank; (ii) the Overnight Bank Funding Rate plus 0.5%; and (iii) the daily SOFR rate plus 1.0%, plus an applicable margin of 3.75%. The Company can designate a loan as a PNC SOFR Loan or PNC Domestic Rate Loan in its discretion.

In connection with the August 2024 Amendments, the Company issued warrants to purchase an aggregate of 380,510 shares of the Common Stock, at an exercise price of $6.20 per share (“August 2024 Warrants”) and had a fair value of $2.0 million. See Note 8: Common Stock for additional discussion related to the August 2024 Warrants.

The August 2024 Amendments to the 2021 Term Loan held by one lender was accounted for as a modification. The $1.2 million fair value of the August 2024 Warrants issued to this lender and the $0.5 million of PIK fees paid to this lender are reflected as a reduction to the carrying amount of their Term Loan and their initial delayed draw term loan and amortized to interest expense over the remaining loan terms. The August 2024 Amendments to the 2021 Term Loan held by another lender was accounted for as a debt extinguishment. The Company recorded a loss on debt extinguishment of $3.0 million related to the write-off of a portion of unamortized debt issuance costs and fees and expenses incurred with the August 2024 Amendments.

The August 2024 Amendments to the PNC Credit Facility were accounted for as a modification, and the $0.7 million in related fees and expenses were recorded to other assets and amortized to interest expense over the remaining term of the agreement.

As of December 31, 2024, the interest rate on the 2021 Term Loan, 2023 Term Loan, and 2024 Term Loans were 14.59%, 14.34%, and 16.59%, respectively. As of December 31, 2024, the interest rate on the PNC Credit Facility for Domestic Rate Loans and Swing Loans was 11.25% and for PNC SOFR Loans was 9.66%.
The Term Loan amendments and certain warrants issued to term lenders during fiscal 2023 and fiscal 2024 were entered into with certain entities managed by Pacific Investment Management Company, LLC ("PIMCO"), which is considered a related party due to the fact that Christopher D. Neumeyer is a member of the Company's Board of Directors and also an executive vice president and portfolio manager at PIMCO. The principal and PIK interest related to the June 2023 Term Loan which totaled $19.6 million as of December 31, 2024, are payable at maturity.

Also, as of December 31, 2024, the PNC Credit Facility had an available borrowing base of 39.1 million, of which $1.6 million was available to borrow at that date.
v3.25.0.1
FAIR VALUE OF FINANCIAL INSTRUMENTS
9 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS FAIR VALUE OF FINANCIAL INSTRUMENTS
The Company’s assets, measured and recorded at fair value on a recurring basis, may consist of money market funds which are included in cash and cash equivalents in the Condensed Consolidated Balance Sheets and are valued using quoted market prices (level 1 fair value measurements) at the respective balance sheet dates.

No impairment charges were recognized for non-financial assets in the nine months ended December 31, 2024 and 2023. The Company has no non-financial liabilities measured and recorded at fair value on a non-recurring basis.

Long-term Debt

The Company’s financial liabilities were comprised primarily of long-term debt as of December 31, 2024. The Company uses significant other observable market data or assumptions (Level 2 inputs as defined in the accounting guidance) that it believes market participants would use in pricing debt.

The carrying value and fair value of the Company’s financial liabilities were primarily comprised of the following (in thousands):

December 31, 2024March 31, 2024
Carrying ValueFair ValueCarrying ValueFair Value
Term Loan$105,880 $96,780 $87,942 $75,143 
PNC Credit Facility37,500 34,470 26,604 24,743 
v3.25.0.1
LEASES
9 Months Ended
Dec. 31, 2024
Leases [Abstract]  
LEASES LEASES
Supplemental balance sheet information related to leases is as follows (in thousands):
Operating LeasesDecember 31, 2024March 31, 2024
Operating lease right-of-use asset$8,670 $9,425 
Operating lease liability within other accrued liabilities
1,227 1,256 
Operating lease liability, net9,067 9,621 
   Total operating lease liabilities$10,294 $10,877 

Components of lease cost were as follows (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
Lease Cost2024202320242023
Operating lease cost  $716 $710 $2,207 $2,316 
Variable lease cost  69 51 221 233 
Total lease cost  $785 $761 $2,428 $2,549 

Maturity of Lease LiabilitiesOperating Leases
Remainder of fiscal year 2025$670 
2026
2,276 
2027
1,770 
2028
1,550 
2029
1,228 
   Thereafter12,095 
Total lease payments$19,589 
Less: imputed interest(9,295)
Present value of lease liabilities$10,294 



Lease Term and Discount RateDecember 31, 2024March 31, 2024
Weighted average remaining operating lease term (years)10.2510.85
Weighted average discount rate for operating leases12.6 %12.7 %

Operating cash outflows related to operating leases totaled $2.1 million and $2.3 million for the nine months ended December 31, 2024 and 2023, respectively.
v3.25.0.1
RESTRUCTURING CHARGES
9 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
RESTRUCTURING CHARGES RESTRUCTURING CHARGES
During the quarters ending December 31, 2024 and 2023, the Company had certain approved restructuring plans to improve operational efficiencies and rationalize its cost structure.
The following tables show the activity and the estimated timing of future payouts for accrued restructuring (in thousands) included in other current liabilities:
 Severance and Benefits
Balance as of March 31, 2023
$— 
   Restructuring charges 3,164 
   Cash payments (3,164)
Balance as of December 31, 2023
 $— 
Balance as of March 31, 2024
 $— 
   Restructuring charges 2,916 
   Cash payments (2,849)
   Other non-cash(67)
Balance as of December 31, 2024
 $— 
v3.25.0.1
COMMON STOCK
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
COMMON STOCK COMMON STOCK
Long-Term Incentive Plan
On September 12, 2023 the stockholders of the Company approved the Quantum Corporation 2023 Long-Term incentive plan (“2023 LTIP”). The 2023 LTIP serves as the successor to the Company’s 2012 Long-Term Incentive Plan and provides for grants of performance share units, restricted stock units and stock options. On August 15, 2024, the stockholders of the Company approved an additional 250,000 shares of Common Stock under the 2023 LTIP for future issuance.
Reverse Stock Split
On August 26, 2024, the Company effected the Reverse Stock Split of the Company’s our issued and outstanding Common Stock. The Common Stock began to trade on a post-split basis on August 27, 2024. The par value of the Common Stock was unchanged as a result of the Reverse Stock Split, remaining at $0.01 per share, which resulted in the reclassification of capital from par value to capital in excess of par value. All share and per share data for comparative periods included within the Company’s Condensed Consolidated Financial Statements and related footnotes have been adjusted to account for the effect of the Reverse Stock Split.
Warrants
In connection with debt refinancing and amendment activities, the Company issued warrants to purchase shares of the Common Stock in December 2018 which are exercisable until December 27, 2028 (the "December 2018 Warrants”), in June 2020 which are exercisable until June 16, 2030 (the "June 2020 Warrants") and issued the June 2023 Warrants and May 2024 Warrants are until June 1, 2033 and May 24, 2034, respectively (collectively, the “Lender Warrants”). In July 2024, the Company issued warrants which are exercisable until July 11, 2034 and additional warrants were issued in August 2024 which are exercisable until August 13, 2034 (the “August 2024 Warrants”).

As part of the August 2024 Warrants, the Company agreed to lower the exercise price of certain outstanding warrants to purchase an aggregate of 430,711 shares of Common Stock held by the Term Loan lenders or their affiliates to $6.20 per share (the “Amended and Restated Warrants”). Other than lowering the exercise price and inserting certain restrictions on adjustments in the event of dilutive issuances at a price lower than the amended exercise price, the terms of the Amended and Restated Warrants are substantially similar to those contained in the original warrants.

On December 30, 2024, 467,248 warrants were exercised in a cashless exercise whereby 61,270 shares with a value of $6.20 per share were used to settle the exercise price and the remaining 405,978 shares were issued to the warrant holders.

The following summarizes the Company's outstanding Lender Warrants (in thousands, except exercise price):

December 2018 WarrantsJune 2020 WarrantsJune 2023 WarrantsMay 2024 WarrantsJuly 2024 WarrantsAugust 2024 WarrantsTotal
March 31, 2024:
   Exercise price$26.60$55.40$20.00n/an/an/a
   Number shares under warrant(s)357 184 63 n/an/an/a604 
   Fair value$2,320 $1,135 $591 n/an/an/a$4,046 
December 31, 2024:
   Exercise price
$6.20 - $26.04
$6.20 - $54.19
$6.20$6.20$6.20$6.20
   Number shares under warrant(s)220 114 63 38 19 224678 
   Fair value$10,518 $5,369 $3,336 $1,979 $989 $11,814 $34,005 

The table below sets forth a summary of changes in the fair value of the Company’s Level 2 warrant liabilities as of December 31, 2023 and 2024:

Balance as of March 31, 2023$7,989 
Issuance of warrants1,194 
Change in fair value of warrant liabilities(7,340)
Balance as of December 31, 2023$1,843 
Balance as of March 31, 2024$4,046 
Issuance of warrants
3,157 
Exercise of warrants
(30,118)
Change in fair value of warrant liabilities56,408 
Repricing adjustment512 
Balance as of December 31, 2024$34,005 

Upon exercise, the aggregate exercise price of the Lender Warrants may be paid, at each warrant holder’s election, in cash or on a net issuance basis, based upon the fair market value of the Common Stock at the time of exercise. The exercise price and the number of shares underlying the Lender Warrants are subject to adjustment in the event of specified events, including dilutive issuances of equity instruments at a price lower than the exercise price of the respective warrants (the "Down Round Feature"), repricing of existing equity-linked instruments at a price lower than the exercise price of the respective warrants (the "Warrant Repricing Feature"), a subdivision or combination of the Common Stock, a reclassification of the Common Stock or specified dividend payments. The Company's warrants also have a provision that determines the potential stock price used when applying the Black-Scholes valuation model to determine the settlement price of the warrants in Successor Major Transactions ("SMT"), as defined in the respective warrant agreements, which include a change in control or liquidation (the "Warrant Settlement Price Provision"). The Warrant Settlement Price Provision requires the use of the greater of the closing price of the Common Stock on the trading day immediately preceding the date on which an SMT is consummated, the closing market price of the Common Stock following the first public announcement of an SMT or the closing market of the Common Stock immediately preceding the announcement of an SMT. Due to these terms, equity classification was precluded, and these warrants are carried as liabilities at fair value.
The Company also issued 2,500 warrants to purchase the Common Stock in June 2020 and June 2023 to advisors of the Company at an exercise price of $60.00 and $20.00, respectively (collectively the "Other Warrants"). The Company has concluded that the Other Warrants do not contain provisions that would require liability classification under Topic 480 or Topic 718 and have been equity classified.
Registration Rights Agreements

The Lender Warrants grant the holders certain registration rights for the shares of Common Stock issuable upon the exercise of the applicable warrants, including (a) the ability of a holder to request that the Company file a Form S-1 registration statement with respect to at least 40% of the registrable securities held by such holder as of the issuance date of the applicable warrants; (b) the ability of a holder to request that the Company file a Form S-3 registration statement with respect to outstanding registrable securities if at any time the Company is eligible to use a Form S-3 registration statement; and (c) certain piggyback registration rights related to potential future equity offerings of the Company, subject to certain limitations.
v3.25.0.1
NET LOSS PER SHARE
9 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
NET LOSS PER SHARE NET LOSS PER SHARE
The Company has performance share units, restricted stock units and options to purchase shares under its Employee Stock Purchase Plan, as amended and restated on July 25, 2023 (“ESPP”), granted under various stock incentive plans that, upon exercise and vesting, would increase shares outstanding. The Company has also issued warrants to purchase shares of the Common Stock.
The dilutive impact related to Common Stock from restricted stock units and warrants is determined by applying the treasury stock method to the assumed vesting of outstanding restricted stock units and the exercise of outstanding warrants. The dilutive impact related to Common Stock from contingently issuable performance share units is determined by applying a two-step approach using both the contingently issuable share guidance and the treasury stock method.
The following weighted-average outstanding shares of Common Stock equivalents were excluded from the computation of diluted net income (loss) per share attributable to common stockholders for the periods presented because including them would have been anti-dilutive (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Stock Awards181 — 76 17 
Warrants678 608 845 608 

The Company had outstanding market based restricted stock units as of December 31, 2024 that were eligible to vest into shares of the Common Stock subject to the achievement of certain stock price targets in addition to a time-based vesting period. These contingently issuable shares are excluded from the computation of diluted earnings per share if, based on current period results, the shares would not be issuable if the end of the reporting period were the end of the contingency period. There were 170,750 shares of contingently issuable market-based restricted stock units that were excluded from the table above as the market conditions were not satisfied as of December 31, 2024.
v3.25.0.1
INCOME TAXES
9 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
INCOME TAXES INCOME TAXES
The effective tax rate for the three and nine months ended December 31, 2024 was (0.1)% and (0.6)%, respectively, as compared to (5.5)% and (7.6)%, for the three and nine months ended December 31, 2023, respectively. The effective tax rates differed from the federal statutory tax rate of 21% during each of these periods due primarily to unbenefited losses experienced in jurisdictions with valuation allowances on deferred tax assets as well as the forecasted mix of earnings in domestic and international jurisdictions.

As of December 31, 2024, including interest and penalties, the Company had $90.9 million of unrecognized tax benefits, $78.5 million of which, if recognized, would favorably affect the effective tax rate without consideration of the valuation allowance. As of December 31, 2024, the Company had accrued interest and penalties related to these unrecognized tax benefits of $1.4 million. The Company recognizes interest and penalties related to income tax matters in the income tax provision in the condensed consolidated statements of operations. As of December 31, 2024, $83.2 million of unrecognized tax benefits were recorded as a contra deferred tax asset in other long-term assets in the condensed consolidated balance sheet and $7.8 million (including interest and penalties) were recorded in other long-term liabilities in the condensed consolidated balance sheets. During the next 12 months, it is reasonably possible that approximately $12.8 million of tax benefits, inclusive of interest and penalties, that are currently unrecognized could be recognized as a result of the expiration of applicable statutes of limitations. Upon recognition of the tax benefit related to the expiring statutes of limitation, $11.8 million will be offset by the establishment of a related valuation allowance. The net tax benefit recognized in the statements of operation is estimated to be $1.0 million.
v3.25.0.1
COMMITMENTS AND CONTINGENCIES
9 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES COMMITMENTS AND CONTINGENCIES
Commitments to Purchase Inventory
The Company uses contract manufacturers for its manufacturing operations. Under these arrangements, the contract manufacturer procures inventory to manufacture products based upon the Company’s forecast of customer demand. The Company has similar arrangements with certain other suppliers. The Company is responsible for the financial impact on the supplier or contract manufacturer of any reduction or product mix shift in the forecast relative to materials that the third party had already purchased under a prior forecast. Such a variance in forecasted demand could require a cash payment for inventory in excess of current customer demand or for costs of excess or obsolete inventory. As of December 31, 2024, the Company had issued non-cancelable commitments for $29.5 million to purchase inventory from its contract manufacturers and suppliers.

Legal Proceedings
Arrow Electronics Matter
On July 27, 2023, an electronics component distributor filed a lawsuit in a federal court in the Northern District of California against Quantum, alleging breach of contract and breach of the covenant of good faith and fair dealing, seeking, among other things just over $4.0 million in damages. Quantum has filed a responsive pleading disputing Arrow Electronics’ claims and plans to aggressively defend itself against them. Written and oral discovery is complete and both parties have filed motions for summary judgment. As of date, Arrow Electronics’ motion for summary judgment has been denied, and Quantum’s motion for summary judgment has been granted in part and denied in part. Quantum also filed a motion to exclude Arrow Electronics’ expert witness report, which was granted. Trial is currently set to commence in February 2025. At this time, Quantum believes the probability that this lawsuit will have a material adverse effect on our business, operating results, or financial condition is remote.
Other Commitments
Additionally, from time to time, the Company is party to various legal proceedings and claims arising from the normal course of business activities. Based on current available information, the Company does not expect that the ultimate outcome of any currently pending matters, individually or in the aggregate, will have a material adverse effect on the Company’s results of operations, cash flows or financial position.
v3.25.0.1
SUBSEQUENT EVENTS
9 Months Ended
Dec. 31, 2024
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS SUBSEQUENT EVENTS
Warrants
On January 3, 2025, 677,905 warrants were exercised in a cashless exercise whereby 228,195 shares with a weighted average value of $35.42 per share were used to settle the exercise price and the remaining 449,710 shares were issued to the warrant holders.
Standby Equity Purchase Agreement
On January 25, 2025, the Company entered into a Standby Equity Purchase Agreement (the “SEPA”), with YA II PN, Ltd., a Cayman Islands exempt limited partnership (“YA”) managed by Yorkville Advisors Global, LP. Pursuant to and subject to the terms of the SEPA, YA has committed to purchase up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA.

Any sale of Common Stock pursuant to the SEPA is subject to certain limitations, including that we may not issue to YA more than 19.99% of the Common Stock outstanding immediately prior to the execution of the SEPA. In connection with the execution of the SEPA, the Company has issued to YA 42,158 shares of Common Stock as consideration for YA’s commitment to purchase shares of Common Stock under the SEPA.

Term Loan Amendments
On January 27, 2025, the Company entered into an amendment (the “January 2025 Term Loan Amendment”) to the Term Loan. The January 2025 Term Loan Amendment, among other things, (i) amends the minimum EBITDA covenant so that such covenant is not tested on December 31, 2024 or March 31, 2025, (ii) amends certain mandatory prepayment events, and (iii) waives certain events of default, in each case, as set forth in the January 2025 Term Loan Amendment.
On January 27, 2025, the Company entered into an amendment (the “January 2025 Revolver Amendment”) to the PNC Credit Facility. The January 2025 Revolver Amendment, among other things, (i) amends the minimum EBITDA covenant so that such covenant is not tested on December 31, 2024 or March 31, 2025, (ii) amends certain mandatory prepayment events, and (iii) waives certain events of default, in each case, as set forth in the January 2025 Revolver Amendment.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure        
Net loss $ (71,433) $ (9,869) $ (105,780) $ (22,342)
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
9 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information. All intercompany balances and transactions have been eliminated. Certain information and footnote disclosures normally included in annual financial statements have been condensed or omitted. The Company believes the disclosures made are adequate to prevent the information presented from being misleading. However, the accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included within the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2024 (the “Annual Report”).

The unaudited condensed consolidated interim financial statements reflect all adjustments, consisting only of normal and recurring items, necessary to present fairly our financial position as of December 31, 2024, the results of operations and comprehensive loss, statements of cash flows, and changes in stockholders’ deficit for the three and nine months ended December 31, 2024 and 2023. Interim results are not necessarily indicative of full year performance because of short-term variations.

Reverse Stock Split

On August 15, 2024, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect a reverse stock split of the issued shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), at a ratio ranging from 1 share-for-5 shares up to a ratio of 1-for-20 shares, with the exact ratio, if any, to be selected by the board of directors (the “Board”). On August 15, 2024, the Board approved a 1-for-20 reverse stock split (the “Reverse Stock Split”) of the Common Stock. The Reverse Stock Split became effective as of August 26, 2024 at 4:01 p.m., Eastern Time (the “Effective Time”). At the Effective Time, every twenty issued shares of Common Stock were automatically reclassified into one issued share of Common Stock, with any fractional shares resulting from the Reverse Stock Split rounded up to the nearest whole share. The number of outstanding shares of Common Stock was reduced from approximately 95.9 million shares to approximately 4.8 million shares.

All share and per share amounts for Common Stock in these condensed consolidated financial statements and notes thereto have been retroactively adjusted for all periods presented to give effect to the Reverse Stock Split.

Going Concern

These consolidated financial statements have been prepared in accordance with GAAP assuming the Company will continue as a going concern. The going concern assumption contemplates the realization of assets and satisfaction of liabilities in the normal course of business. However, substantial doubt about the Company’s ability to continue as a going concern has been raised.
The Company believes it is probable that it will be in violation of the net leverage covenant at the testing date for the first quarter of fiscal 2026. If the Company is unable to obtain waivers, the Term Loan and PNC Credit Facility will become immediately due, and additional liquidity will be required to satisfy the obligations. Due to the fact that a violation of the debt covenants results in the debt becoming currently payable, the long-term portion of the Term Loan and PNC Credit Facility have been classified as a current liability in the accompanying consolidated balance sheet as of December 31, 2024. See Note 4: Debt for additional information related to the Company’s debt agreements.
The Company entered into a Standby Equity Purchase Agreement (the “SEPA”) on January 25, 2025, pursuant to which the Company has the right, but not the obligation, to sell up to $200 million of Common Stock at any time during the three-year period following the date of the SEPA. See Note 12: Subsequent Events for additional information related to the SEPA. Additionally, the Company is evaluating strategies to obtain additional funding, however there is no assurance that the Company will be able to obtain additional liquidity when needed or under acceptable terms.

The consolidated financial statements do not include any adjustments to the carrying amounts and classification of assets, liabilities, and reported expenses that may be necessary if the Company were unable to continue as a going concern. Our credit facilities are collateralized by a pledge of all our assets.
Use of Estimates
Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ from these estimates and assumptions due to risks and uncertainties. Such estimates include, but are not limited to, the determination of standalone selling price for revenue arrangements with multiple performance obligations, inventory adjustments, useful lives of intangible assets and property and equipment, stock-based compensation, fair value of warrants, and provision for income taxes including related reserves. Management bases its estimates on historical experience and on various other assumptions which management believes to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
Restricted Cash
Restricted Cash

Restricted cash is comprised of bank guarantees and similar required minimum balances that serve as cash collateral in connection with various items including insurance requirements, value added taxes, ongoing tax audits and leases in certain countries.
Recent Accounting Pronouncements
Recent Accounting Pronouncements

In November 2024, the FASB issued Accounting Standards Update ("ASU") 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Topic 220), which requires public entities to disclose information about purchases of inventory, employee compensation, depreciation, intangible asset amortization, and depletion for each income statement line item that contains those expenses. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2024-03.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, which includes amendments that further enhance tax disclosures, primarily through standardization and disaggregation of rate reconciliation categories and income taxes paid by jurisdiction. The amendments are effective for annual periods beginning after December 15, 2024 and may be applied either prospectively or retrospectively. The Company does not anticipate the adoption will have a material impact to the Company's financial statements.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires disclosure of incremental segment information on an annual and interim basis. ASU 2023-07 will be effective for our fiscal year beginning April 1, 2024, and interim periods within our fiscal year beginning April 1, 2025, with early adoption permitted and requires application on a fully retrospective basis. We are currently evaluating the impact of this standard on our financial statement disclosures.
v3.25.0.1
REVENUE (Tables)
9 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Revenue from External Customers by Geographic Areas
In the following table, revenue is disaggregated by major product offerings and geographies (in thousands):
 Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Americas1
   Product revenue18,294 16,159 62,410 78,287 
   Service and subscription16,563 18,282 48,975 53,871 
Total revenue34,857 48 %34,441 47 %111,385 52 %132,158 55 %
EMEA
   Product revenue15,235 14,786 39,892 42,609 
   Service and subscription12,077 12,282 33,471 34,234 
Total revenue27,312 38 %27,068 38 %73,363 34 %76,843 32 %
APAC
   Product revenue5,081 6,168 14,087 17,739 
   Service and subscription2,975 2,207 7,937 6,124 
Total revenue8,056 11 %8,375 12 %22,024 10 %23,863 10 %
Consolidated
   Product revenue38,610 37,113 116,389 138,635 
   Service and subscription31,615 32,771 90,383 94,229 
   Royalty2
2,326 %2,042 %7,592 %7,235 %
Total revenue$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Revenue for the Americas geographic region outside of the United States is not significant.
2 Royalty revenue is not allocatable to geographic regions.


Revenue by Solution
Three Months Ended December 31,Nine Months Ended December 31,
2024%2023%2024%2023%
Primary storage systems$12,404 17 %$12,887 18 %$41,034 19 %$41,394 17 %
Secondary storage systems23,276 33 %20,206 28 %60,787 28 %82,118 34 %
Device and media7,575 10 %7,716 11 %24,254 11 %23,801 10 %
Service 26,970 37 %29,075 40 %80,697 38 %85,551 36 %
Royalty2,326 %2,042 %7,592 %7,235 %
Total revenue1
$72,551 100 %$71,926 100 %$214,364 100 %$240,099 100 %

1 Subscription revenue of $4.6 million and $2.3 million was allocated to Primary and Secondary storage systems for the three months ended December 31, 2024 and 2023, respectively. Subscription revenue of $11.3 million and $4.8 million was allocated to Primary and Secondary storage systems for the nine months ended December 31, 2024 and 2023, respectively.
Schedule of Contract Asset, Contract Liability and Receivable
The following table presents the Company’s contract liabilities and certain information related to this balance as of March 31, 2024 and December 31, 2024 (in thousands): 

March 31, 2024
Deferred revenue$116,687 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$76,304 
December 31, 2024
Deferred revenue$105,266 
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period$64,539 
The table below reflects the Company’s deferred revenue as of December 31, 2024 (in thousands):
Deferred revenue by period
Total1 year or less1 – 3 Years3 year or greater
Service revenue84,624 60,782 21,815 $2,027 
Subscription revenue$20,642 $9,134 $8,773 $2,735 
Balance as of December 31, 2024$105,266 $69,916 $30,588 $4,762 
Schedule of Remaining Performance Obligations
RPO consisted of the following (in thousands):
CurrentNon-CurrentTotal
As of December 31, 2024
$84,644 $37,929 $122,573 
v3.25.0.1
BALANCE SHEET INFORMATION (Tables)
9 Months Ended
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]  
Schedule of Manufacturing Inventories
Manufacturing inventories
December 31, 2024March 31, 2024
   Finished goods$9,741 $7,074 
   Work in progress1,399 770 
   Raw materials7,721 9,909 
Total manufacturing inventories$18,861 $17,753 
Schedule of Service Part Inventories
Service parts inventories
December 31, 2024March 31, 2024
   Finished goods$1,377 $3,660 
   Component parts507 6,123 
Total service parts inventories$1,884 $9,783 
Schedule of Carrying Value of Intangible Assets
Intangibles, net
December 31, 2024March 31, 2024
GrossAccumulated AmortizationNetGrossAccumulated AmortizationNet
   Developed technology$9,013 $(9,013)$— $9,013 $(8,550)$463 
   Customer lists4,398 (3,889)509 4,398 (3,192)1,206 
Intangible assets, net$13,411 $(12,902)$509 $13,411 $(11,742)$1,669 
Schedule of Future Expected Amortization Expense for Intangible Assets
As of December 31, 2024, the future expected amortization expense for intangible assets is as follows (in thousands):

Fiscal year ending Estimated future amortization expense
Remainder of 2025$228 
2026281 
Total$509 
Schedule of Other Long-term Assets
Other long-term assets
December 31, 2024March 31, 2024
Capitalized SaaS implementation costs for internal use$14,786 $15,349 
Capitalized debt costs3,292 1,923 
Contract asset1,264 1,477 
Deferred taxes711 734 
Other759 257 
   Total other long-term assets$20,812 $19,740 
Schedule of Other Accrued Liabilities
Other accrued liabilities
December 31, 2024March 31, 2024
Accrued expenses
$8,093 $4,251 
Asset retirement obligation
3,683 2,069 
Accrued warranty
1,195 1,545 
Accrued interest
506 524 
Lease liability1,227 1,256 
Accrued income taxes
390 1,044 
Other
4,014 3,297 
   Total other accrued liabilities$19,108 $13,986 
Schedule of Accrued Warranty Balance
The following table details the change in the accrued warranty balance (in thousands):
December 31, 2024March 31, 2024
Beginning balance$1,545 $2,094 
   Current period accruals1,696 2,563 
   Adjustments to prior estimates46 (141)
   Charges incurred(2,092)(2,971)
Ending balance$1,195 $1,545 
v3.25.0.1
DEBT (Tables)
9 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Debt
The Company’s debt consisted of the following (in thousands):
 December 31, 2024March 31, 2024
Term Loan$105,880 $87,942 
PNC Credit Facility37,500 26,604 
Less: current portion(136,109)(109,100)
Less: unamortized debt issuance costs (1)
(7,271)(5,446)
Long-term debt, net$— $— 
(1) The unamortized debt issuance costs related to the Term Loan are presented as a reduction of the carrying amount of the corresponding debt balance on the accompanying condensed consolidated balance sheets. Unamortized debt issuance costs related to the PNC Credit Facility are presented within other assets on the accompanying condensed consolidated balance sheets.
v3.25.0.1
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
9 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Carrying Value and Total Estimated Fair Value
The carrying value and fair value of the Company’s financial liabilities were primarily comprised of the following (in thousands):

December 31, 2024March 31, 2024
Carrying ValueFair ValueCarrying ValueFair Value
Term Loan$105,880 $96,780 $87,942 $75,143 
PNC Credit Facility37,500 34,470 26,604 24,743 
v3.25.0.1
LEASES (Tables)
9 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Supplemental Balance Sheet
Supplemental balance sheet information related to leases is as follows (in thousands):
Operating LeasesDecember 31, 2024March 31, 2024
Operating lease right-of-use asset$8,670 $9,425 
Operating lease liability within other accrued liabilities
1,227 1,256 
Operating lease liability, net9,067 9,621 
   Total operating lease liabilities$10,294 $10,877 
Schedule of Components of Lease Cost
Components of lease cost were as follows (in thousands):
Three Months Ended December 31,Nine Months Ended December 31,
Lease Cost2024202320242023
Operating lease cost  $716 $710 $2,207 $2,316 
Variable lease cost  69 51 221 233 
Total lease cost  $785 $761 $2,428 $2,549 
Lease Term and Discount RateDecember 31, 2024March 31, 2024
Weighted average remaining operating lease term (years)10.2510.85
Weighted average discount rate for operating leases12.6 %12.7 %
Schedule of Maturity of Operating Lease Liability
Maturity of Lease LiabilitiesOperating Leases
Remainder of fiscal year 2025$670 
2026
2,276 
2027
1,770 
2028
1,550 
2029
1,228 
   Thereafter12,095 
Total lease payments$19,589 
Less: imputed interest(9,295)
Present value of lease liabilities$10,294 
v3.25.0.1
RESTRUCTURING CHARGES (Tables)
9 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Activity for accrued restructuring charges
The following tables show the activity and the estimated timing of future payouts for accrued restructuring (in thousands) included in other current liabilities:
 Severance and Benefits
Balance as of March 31, 2023
$— 
   Restructuring charges 3,164 
   Cash payments (3,164)
Balance as of December 31, 2023
 $— 
Balance as of March 31, 2024
 $— 
   Restructuring charges 2,916 
   Cash payments (2,849)
   Other non-cash(67)
Balance as of December 31, 2024
 $— 
v3.25.0.1
COMMON STOCK (Tables)
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Outstanding Lender Warrants
The following summarizes the Company's outstanding Lender Warrants (in thousands, except exercise price):
December 2018 WarrantsJune 2020 WarrantsJune 2023 WarrantsMay 2024 WarrantsJuly 2024 WarrantsAugust 2024 WarrantsTotal
March 31, 2024:
   Exercise price$26.60$55.40$20.00n/an/an/a
   Number shares under warrant(s)357 184 63 n/an/an/a604 
   Fair value$2,320 $1,135 $591 n/an/an/a$4,046 
December 31, 2024:
   Exercise price
$6.20 - $26.04
$6.20 - $54.19
$6.20$6.20$6.20$6.20
   Number shares under warrant(s)220 114 63 38 19 224678 
   Fair value$10,518 $5,369 $3,336 $1,979 $989 $11,814 $34,005 
Summary of Changes in Level 2 Liabilities
The table below sets forth a summary of changes in the fair value of the Company’s Level 2 warrant liabilities as of December 31, 2023 and 2024:

Balance as of March 31, 2023$7,989 
Issuance of warrants1,194 
Change in fair value of warrant liabilities(7,340)
Balance as of December 31, 2023$1,843 
Balance as of March 31, 2024$4,046 
Issuance of warrants
3,157 
Exercise of warrants
(30,118)
Change in fair value of warrant liabilities56,408 
Repricing adjustment512 
Balance as of December 31, 2024$34,005 
v3.25.0.1
NET LOSS PER SHARE (Tables)
9 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities
Three Months Ended December 31,Nine Months Ended December 31,
2024202320242023
Stock Awards181 — 76 17 
Warrants678 608 845 608 
v3.25.0.1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES- Narrative (Details)
$ in Millions
Jan. 25, 2025
USD ($)
Aug. 15, 2024
Subsequent Event | Standby Equity Purchase Agreement    
Class of Stock    
Sale of stock, term 3 years  
Minimum    
Class of Stock    
Stock split conversion ratio   0.2
Maximum    
Class of Stock    
Stock split conversion ratio   0.05
Maximum | Subsequent Event | Standby Equity Purchase Agreement    
Class of Stock    
Proceeds from issuance of stock, net $ 200  
v3.25.0.1
REVENUE - Narrative (Details)
$ in Thousands
9 Months Ended
Dec. 31, 2024
USD ($)
region
segment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction  
Number of reportable segments | segment 1
Number of geographic regions operated (regions) | region 3
Revenue, remaining performance obligation, amount $ 122,573
Revenue, remaining performance obligation, amount, invoiced 105,400
Remaining performance obligation, amount, uninvoiced $ 17,200
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction  
Remaining performance obligation, timing of satisfaction 13 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction  
Remaining performance obligation, timing of satisfaction 60 months
v3.25.0.1
REVENUE - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue        
Total revenue $ 72,551 $ 71,926 $ 214,364 $ 240,099
Americas        
Disaggregation of Revenue        
Total revenue $ 34,857 $ 34,441 $ 111,385 $ 132,158
Americas | Revenue Benchmark | Geographic Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 48.00% 47.00% 52.00% 55.00%
EMEA        
Disaggregation of Revenue        
Total revenue $ 27,312 $ 27,068 $ 73,363 $ 76,843
EMEA | Revenue Benchmark | Geographic Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 38.00% 38.00% 34.00% 32.00%
APAC        
Disaggregation of Revenue        
Total revenue $ 8,056 $ 8,375 $ 22,024 $ 23,863
APAC | Revenue Benchmark | Geographic Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 11.00% 12.00% 10.00% 10.00%
Product revenue        
Disaggregation of Revenue        
Total revenue $ 38,610 $ 37,113 $ 116,389 $ 138,635
Product revenue | Americas        
Disaggregation of Revenue        
Total revenue 18,294 16,159 62,410 78,287
Product revenue | EMEA        
Disaggregation of Revenue        
Total revenue 15,235 14,786 39,892 42,609
Product revenue | APAC        
Disaggregation of Revenue        
Total revenue 5,081 6,168 14,087 17,739
Service and subscription        
Disaggregation of Revenue        
Total revenue 31,615 32,771 90,383 94,229
Service and subscription | Americas        
Disaggregation of Revenue        
Total revenue 16,563 18,282 48,975 53,871
Service and subscription | EMEA        
Disaggregation of Revenue        
Total revenue 12,077 12,282 33,471 34,234
Service and subscription | APAC        
Disaggregation of Revenue        
Total revenue 2,975 2,207 7,937 6,124
Primary storage systems        
Disaggregation of Revenue        
Total revenue $ 12,404 $ 12,887 $ 41,034 $ 41,394
Primary storage systems | Revenue Benchmark | Product Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 17.00% 18.00% 19.00% 17.00%
Secondary storage systems        
Disaggregation of Revenue        
Total revenue $ 23,276 $ 20,206 $ 60,787 $ 82,118
Secondary storage systems | Revenue Benchmark | Product Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 33.00% 28.00% 28.00% 34.00%
Device and media        
Disaggregation of Revenue        
Total revenue $ 7,575 $ 7,716 $ 24,254 $ 23,801
Device and media | Revenue Benchmark | Product Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 10.00% 11.00% 11.00% 10.00%
Service revenue        
Disaggregation of Revenue        
Total revenue $ 26,970 $ 29,075 $ 80,697 $ 85,551
Service revenue | Revenue Benchmark | Product Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 37.00% 40.00% 38.00% 36.00%
Royalty        
Disaggregation of Revenue        
Total revenue $ 2,326 $ 2,042 $ 7,592 $ 7,235
Royalty | Revenue Benchmark | Geographic Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 3.00% 3.00% 4.00% 3.00%
Royalty | Revenue Benchmark | Product Concentration Risk        
Disaggregation of Revenue        
Concentration risk (as a percent) 3.00% 3.00% 4.00% 3.00%
Subscription revenue        
Disaggregation of Revenue        
Total revenue $ 4,600 $ 2,300 $ 11,300 $ 4,800
v3.25.0.1
REVENUE - Certain Information Related to Contract Liabilities (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2024
Revenue from Contract with Customer [Abstract]    
Deferred revenue $ 105,266 $ 116,687
Revenue recognized in the period from amounts included in contract liabilities at the beginning of the period $ 64,539 $ 76,304
v3.25.0.1
REVENUE - Remaining Performance Obligations (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Revenue from Contract with Customer [Abstract]  
Current $ 84,644
Non-Current 37,929
Total $ 122,573
v3.25.0.1
REVENUE - Deferred Revenue, by Arrangement, Disclosure (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Disaggregation of Revenue    
Total $ 105,266 $ 116,687
1 year or less 69,916 $ 78,511
1 – 3 Years 30,588  
3 year or greater 4,762  
Service revenue    
Disaggregation of Revenue    
Total 84,624  
1 year or less 60,782  
1 – 3 Years 21,815  
3 year or greater 2,027  
Subscription revenue    
Disaggregation of Revenue    
Total 20,642  
1 year or less 9,134  
1 – 3 Years 8,773  
3 year or greater $ 2,735  
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Manufacturing Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Inventories    
Finished goods $ 9,741 $ 7,074
Work in progress 1,399 770
Raw materials 7,721 9,909
Total manufacturing inventories $ 18,861 $ 17,753
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Service Parts Inventories (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]    
Finished goods $ 1,377 $ 3,660
Component parts 507 6,123
Total service parts inventories $ 1,884 $ 9,783
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Intangible Assets, Net (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Finite-Lived Intangible Assets    
Gross $ 13,411 $ 13,411
Accumulated Amortization (12,902) (11,742)
Net 509 1,669
Developed technology    
Finite-Lived Intangible Assets    
Gross 9,013 9,013
Accumulated Amortization (9,013) (8,550)
Net 0 463
Customer lists    
Finite-Lived Intangible Assets    
Gross 4,398 4,398
Accumulated Amortization (3,889) (3,192)
Net $ 509 $ 1,206
v3.25.0.1
BALANCE SHEET INFORMATION - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]          
Intangible assets amortization expense $ 200,000 $ 800,000 $ 1,200,000 $ 3,000,000  
Weighted-average remaining amortization period (in years) 7 months 6 days   7 months 6 days    
Goodwill $ 12,969,000   $ 12,969,000   $ 12,969,000
Goodwill impairment loss     $ 0   $ 0
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Estimated Future Amortization Expense (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Fiscal year ending    
Remainder of 2025 $ 228  
2026 281  
Net $ 509 $ 1,669
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Other Long Term Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Offsetting [Abstract]    
Capitalized SaaS implementation costs for internal use $ 14,786 $ 15,349
Capitalized debt costs 3,292 1,923
Contract asset 1,264 1,477
Deferred taxes 711 734
Other 759 257
Total other long-term assets $ 20,812 $ 19,740
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Other Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Balance Sheet Related Disclosures [Abstract]    
Accrued expenses $ 8,093 $ 4,251
Asset retirement obligation 3,683 2,069
Accrued warranty 1,195 1,545
Accrued interest 506 524
Lease liability 1,227 1,256
Accrued income taxes 390 1,044
Other 4,014 3,297
Total other accrued liabilities $ 19,108 $ 13,986
Operating Lease, Liability, Current, Statement of Financial Position Total other accrued liabilities Total other accrued liabilities
v3.25.0.1
BALANCE SHEET INFORMATION - Schedule of Change in Accrued Warranty Balance (Details) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2024
Mar. 31, 2024
Change in accrued warranty:    
Beginning balance $ 1,545 $ 2,094
Current period accruals 1,696 2,563
Adjustments to prior estimates 46 (141)
Charges incurred (2,092) (2,971)
Ending balance $ 1,195 $ 1,545
v3.25.0.1
DEBT - Schedule of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Debt Instrument    
Less: current portion $ (136,109) $ (109,100)
Less: unamortized debt issuance costs (7,271) (5,446)
Term debt, net of current portion 0 0
Term Loan | Senior Secured Debt    
Debt Instrument    
Term Loan 105,880 87,942
PNC Credit Facility | Line of Credit    
Debt Instrument    
PNC Credit Facility $ 37,500 $ 26,604
v3.25.0.1
DEBT - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Aug. 31, 2024
Aug. 14, 2024
May 24, 2024
Feb. 14, 2024
Jun. 01, 2023
Dec. 31, 2024
Jun. 30, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Sep. 30, 2024
Aug. 13, 2024
Jul. 31, 2024
Jul. 11, 2024
May 31, 2024
Mar. 31, 2024
Aug. 05, 2021
Debt Instrument                                  
Borrowings of long-term debt, net of debt issuance costs                 $ 25,000,000 $ 14,083,000              
Repayments of long-term debt                 14,092,000 4,497,000              
Loss on debt extinguishment           $ 0   $ 0 3,003,000 0              
Warrants fair value disclosure           34,005,000     34,005,000             $ 4,046,000  
Borrowings of credit facility                 311,135,000 318,223,000              
Paid-in-kind interest                 3,515,000 $ 1,401,000              
Term debt           $ 98,609,000     $ 98,609,000             82,496,000  
2024 Term Loan Warrants                                  
Debt Instrument                                  
Issuance and sale of warrants     $ 800,000                            
July 2024 Warrants                                  
Debt Instrument                                  
Warrant exercise price (in dollars per share)           $ 6.20     $ 6.20         $ 8.20      
Warrants fair value disclosure           $ 989,000     $ 989,000                
Warrants to purchase (in shares)                           50,000      
August 2024 Warrants                                  
Debt Instrument                                  
Warrant exercise price (in dollars per share)           $ 6.20     $ 6.20                
Issuance and sale of warrants $ 1,200,000                                
Warrants fair value disclosure           $ 11,814,000     $ 11,814,000                
Amended PNC Credit Facility                                  
Debt Instrument                                  
Line of credit facility daily minimum liquidity                       $ 10,000,000       $ 15,000,000  
PNC Credit Facility | Line of Credit                                  
Debt Instrument                                  
Line of credit facility, maximum borrowing amount                                 $ 40,000,000
Debt issuance cost                         $ 100,000        
Stated interest rate (as a percent)           9.66%     9.66%                
Fee amount 700,000     $ 200,000 $ 700,000                        
Line of credit facility, remaining borrowing amount           $ 39,100,000     $ 39,100,000                
Line of credit, current borrowing capacity           $ 1,600,000     $ 1,600,000                
PNC Credit Facility | Senior Secured Debt                                  
Debt Instrument                                  
Debt issuance cost                             $ 500,000    
Fee amount     500,000                            
Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Line of credit facility, maximum borrowing amount $ 26,300,000                                
Borrowings of long-term debt, net of debt issuance costs         15,000,000                        
Debt issuance cost         $ 900,000                        
Stated interest rate (as a percent) 5.00%       9.00%                        
Warrants issued (in shares) 380,510                                
Warrant exercise price (in dollars per share) $ 6.20                                
Debt settlement fees       1,200,000                          
Debt instrument, amendment fees     $ 800,000 $ 100,000                          
Repayments of long-term debt             $ 12,300,000                    
Loss on debt extinguishment $ 3,000,000           $ 700,000                    
Line of credit facility, maximum borrowing amount, net 25,000,000                                
Borrowings of credit facility 10,500,000                                
Line of credit facility, remaining borrowing amount 15,800,000                                
Term Loan | Senior Secured Debt | Related Party                                  
Debt Instrument                                  
Term debt                     $ 19,600,000            
Term Loan | Senior Secured Debt | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent)         10.00%                        
Term Loan | Senior Secured Debt | Term Loan Warrant                                  
Debt Instrument                                  
Warrants issued (in shares)     100,000   60,000.00                        
Fee amount         $ 700,000                        
Term Loan | Senior Secured Debt | July 2024 Warrants                                  
Debt Instrument                                  
Warrants fair value disclosure                         $ 400,000        
Term Loan | Senior Secured Debt | August 2024 Warrants                                  
Debt Instrument                                  
Warrants fair value disclosure 2,000,000                                
Term Loan | Term Loan | Term Loan Warrant                                  
Debt Instrument                                  
Warrant exercise price (in dollars per share)     $ 9.20   $ 20.00                        
2021 Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Stated interest rate (as a percent)           14.59%     14.59%                
Term Loan Credit Agreement | Senior Secured Debt | August 2024 Warrants                                  
Debt Instrument                                  
Paid-in-kind interest $ 500,000                                
2023 Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Stated interest rate (as a percent)           14.34%     14.34%                
2024 Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Stated interest rate (as a percent)           16.59%     16.59%                
Domestic Rate and Swing Line Loans | Line of Credit                                  
Debt Instrument                                  
Stated interest rate (as a percent)           11.25%     11.25%                
Covenant Period One | PNC Credit Facility | Line of Credit                                  
Debt Instrument                                  
Applicable margin rate, percent (as a percent)   4.75%                              
Covenant Period One | PNC Credit Facility | Line of Credit | Minimum | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent)   0.00%                              
Covenant Period One | Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Stated interest rate (as a percent) 11.00%                                
Paid-in-kind interest rate margin (as a percent) 6.00%                                
Covenant Period One | Term Loan | Senior Secured Debt | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent) 12.00%                                
Covenant Period One | 2021 Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Paid-in-kind interest rate margin (as a percent)   3.75%                              
Debt instrument amortization rate (as a percent)   5.00%                              
Applicable margin rate, percent (as a percent)   9.75%                              
Covenant Period One | 2021 Term Loan | Senior Secured Debt | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent)   1.00%                              
Covenant Period One | 2021 Term Loan | Senior Secured Debt | ABR                                  
Debt Instrument                                  
Variable rate (as a percent)   1.75%                              
Covenant Period One | 2021 Term Loan | Senior Secured Debt | Federal Funds Rate                                  
Debt Instrument                                  
Variable rate (as a percent)   0.50%                              
Covenant Period One | 2021 Term Loan | Senior Secured Debt | Prime Rate                                  
Debt Instrument                                  
Variable rate (as a percent)   8.75%                              
Covenant Period Two | PNC Credit Facility | Line of Credit                                  
Debt Instrument                                  
Applicable margin rate, percent (as a percent)   3.75%                              
Covenant Period Two | PNC Credit Facility | Line of Credit | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent)   1.00%                              
Covenant Period Two | PNC Credit Facility | Line of Credit | Overnight Banking Fund Rate                                  
Debt Instrument                                  
Variable rate (as a percent)   0.50%                              
Covenant Period Two | Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Stated interest rate (as a percent) 13.00%                                
Paid-in-kind interest rate margin (as a percent) 8.00%                                
Covenant Period Two | Term Loan | Senior Secured Debt | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent) 14.00%                                
Covenant Period Two | 2021 Term Loan | Senior Secured Debt                                  
Debt Instrument                                  
Paid-in-kind interest rate margin (as a percent)   3.75%                              
Applicable margin rate, percent (as a percent)   9.75%                              
Debt instrument, step-up fee, percent (as a percent)   1.00%                              
Covenant Period Two | 2021 Term Loan | Senior Secured Debt | Paid in Kind Threshold One                                  
Debt Instrument                                  
Debt instrument, net leverage ratio   4.00                              
Covenant Period Two | 2021 Term Loan | Senior Secured Debt | Paid in Kind Threshold Two                                  
Debt Instrument                                  
Debt instrument, net leverage ratio   3.50                              
Covenant Period Two | 2021 Term Loan | Senior Secured Debt | ABR                                  
Debt Instrument                                  
Variable rate (as a percent)   8.75%                              
Covenant Period Two | 2021 Term Loan | Senior Secured Debt | Minimum | SOFR                                  
Debt Instrument                                  
Variable rate (as a percent)   2.00%                              
v3.25.0.1
FAIR VALUE OF FINANCIAL INSTRUMENTS - Debt (Details) - Level 2 fair value measurements - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Carrying Value | Term Loan    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Term Loan $ 105,880 $ 87,942
Carrying Value | PNC Credit Facility | Line of Credit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
PNC Credit Facility 37,500 26,604
Fair Value | Term Loan    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
Term Loan 96,780 75,143
Fair Value | PNC Credit Facility | Line of Credit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis    
PNC Credit Facility $ 34,470 $ 24,743
v3.25.0.1
LEASES - Supplemental Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Leases [Abstract]    
Operating lease right-of-use asset $ 8,670 $ 9,425
Operating lease liability within other accrued liabilities 1,227 1,256
Operating lease liability, net 9,067 9,621
Total operating lease liabilities $ 10,294 $ 10,877
Operating Lease, Liability, Current, Statement of Financial Position Other accrued liabilities Other accrued liabilities
v3.25.0.1
LEASES - Lease Cost (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]        
Operating lease cost $ 716 $ 710 $ 2,207 $ 2,316
Variable lease cost 69 51 221 233
Total lease cost $ 785 $ 761 $ 2,428 $ 2,549
v3.25.0.1
LEASES - Schedule of Lessee Operating Lease Liability Maturity (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Mar. 31, 2024
Maturity of Lease Liabilities    
Remainder of fiscal year 2025 $ 670  
2026 2,276  
2027 1,770  
2028 1,550  
2029 1,228  
Thereafter 12,095  
Total lease payments 19,589  
Less: imputed interest (9,295)  
Present value of lease liabilities $ 10,294 $ 10,877
v3.25.0.1
LEASES - Supplemental Balance Sheet Information (Details)
Dec. 31, 2024
Mar. 31, 2024
Weighted average remaining lease term and discount rate    
Weighted average remaining operating lease term (years) 10 years 3 months 10 years 10 months 6 days
Weighted average discount rate for operating leases 12.60% 12.70%
v3.25.0.1
LEASES - Narrative (Details) - USD ($)
$ in Millions
9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating cash flows from operating leases $ 2.1 $ 2.3
v3.25.0.1
RESTRUCTURING CHARGES - Summary of Restructuring Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Restructuring Reserve        
Restructuring charges $ 1,342 $ 497 $ 2,916 $ 3,164
Severance and Benefits        
Restructuring Reserve        
Beginning balance     0 0
Restructuring charges     2,916 3,164
Cash payments     (2,849) (3,164)
Other non-cash     (67)  
Ending balance $ 0 $ 0 $ 0 $ 0
v3.25.0.1
COMMON STOCK - Narrative (Details) - $ / shares
9 Months Ended
Aug. 15, 2024
Dec. 31, 2024
Dec. 30, 2024
Aug. 26, 2024
Mar. 31, 2024
Jun. 30, 2023
Jun. 30, 2020
Jun. 16, 2020
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Common stock, par value (in dollars per share) $ 0.01 $ 0.01   $ 0.01 $ 0.01      
Number shares under warrant (in shares)   678,000     604,000      
Senior Secured Term Loan                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Minimum registrable securities to request a S-1 (in percent)               40.00%
Amended and Restated Warrants                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Warrants to purchase (in shares)   61,270   430,711        
Warrant exercise price (in dollars per share)   $ 6.20   $ 6.20        
Cashless warrants exercised (in shares)   467,248            
Number shares under warrant (in shares)     405,978          
June 2020 Warrants                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Warrant exercise price (in dollars per share)         $ 55.40      
Number shares under warrant (in shares)   114,000     184,000      
June 2023 Warrants                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Warrant exercise price (in dollars per share)   $ 6.20     $ 20.00      
Number shares under warrant (in shares)   63,000     63,000      
Advisor | June 2020 Warrants                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Warrant exercise price (in dollars per share)             $ 60.00  
Additional warrants issues (in shares)             2,500  
Advisor | June 2023 Warrants                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Warrant exercise price (in dollars per share)           $ 20.00    
Additional warrants issues (in shares)           2,500    
2023 Long Term Incentive Plan                
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]                
Common stock for future issuance (in shares) 250,000              
v3.25.0.1
COMMON STOCK - Schedule of Outstanding Lender Warrants (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
Dec. 31, 2024
Jul. 11, 2024
Mar. 31, 2024
Class of Warrant or Right      
Number shares under warrant (in shares) 678   604
Fair value $ 34,005   $ 4,046
December 2018 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share)     $ 26.60
Number shares under warrant (in shares) 220   357
Fair value $ 10,518   $ 2,320
December 2018 Warrants | Minimum      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20    
December 2018 Warrants | Maximum      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 26.04    
June 2020 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share)     $ 55.40
Number shares under warrant (in shares) 114   184
Fair value $ 5,369   $ 1,135
June 2020 Warrants | Minimum      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20    
June 2020 Warrants | Maximum      
Class of Warrant or Right      
Exercise price (in dollars per share) 54.19    
June 2023 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20   $ 20.00
Number shares under warrant (in shares) 63   63
Fair value $ 3,336   $ 591
May 2024 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20    
Number shares under warrant (in shares) 38    
Fair value $ 1,979    
July 2024 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20 $ 8.20  
Number shares under warrant (in shares) 19    
Fair value $ 989    
August 2024 Warrants      
Class of Warrant or Right      
Exercise price (in dollars per share) $ 6.20    
Number shares under warrant (in shares) 224    
Fair value $ 11,814    
v3.25.0.1
COMMON STOCK - Level 2 Warrants Rollforward (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Warrants Activity        
Change in fair value of warrant liabilities $ 61,630 $ (2,213) $ 56,414 $ (7,341)
Derivative Liability, Statement of Financial Position [Extensible Enumeration] Warrant liabilities Warrant liabilities Warrant liabilities Warrant liabilities
Level 2 fair value measurements        
Warrants Activity        
Beginning balance     $ 4,046 $ 7,989
Issuance and sale of warrants     3,157 1,194
Warrants exercised     (30,118)  
Change in fair value of warrant liabilities     56,408 (7,340)
Repricing adjustment     512  
Ending balance $ 34,005 $ 1,843 $ 34,005 $ 1,843
v3.25.0.1
NET LOSS PER SHARE - Anti-Dilutive Shares Excluded from the Computations of Diluted Net Income (Loss) (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Stock Awards        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Anti-dilutive shares excluded (in shares) 181 0 76 17
Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share        
Anti-dilutive shares excluded (in shares) 678 608 845 608
v3.25.0.1
NET LOSS PER SHARE - Narrative (Details)
9 Months Ended
Dec. 31, 2024
shares
Restricted Stock Units (RSUs)  
Antidilutive Securities Excluded from Computation of Earnings Per Share  
Anti-dilutive shares excluded (in shares) 170,750
v3.25.0.1
INCOME TAXES (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Income Tax Contingency        
Effective income tax rate (as a percent) (0.10%) (5.50%) (0.60%) (7.60%)
Unrecognized tax benefits $ 90.9   $ 90.9  
Unrecognized tax benefits that would impact effective tax rate 78.5   78.5  
Accrued interest and penalties related to unrecognized tax benefits 1.4   1.4  
Deferred tax assets, gross 12.8   12.8  
Deferred tax assets, valuation allowance 11.8   11.8  
Deferred tax assets, net of valuation allowance 1.0   1.0  
Other long-term assets        
Income Tax Contingency        
Unrecognized tax benefits 83.2   83.2  
Other long-term liabilities        
Income Tax Contingency        
Unrecognized tax benefits $ 7.8   $ 7.8  
v3.25.0.1
COMMITMENTS AND CONTINGENCIES (Details) - USD ($)
$ in Millions
Jul. 27, 2023
Dec. 31, 2024
Loss Contingencies    
Remaining purchase commitments   $ 29.5
Arrow Electronics Matter    
Loss Contingencies    
Loss contingency, damages sought $ 4.0  
v3.25.0.1
SUBSEQUENT EVENTS - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
9 Months Ended
Jan. 25, 2025
Jan. 03, 2025
Dec. 31, 2024
Dec. 30, 2024
Aug. 26, 2024
Mar. 31, 2024
Subsequent Event            
Number shares under warrant (in shares)     678,000     604,000
Subsequent Event | Standby Equity Purchase Agreement            
Subsequent Event            
Sale of stock, term 3 years          
Sale of stock, maximum ownership potential threshold (in dollars per share) 19.99%          
Commitment shares (in shares) 42,158          
Subsequent Event | Standby Equity Purchase Agreement | Maximum            
Subsequent Event            
Proceeds from issuance of stock, net $ 200          
Amended and Restated Warrants            
Subsequent Event            
Cashless warrants exercised (in shares)     467,248      
Warrants to purchase (in shares)     61,270   430,711  
Warrant exercise price (in dollars per share)     $ 6.20   $ 6.20  
Number shares under warrant (in shares)       405,978    
Amended and Restated Warrants | Subsequent Event            
Subsequent Event            
Cashless warrants exercised (in shares)   677,905        
Warrants to purchase (in shares)   228,195        
Warrant exercise price (in dollars per share)   $ 35.42        
Number shares under warrant (in shares)   449,710        

Quantum (NASDAQ:QMCO)
Historical Stock Chart
From Jan 2025 to Feb 2025 Click Here for more Quantum Charts.
Quantum (NASDAQ:QMCO)
Historical Stock Chart
From Feb 2024 to Feb 2025 Click Here for more Quantum Charts.